0001104659-26-052679.txt : 20260430 0001104659-26-052679.hdr.sgml : 20260430 20260430142333 ACCESSION NUMBER: 0001104659-26-052679 CONFORMED SUBMISSION TYPE: N-VPFS PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20251231 FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 EFFECTIVENESS DATE: 20260430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EQUITRUST LIFE VARIABLE ACCOUNT CENTRAL INDEX KEY: 0001054819 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: IA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-VPFS SEC ACT: 1940 Act SEC FILE NUMBER: 811-08641 FILM NUMBER: 26923411 BUSINESS ADDRESS: STREET 1: 5400 UNIVERSITY AVE CITY: WEST DES MOINES STATE: IA ZIP: 50266 BUSINESS PHONE: 5152254005 MAIL ADDRESS: STREET 1: 5400 UNIVERSITY AVE CITY: WEST DES MOINES STATE: IA ZIP: 50266 0001054819 S000007263 EQUITRUST LIFE VARIABLE ACCOUNT C000019926 Flexible Premium Variable Life Insurance Policy C000023450 Flexible Premium Last Survivor Variable Life Insurance Policy C000062175 Variable Universal Life Insurance Policy N-VPFS 1 tm262349d3_nvpfs.htm N-VPFS

 

Report of Independent Registered Public Accounting Firm

 

 

 

The Board of Directors and Contract Owners of

EquiTrust Life Variable Account

EquiTrust Life Insurance Company

 

Opinion on the Financial Statements

 

We have audited the accompanying statements of assets and liabilities of each of the subaccounts listed in the Appendix that comprise EquiTrust Life Variable Account (the Accounts) as of December 31, 2025, and the related statements of operations for the year then ended, and the statements of changes in net assets for each of the years in the two-year period then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Accounts as of December 31, 2025, and the results of their operations for the year then ended and changes in net assets for each of the years in the two-year period then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Accounts’ management. Our responsibility is to express an opinion on the Accounts’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Accounts in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Such procedures also included confirmation of securities owned as of December 31, 2025, by correspondence with the fund companies or their transfer agents, as applicable. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Forvis Mazars LLP

 

We have served as the Accounts’ auditor since 2024.

 

West Des Moines, Iowa

April 30, 2026

 

 

 

 

Appendix

 

Subaccounts comprising EquiTrust Life Variable Account

 

Fund Name
Product A & B Product C
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares CVT EAFE International Index Portfolio – Class F
BNY Mellon VIF Appreciation Portfolio - Initial Shares CVT NASDAQ-100 Index Portfolio
BNY Mellon VIF Growth & Income Portfolio - Initial Shares CVT Russell 2000® Small Cap Index Portfolio - Class F
BNY Mellon VIF Small Cap Portfolio - Initial Shares CVT S&P MidCap 400 Index Portfolio - Class F
CVT NASDAQ-100 Index Portfolio Columbia VP Small Cap Value Fund - Class 2
CVT Russell 2000® Small Cap Index Portfolio DWS International Opportunities VIP - Class A
CVT S&P MidCap 400 Index Portfolio Federated Hermes Government Money Fund II - Service Shares
Federated Hermes Government Money Fund II - Service Shares Federated Hermes Managed Volatility Fund II - Primary Shares
Federated Hermes Managed Volatility Fund II - Primary Shares Federated Hermes Quality Bond Fund II - Primary Shares
Federated Hermes Quality Bond Fund II - Primary Shares Fidelity® VIP Contrafund® Portfolio - Service Class 2
Fidelity® VIP Contrafund® Portfolio - Initial Class Fidelity® VIP Growth Portfolio - Service Class 2
Fidelity® VIP Growth & Income Portfolio - Initial Class Fidelity® VIP High Income Portfolio - Service Class 2
Fidelity® VIP Growth Portfolio - Initial Class Fidelity® VIP Index 500 Portfolio - Service Class 2
Fidelity® VIP High Income Portfolio - Service Class 2 Fidelity® VIP Mid Cap Portfolio - Service Class 2
Fidelity® VIP Index 500 Portfolio - Initial Class Fidelity® VIP Real Estate Portfolio - Service Class 2
Fidelity® VIP Mid Cap Portfolio - Service Class 2 Franklin Mutual Shares VIP Fund - Class 2
Fidelity® VIP Overseas Portfolio - Initial Class Franklin Small Cap Value VIP Fund - Class 2
Franklin Global Real Estate VIP Fund - Class 2 Franklin U.S. Government Securities VIP Fund - Class 2
Franklin Mutual Shares VIP Fund - Class 2 Templeton Global Bond VIP Fund - Class 2
Franklin Small Cap Value VIP Fund - Class 2 T. Rowe Price Equity Income Portfolio
Franklin Small-Mid Cap Growth VIP Fund - Class 2 T. Rowe Price International Stock Portfolio
Franklin U.S. Government Securities VIP Fund - Class 2  
Templeton Growth VIP Fund - Class 2  
LVIP American Century Capital Appreciation Fund – Standard II  
LVIP American Century Inflation Protection Fund – Standard II  
LVIP American Century Mid Cap Value Fund – Standard II  
LVIP American Century Ultra Fund – Standard II  
LVIP American Century Value Fund – Standard II  
LVIP JPMorgan Mid Cap Value Fund - Standard  
LVIP JPMorgan Small Cap Core Fund - Standard  
T. Rowe Price All-Cap Opportunities Portfolio  
T. Rowe Price Equity Income Portfolio  
T. Rowe Price Mid-Cap Growth Portfolio  
T. Rowe Price Moderate Allocation Portfolio  
T. Rowe Price International Stock Portfolio  

 

 

 

EquiTrust Life Variable Account
Statements of Assets and Liabilities
December 31, 2025 

 

       Net assets   Investments in mutual funds     

Subaccount

  Investments in
shares of mutual
funds, at fair
value
  

Accumulation
units

  

Total net assets

  

Cost

  

Shares owned

  

Accumulation
units outstanding

 
Product A & B                              
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares  $136,686   $136,686   $136,686   $92,048    2,392.96    2,613.82 
BNY Mellon VIF Appreciation Portfolio - Initial Shares   756,961    756,961    756,961    786,686    22,481.77    11,809.25 
BNY Mellon VIF Growth & Income Portfolio - Initial Shares   244,832    244,832    244,832    188,397    6,154.65    4,143.77 
BNY Mellon VIF Small Cap Portfolio - Initial Shares   441,753    441,753    441,753    413,241    9,203.18    10,978.67 
CVT NASDAQ-100 Index Portfolio   847,655    847,655    847,655    352,137    4,281.52    6,166.41 
CVT Russell 2000® Small Cap Index Portfolio   249,022    249,022    249,022    213,965    2,747.99    4,552.97 
CVT S&P MidCap 400 Index Portfolio   183,397    183,397    183,397    163,202    1,439.20    2,534.85 
Federated Hermes Government Money Fund II - Service Shares   283,351    283,351    283,351    283,351    283,350.93    27,161.61 
Federated Hermes Managed Volatility Fund II - Primary Shares   768,431    768,431    768,431    720,971    73,887.55    33,937.31 
Federated Hermes Quality Bond Fund II - Primary Shares   725,590    725,590    725,590    728,478    68,581.33    54,364.75 
Fidelity® VIP Contrafund® Portfolio - Initial Class   1,204,410    1,204,410    1,204,410    898,700    20,110.37    10,523.98 
Fidelity® VIP Growth & Income Portfolio - Initial Class   356,283    356,283    356,283    263,774    10,683.14    5,483.21 
Fidelity® VIP Growth Portfolio - Initial Class   679,230    679,230    679,230    602,747    6,950.78    7,509.60 
Fidelity® VIP High Income Portfolio - Service Class 2   428,604    428,604    428,604    451,261    92,972.70    12,609.86 
Fidelity® VIP Index 500 Portfolio - Initial Class   883,657    883,657    883,657    397,502    1,338.61    11,815.81 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   613,969    613,969    613,969    598,421    17,457.17    7,226.35 
Fidelity® VIP Overseas Portfolio - Initial Class   220,246    220,246    220,246    189,666    8,003.13    5,950.22 
Franklin Global Real Estate VIP Fund - Class 2   221,886    221,886    221,886    241,153    16,989.72    10,368.13 
Franklin Mutual Shares VIP Fund - Class 2   217,233    217,233    217,233    214,331    13,492.74    5,802.78 
Franklin Small Cap Value VIP Fund - Class 2   286,095    286,095    286,095    263,544    20,626.86    4,394.99 
Franklin Small-Mid Cap Growth VIP Fund - Class 2   228,147    228,147    228,147    233,858    15,943.20    4,775.62 
Franklin U.S. Government Securities VIP Fund - Class 2   292,157    292,157    292,157    318,947    27,824.49    19,516.72 
Templeton Growth VIP Fund - Class 2   151,516    151,516    151,516    119,294    10,707.86    4,982.23 
LVIP American Century Capital Appreciation Fund – Standard II   404,527    404,527    404,527    389,341    26,683.83    6,276.20 
LVIP American Century Inflation Protection Fund – Standard II   24,794    24,794    24,794    27,620    2,746.66    1,583.27 
LVIP American Century Mid Cap Value Fund – Standard II   12,083    12,083    12,083    12,431    624.46    273.30 
LVIP American Century Ultra Fund – Standard II   401,855    401,855    401,855    277,913    12,758.92    4,607.82 
LVIP American Century Value Fund – Standard II   160,992    160,992    160,992    141,830    12,461.68    4,263.45 
LVIP JPMorgan Mid Cap Value Fund - Standard   414,213    414,213    414,213    462,256    45,962.35    5,375.87 
LVIP JPMorgan Small Cap Core Fund - Standard   185,949    185,949    185,949    174,600    8,473.05    3,337.17 
T. Rowe Price All-Cap Opportunities Portfolio   494,821    494,821    494,821    451,830    12,476.57    4,756.58 
T. Rowe Price Equity Income Portfolio   560,118    560,118    560,118    532,615    19,374.53    9,881.04 

 

See accompanying notes, including note 6 which includes per unit information. 

3

 

EquiTrust Life Variable Account
Statements of Assets and Liabilities (continued)
December 31, 2025
 

 

       Net assets   Investments in mutual funds     

Subaccount

  Investments in
shares of mutual
funds, at fair
value
  

Accumulation
units

  

Total net assets

  

Cost

  

Shares owned

  

Accumulation
units outstanding

 
T. Rowe Price Mid-Cap Growth Portfolio  $257,746   $257,746   $257,746   $275,399    9,837.63    2,276.93 
T. Rowe Price Moderate Allocation Portfolio   654,659    654,659    654,659    598,773    29,186.74    12,999.03 
T. Rowe Price International Stock Portfolio   435,908    435,908    435,908    412,533    27,415.57    16,462.42 
Product C                              
CVT Russell 2000® Small Cap Index Portfolio - Class F  $3,281   $3,281   $3,281   $2,870    36.82    80.79 
CVT S&P MidCap 400 Index Portfolio - Class F   114,541    114,541    114,541    101,782    905.11    4,153.62 
Columbia VP Small Cap Value Fund - Class 2   78,889    78,889    78,889    75,218    6,341.56    1,930.00 
DWS International Opportunities VIP - Class A   1,071    1,071    1,071    841    55.70    42.23 
Federated Hermes Government Money Fund II - Service Shares   2,921    2,921    2,921    2,921    2,920.75    246.05 
Federated Hermes Managed Volatility Fund II - Primary Shares   283    283    283    263    27.18    17.05 
Federated Hermes Quality Bond Fund II - Primary Shares   159,290    159,290    159,290    160,203    15,055.73    10,484.46 
Fidelity® VIP Contrafund® Portfolio - Service Class 2   197,079    197,079    197,079    155,834    3,466.04    2,631.01 
Fidelity® VIP Growth Portfolio - Service Class 2   185,371    185,371    185,371    175,234    1,995.81    2,114.84 
Fidelity® VIP High Income Portfolio - Service Class 2   78,921    78,921    78,921    82,158    17,119.42    3,317.66 
Fidelity® VIP Index 500 Portfolio - Service Class 2   11,080    11,080    11,080    6,609    17.04    154.55 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   76,349    76,349    76,349    73,892    2,170.85    1,655.94 
Fidelity® VIP Real Estate Portfolio - Service Class 2   50,793    50,793    50,793    50,841    2,915.78    1,865.59 
Franklin Mutual Shares VIP Fund - Class 2   177,081    177,081    177,081    171,653    10,998.84    7,435.17 
Franklin Small Cap Value VIP Fund - Class 2   2,839    2,839    2,839    2,581    204.70    67.00 
Franklin U.S. Government Securities VIP Fund - Class 2   152,400    152,400    152,400    163,882    14,514.30    10,905.16 
Templeton Global Bond VIP Fund - Class 2   55,745    55,745    55,745    58,799    4,232.70    5,392.38 
T. Rowe Price Equity Income Portfolio   35,698    35,698    35,698    33,644    1,234.79    815.12 
T. Rowe Price International Stock Portfolio   191,549    191,549    191,549    179,782    12,047.11    8,300.91 

 

See accompanying notes, including note 6 which includes per unit information. 

4

 

EquiTrust Life Variable Account
Statements of Operations
Year Ended December 31, 2025

 

   Income   Expenses           Realized gain (loss) on investments             
Subaccount  Dividends   Mortality and expense risk   Net investment income (loss)   Realized gain (loss) on sale of fund shares   Realized gain distributions   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase in net assets from operations 
Product A & B                                
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares  $72   $(1,135)  $(1,063)  $8,110   $10,327   $18,437   $1,166   $18,540 
BNY Mellon VIF Appreciation Portfolio - Initial Shares   2,670    (6,530)   (3,860)   (10,122)   108,932    98,810    (30,597)   64,353 
BNY Mellon VIF Growth & Income Portfolio - Initial Shares   1,057    (2,123)   (1,066)   10,401    18,567    28,968    5,723    33,625 
BNY Mellon VIF Small Cap Portfolio - Initial Shares   2,779    (3,808)   (1,029)   998    -    998    41,838    41,807 
CVT NASDAQ-100 Index Portfolio   2,153    (7,012)   (4,859)   49,796    12,636    62,432    83,651    141,224 
CVT Russell 2000® Small Cap Index Portfolio   3,638    (2,024)   1,614    1,154    11,836    12,990    11,197    25,801 
CVT S&P MidCap 400 Index Portfolio   2,190    (1,770)   420    8,360    13,182    21,542    (9,959)   12,003 
Federated Hermes Government Money Fund II - Service Shares   10,304    (2,519)   7,785    -    -    -    -    7,785 
Federated Hermes Managed Volatility Fund II - Primary Shares   21,450    (6,692)   14,758    (5,880)   13,086    7,206    23,270    45,234 
Federated Hermes Quality Bond Fund II - Primary Shares   24,092    (6,544)   17,548    (9,266)   -    (9,266)   35,217    43,499 
Fidelity® VIP Contrafund® Portfolio - Initial Class   1,573    (9,950)   (8,377)   61,636    179,280    240,916    (21,058)   211,481 
Fidelity® VIP Growth & Income Portfolio - Initial Class   5,131    (3,098)   2,033    19,374    31,165    50,539    13,049    65,621 
Fidelity® VIP Growth Portfolio - Initial Class   1,872    (5,698)   (3,826)   14,789    82,988    97,777    (9,547)   84,404 
Fidelity® VIP High Income Portfolio - Service Class 2   27,944    (3,713)   24,231    (5,755)   -    (5,755)   18,775    37,251 
Fidelity® VIP Index 500 Portfolio - Initial Class   9,470    (7,359)   2,111    100,004    4,209    104,213    25,397    131,721 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   1,436    (5,138)   (3,702)   1,460    68,800    70,260    (7,432)   59,126 
Fidelity® VIP Overseas Portfolio - Initial Class   3,431    (1,990)   1,441    9,491    19,106    28,597    8,394    38,432 
Franklin Global Real Estate VIP Fund - Class 2   3,057    (1,959)   1,098    (3,288)   -    (3,288)   16,793    14,603 
Franklin Mutual Shares VIP Fund - Class 2   4,240    (1,844)   2,396    (2,664)   20,892    18,228    476    21,100 
Franklin Small Cap Value VIP Fund - Class 2   3,028    (2,490)   538    (13,675)   23,619    9,944    8,965    19,447 
Franklin Small-Mid Cap Growth VIP Fund - Class 2   -    (2,122)   (2,122)   (5,311)   13,467    8,156    (1,880)   4,154 
Franklin U.S. Government Securities VIP Fund - Class 2   10,018    (2,696)   7,322    (7,349)   -    (7,349)   16,989    16,962 
Templeton Growth VIP Fund - Class 2   1,197    (1,225)   (28)   (1,436)   10,279    8,843    19,337    28,152 
LVIP American Century Capital Appreciation Fund – Standard II   -    (3,623)   (3,623)   2,445    65,860    68,305    (42,071)   22,611 
LVIP American Century Inflation Protection Fund – Standard II   1,943    (214)   1,729    (59)   -    (59)   (376)   1,294 
LVIP American Century Mid Cap Value Fund – Standard II   226    (104)   122    73    971    1,044    (256)   910 
LVIP American Century Ultra Fund – Standard II   -    (3,321)   (3,321)   5,977    31,901    37,878    8,299    42,856 
LVIP American Century Value Fund – Standard II   2,485    (1,347)   1,138    2,463    11,727    14,190    6,096    21,424 
LVIP JPMorgan Mid Cap Value Fund - Standard   4,614    (3,782)   832    (5,910)   46,246    40,336    (24,840)   16,328 
LVIP JPMorgan Small Cap Core Fund - Standard   1,107    (1,553)   (446)   (380)   14,162    13,782    2,795    16,131 
T. Rowe Price All-Cap Opportunities Portfolio   -    (4,196)   (4,196)   39,585    54,295    93,880    (19,023)   70,661 
T. Rowe Price Equity Income Portfolio   8,756    (4,762)   3,994    1,720    53,279    54,999    8,520    67,513 

 

See accompanying notes. 

5

 

EquiTrust Life Variable Account
Statements of Operations (continued)
Year Ended December 31, 2025

  

   Income   Expenses           Realized gain (loss) on investments             
Subaccount  Dividends   Mortality and expense risk   Net investment income (loss)   Realized gain (loss) on sale of fund shares   Realized gain distributions   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase in net assets from operations 
T. Rowe Price Mid-Cap Growth Portfolio  $-   $(2,348)  $(2,348)  $395   $32,529   $32,924   $(24,119)  $6,457 
T. Rowe Price Moderate Allocation Portfolio   14,117    (5,564)   8,553    4,557    27,951    32,508    38,284    79,345 
T. Rowe Price International Stock Portfolio   8,153    (3,724)   4,429    2,998    35,810    38,808    22,437    65,674 
Product C                                        
CVT Russell 2000® Small Cap Index Portfolio - Class F  $48   $-   $48   $6   $157   $163   $146   $357 
CVT S&P MidCap 400 Index Portfolio - Class F   1,210    -    1,210    841    7,286    8,127    (1,959)   7,378 
Columbia VP Small Cap Value Fund - Class 2   685    -    685    87    11,794    11,881    (2,484)   10,082 
DWS International Opportunities VIP - Class A   9    -    9    20    -    20    140    169 
Federated Hermes Government Money Fund II - Service Shares   102    -    102    -    -    -    -    102 
Federated Hermes Managed Volatility Fund II - Primary Shares   7    -    7    (1)   5    4    8    19 
Federated Hermes Quality Bond Fund II - Primary Shares   4,947    -    4,947    (738)   -    (738)   6,191    10,400 
Fidelity® VIP Contrafund® Portfolio - Service Class 2   -    -    -    6,634    30,479    37,113    (2,546)   34,567 
Fidelity® VIP Growth Portfolio - Service Class 2   88    -    88    4,890    23,640    28,530    (4,964)   23,654 
Fidelity® VIP High Income Portfolio - Service Class 2   5,095    -    5,095    (1,172)   -    (1,172)   3,412    7,335 
Fidelity® VIP Index 500 Portfolio - Service Class 2   95    -    95    131    52    183    1,374    1,652 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   178    -    178    671    8,394    9,065    (1,389)   7,854 
Fidelity® VIP Real Estate Portfolio - Service Class 2   978    -    978    174    23    197    214    1,389 
Franklin Mutual Shares VIP Fund - Class 2   3,446    -    3,446    (4,325)   16,980    12,655    2,117    18,218 
Franklin Small Cap Value VIP Fund - Class 2   28    -    28    10    221    231    (57)   202 
Franklin U.S. Government Securities VIP Fund - Class 2   4,753    -    4,753    (2,441)   -    (2,441)   7,126    9,438 
Templeton Global Bond VIP Fund - Class 2   -    -    -    (2,097)   -    (2,097)   9,555    7,458 
T. Rowe Price Equity Income Portfolio   546    -    546    12    3,388    3,400    512    4,458 
T. Rowe Price International Stock Portfolio   3,578    -    3,578    (1,955)   15,714    13,759    12,275    29,612 

 

See accompanying notes.

6

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets
For the Year Ended December 31, 2025

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2024   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2025 
Product A & B                                                                 
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares   $139,161   $(1,063)  $18,437   $1,166   $18,540   $2,016   $(19,368)  $-   $(3,647)  $(16)  $(21,015)  $(2,475)  $136,686 
BNY Mellon VIF Appreciation Portfolio - Initial Shares    726,710    (3,860)   98,810    (30,597)   64,353    20,305    (28,703)   (1,325)   (24,113)   (266)   (34,102)   30,251    756,961 
BNY Mellon VIF Growth & Income Portfolio - Initial Shares    249,473    (1,066)   28,968    5,723    33,625    4,908    (16,178)   (17,870)   (8,577)   (549)   (38,266)   (4,641)   244,832 
BNY Mellon VIF Small Cap Portfolio - Initial Shares    428,054    (1,029)   998    41,838    41,807    18,228    (24,637)   (5,461)   (15,563)   (675)   (28,108)   13,699    441,753 
CVT NASDAQ-100 Index Portfolio    752,045    (4,859)   62,432    83,651    141,224    5,560    (15,346)   -    (35,923)   95    (45,614)   95,610    847,655 
CVT Russell 2000® Small Cap Index Portfolio    222,898    1,614    12,990    11,197    25,801    8,512    -    (146)   (8,019)   (24)   323    26,124    249,022 
CVT S&P MidCap 400 Index Portfolio    204,684    420    21,542    (9,959)   12,003    6,016    (23,942)   (258)   (14,440)   (666)   (33,290)   (21,287)   183,397 
Federated Hermes Government Money Fund II - Service Shares    279,976    7,785    -    -    7,785    21,525    (11,015)   (422)   (14,482)   (16)   (4,410)   3,375    283,351 
Federated Hermes Managed Volatility Fund II - Primary Shares    760,549    14,758    7,206    23,270    45,234    37,469    (34,981)   (2,019)   (36,807)   (1,014)   (37,352)   7,882    768,431 
Federated Hermes Quality Bond Fund II - Primary Shares   749,191    17,548    (9,266)   35,217    43,499    40,611    (65,741)   (4,370)   (36,823)   (777)   (67,100)   (23,601)   725,590 
Fidelity® VIP Contrafund® Portfolio - Initial Class    1,115,252    (8,377)   240,916    (21,058)   211,481    22,124    (85,172)   (16,314)   (42,750)   (211)   (122,323)   89,158    1,204,410 
Fidelity® VIP Growth & Income Portfolio - Initial Class   325,630    2,033    50,539    13,049    65,621    10,294    (29,636)   -    (14,008)   (1,618)   (34,968)   30,653    356,283 
Fidelity® VIP Growth Portfolio - Initial Class    616,416    (3,826)   97,777    (9,547)   84,404    10,134    (14,561)   -    (17,137)   (26)   (21,590)   62,814    679,230 
Fidelity® VIP High Income Portfolio - Service Class 2    419,311    24,231    (5,755)   18,775    37,251    18,189    (26,629)   (1,458)   (17,981)   (79)   (27,958)   9,293    428,604 
Fidelity® VIP Index 500 Portfolio - Initial Class    865,217    2,111    104,213    25,397    131,721    13,100    (99,950)   (4,722)   (22,143)   434    (113,281)   18,440    883,657 
Fidelity® VIP Mid Cap Portfolio - Service Class 2    587,835    (3,702)   70,260    (7,432)   59,126    18,377    (18,023)   (10,192)   (22,916)   (238)   (32,992)   26,134    613,969 

 

See accompanying notes.

7

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets (continued)
For the Year Ended December 31, 2025
 

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2024   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2025 
Fidelity® VIP Overseas Portfolio - Initial Class  $200,241   $1,441   $28,597   $8,394   $38,432   $7,060   $(14,825)  $(3,704)  $(6,500)  $(458)  $(18,427)  $20,005   $220,246 
Franklin Global Real Estate VIP Fund - Class 2   211,107    1,098    (3,288)   16,793    14,603    13,309    (2,372)   (2,609)   (11,924)   (228)   (3,824)   10,779    221,886 
Franklin Mutual Shares VIP Fund - Class 2   205,160    2,396    18,228    476    21,100    6,999    (8,262)   (1,075)   (6,630)   (59)   (9,027)   12,073    217,233 
Franklin Small Cap Value VIP Fund - Class 2   315,205    538    9,944    8,965    19,447    8,803    (45,891)   (2,190)   (9,177)   (102)   (48,557)   (29,110)   286,095 
Franklin Small-Mid Cap Growth VIP Fund - Class 2   239,464    (2,122)   8,156    (1,880)   4,154    9,524    (14,908)   (404)   (9,668)   (15)   (15,471)   (11,317)   228,147 
Franklin U.S. Government Securities VIP Fund - Class 2   301,593    7,322    (7,349)   16,989    16,962    15,023    (25,460)   (283)   (15,057)   (621)   (26,398)   (9,436)   292,157 
Templeton Growth VIP Fund - Class 2   127,003    (28)   8,843    19,337    28,152    6,837    (5,596)   -    (4,862)   (18)   (3,639)   24,513    151,516 
LVIP American Century Capital Appreciation Fund – Standard II   389,915    (3,623)   68,305    (42,071)   22,611    13,352    (2,560)   (3,461)   (15,289)   (41)   (7,999)   14,612    404,527 
LVIP American Century Inflation Protection Fund – Standard II   22,628    1,729    (59)   (376)   1,294    1,211    -    -    (339)   -    872    2,166    24,794 
LVIP American Century Mid Cap Value Fund – Standard II   11,357    122    1,044    (256)   910    1,118    -    -    (1,284)   (18)   (184)   726    12,083 
LVIP American Century Ultra Fund – Standard II   365,403    (3,321)   37,878    8,299    42,856    7,478    -    -    (13,850)   (32)   (6,404)   36,452    401,855 
LVIP American Century Value Fund – Standard II   149,995    1,138    14,190    6,096    21,424    5,577    (7,845)   (946)   (7,159)   (54)   (10,427)   10,997    160,992 
LVIP JPMorgan Mid Cap Value Fund - Standard   439,001    832    40,336    (24,840)   16,328    14,841    (36,481)   (1,161)   (18,059)   (256)   (41,116)   (24,788)   414,213 
LVIP JPMorgan Small Cap Core Fund - Standard   182,536    (446)   13,782    2,795    16,131    5,228    (10,264)   -    (7,678)   (4)   (12,718)   3,413    185,949 
T. Rowe Price All-Cap Opportunities Portfolio   537,830    (4,196)   93,880    (19,023)   70,661    8,024    (104,295)   (3,570)   (13,558)   (271)   (113,670)   (43,009)   494,821 
T. Rowe Price Equity Income Portfolio   523,623    3,994    54,999    8,520    67,513    15,900    (21,580)   (1,977)   (23,281)   (80)   (31,018)   36,495    560,118 

 

See accompanying notes.

8

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets (continued)
For the Year Ended December 31, 2025
  

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2024   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2025 
T. Rowe Price Mid-Cap Growth Portfolio  $274,557   $(2,348)  $32,924   $(24,119)  $6,457   $6,064   $(17,642)  $(3,585)  $(7,593)  $(512)  $(23,268)  $(16,811)  $257,746 
T. Rowe Price Moderate Allocation Portfolio   608,200    8,553    32,508    38,284    79,345    27,280    (31,860)   (3,074)   (25,005)   (227)   (32,886)   46,459    654,659 
T. Rowe Price International Stock Portfolio   388,243    4,429    38,808    22,437    65,674    14,868    (15,682)   (1,789)   (15,308)   (98)   (18,009)   47,665    435,908 
Product C                                                                 
CVT Russell 2000® Small Cap Index Portfolio - Class F  $2,822   $48   $163   $146   $357   $151   $-   $-   $(49)  $-   $102   $459   $3,281 
CVT S&P MidCap 400 Index Portfolio - Class F   115,739    1,210    8,127    (1,959)   7,378    5,272    -    -    (5,283)   (8,565)   (8,576)   (1,198)   114,541 
Columbia VP Small Cap Value Fund - Class 2   73,694    685    11,881    (2,484)   10,082    3,260    -    -    (3,202)   (4,945)   (4,887)   5,195    78,889 
DWS International Opportunities VIP - Class A   885    9    20    140    169    104    -    -    (87)   -    17    186    1,071 
Federated Hermes Government Money Fund II - Service Shares   2,587    102    -    -    102    396    -    -    (164)   -    232    334    2,921 
Federated Hermes Managed Volatility Fund II - Primary Shares   257    7    4    8    19    30    -    -    (23)   -    7    26    283 
Federated Hermes Quality Bond Fund II - Primary Shares   153,897    4,947    (738)   6,191    10,400    9,944    -    -    (6,920)   (8,031)   (5,007)   5,393    159,290 
Fidelity® VIP Contrafund® Portfolio - Service Class 2   175,594    -    37,113    (2,546)   34,567    6,629    -    -    (7,987)   (11,724)   (13,082)   21,485    197,079 
Fidelity® VIP Growth Portfolio - Service Class 2   173,056    88    28,530    (4,964)   23,654    6,428    -    -    (7,285)   (10,482)   (11,339)   12,315    185,371 
Fidelity® VIP High Income Portfolio - Service Class 2   75,100    5,095    (1,172)   3,412    7,335    4,300    -    -    (3,465)   (4,349)   (3,514)   3,821    78,921 
Fidelity® VIP Index 500 Portfolio - Service Class 2   9,348    95    183    1,374    1,652    375    -    -    (295)   -    80    1,732    11,080 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   72,031    178    9,065    (1,389)   7,854    3,188    -    -    (2,823)   (3,901)   (3,536)   4,318    76,349 

 

See accompanying notes.

9

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets (continued)
For the Year Ended December 31, 2025 

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2024   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2025 
Fidelity® VIP Real Estate Portfolio - Service Class 2   $52,356   $978   $197   $214   $1,389   $2,721   $-   $-   $(2,284)  $(3,389)  $(2,952)  $(1,563)  $50,793 
Franklin Mutual Shares VIP Fund - Class 2   172,796    3,446    12,655    2,117    18,218    8,561    -    -    (8,644)   (13,850)   (13,933)   4,285    177,081 
Franklin Small Cap Value VIP Fund - Class 2   2,585    28    231    (57)   202    151    -    -    (99)   -    52    254    2,839 
Franklin U.S. Government Securities VIP Fund - Class 2   147,478    4,753    (2,441)   7,126    9,438    9,886    -    -    (6,674)   (7,728)   (4,516)   4,922    152,400 
Templeton Global Bond VIP Fund - Class 2   50,519    -    (2,097)   9,555    7,458    3,998    -    -    (2,830)   (3,400)   (2,232)   5,226    55,745 
T. Rowe Price Equity Income Portfolio   30,767    546    3,400    512    4,458    1,114    -    -    (641)   -    473    4,931    35,698 
T. Rowe Price International Stock Portfolio   172,194    3,578    13,759    12,275    29,612    9,319    -    -    (8,239)   (11,337)   (10,257)   19,355    191,549 

 

See accompanying notes.

10

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets
For the Year Ended December 31, 2024
 

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2023   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase (decrease) in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2024 
Product A & B                                                    
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares  $130,149   $(793)  $9,959   $21,766   $30,932   $2,289   $-   $(34)  $(4,139)  $(20,036)  $(21,920)  $9,012   $139,161 
BNY Mellon VIF Appreciation Portfolio - Initial Shares   700,817    (3,570)   49,583    36,268    82,281    22,597    (48,001)   (3,969)   (25,452)   (1,563)   (56,388)   25,893    726,710 
BNY Mellon VIF Growth & Income Portfolio - Initial Shares   223,162    (895)   15,917    31,856    46,878    5,316    (19,480)   -    (8,366)   1,963    (20,567)   26,311    249,473 
BNY Mellon VIF Small Cap Portfolio - Initial Shares   434,362    (952)   1,316    15,791    16,155    21,169    (956)   -    (16,980)   (25,696)   (22,463)   (6,308)   428,054 
CVT NASDAQ-100 Index Portfolio   623,833    (3,921)   76,069    75,461    147,609    6,090    (651)   (883)   (32,217)   8,264    (19,397)   128,212    752,045 
CVT Russell 2000® Small Cap Index Portfolio   200,994    754    5,012    15,124    20,890    8,906    (1,764)   (1,069)   (7,993)   2,934    1,014    21,904    222,898 
CVT S&P MidCap 400 Index Portfolio   187,077    601    12,229    10,624    23,454    6,219    -    (1,037)   (13,785)   2,756    (5,847)   17,607    204,684 
Federated Hermes Government Money Fund II - Service Shares   285,389    10,566    -    -    10,566    23,924    (24,885)   (467)   (14,399)   (152)   (15,979)   (5,413)   279,976 
Federated Hermes Managed Volatility Fund II - Primary Shares   682,705    9,406    (7,626)   97,166    98,946    39,557    (11,898)   (857)   (35,328)   (12,576)   (21,102)   77,844    760,549 
Federated Hermes Quality Bond Fund II - Primary Shares   775,486    15,897    (10,055)   16,639    22,481    43,281    (35,145)   (6,578)   (38,489)   (11,845)   (48,776)   (26,295)   749,191 
Fidelity® VIP Contrafund® Portfolio - Initial Class   892,512    (7,578)   170,969    123,954    287,345    25,985    (35,589)   (5,434)   (42,408)   (7,159)   (64,605)   222,740    1,115,252 
Fidelity® VIP Growth & Income Portfolio - Initial Class   294,904    1,897    40,889    18,339    61,125    11,614    (9,833)   (1,110)   (13,571)   (17,499)   (30,399)   30,726    325,630 
Fidelity® VIP Growth Portfolio - Initial Class   473,842    (5,100)   137,083    6,067    138,050    10,288    -    -    (15,562)   9,798    4,524    142,574    616,416 
Fidelity® VIP High Income Portfolio - Service Class 2   423,919    22,657    (13,027)   22,100    31,730    21,079    (19,070)   (3,729)   (18,950)   (15,668)   (36,338)   (4,608)   419,311 
Fidelity® VIP Index 500 Portfolio - Initial Class   720,436    3,241    39,457    128,672    171,370    14,881    (565)   (1,165)   (25,457)   (14,283)   (26,589)   144,781    865,217 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   520,740    (3,167)   82,185    4,449    83,467    20,394    (9,858)   (5,924)   (22,966)   1,982    (16,372)   67,095    587,835 

 

See accompanying notes.

11

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets (continued)
For the Year Ended December 31, 2024
 

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2023   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase (decrease) in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2024 
Fidelity® VIP Overseas Portfolio - Initial Class  $192,649   $1,543   $11,810   $(5,458)  $7,895   $7,497   $(992)  $(392)  $(6,309)  $(107)  $(303)  $7,592   $200,241 
Franklin Global Real Estate VIP Fund - Class 2   214,466    1,985    (1,552)   (2,967)   (2,534)   14,627    (1,031)   (1,621)   (11,927)   (873)   (825)   (3,359)   211,107 
Franklin Mutual Shares VIP Fund - Class 2   203,664    2,133    (106)   18,758    20,785    7,697    (15,247)   (2,926)   (7,467)   (1,346)   (19,289)   1,496    205,160 
Franklin Small Cap Value VIP Fund - Class 2   294,815    93    422    30,496    31,011    10,752    (9,078)   (922)   (11,033)   (340)   (10,621)   20,390    315,205 
Franklin Small-Mid Cap Growth VIP Fund - Class 2   225,614    (2,120)   (3,364)   27,951    22,467    10,519    (9,569)   (2,282)   (9,685)   2,400    (8,617)   13,850    239,464 
Franklin U.S. Government Securities VIP Fund - Class 2   328,877    6,971    (8,932)   3,753    1,792    16,388    (21,758)   (5,132)   (16,625)   (1,949)   (29,076)   (27,284)   301,593 
Templeton Growth VIP Fund - Class 2   135,948    52    (534)   6,667    6,185    7,463    (459)   (2,016)   (4,896)   (15,222)   (15,130)   (8,945)   127,003 
LVIP American Century Capital Appreciation Fund – Standard II    312,601    (3,199)   21,447    57,047    75,295    13,986    -    (1,084)   (13,732)   2,849    2,019    77,314    389,915 
LVIP American Century Inflation Protection Fund – Standard II    21,546    694    (53)   (447)   194    1,211    -    -    (323)   -    888    1,082    22,628 
LVIP American Century Mid Cap Value Fund – Standard II    8,779    188    419    56    663    1,070    -    -    (1,101)   1,946    1,915    2,578    11,357 
LVIP American Century Ultra Fund – Standard II    335,899    (3,480)   69,685    28,515    94,720    9,039    -    (1,147)   (14,259)   (58,849)   (65,216)   29,504    365,403 
LVIP American Century Value Fund – Standard II    156,768    3,069    13,461    (3,461)   13,069    6,145    (14,474)   (2,666)   (7,570)   (1,277)   (19,842)   (6,773)   149,995 
LVIP JPMorgan Mid Cap Value Fund - Standard   412,334    1,440    67,337    (15,086)   53,691    17,040    (20,042)   (6,722)   (18,575)   1,275    (27,024)   26,667    439,001 
LVIP JPMorgan Small Cap Core Fund - Standard   177,074    (161)   2,613    15,498    17,950    5,561    (7,925)   (2,553)   (7,488)   (83)   (12,488)   5,462    182,536 
T. Rowe Price All-Cap Opportunities Portfolio   441,362    (4,185)   66,374    42,610    104,799    11,453    (12,203)   (45)   (15,171)   7,635    (8,331)   96,468    537,830 
T. Rowe Price Equity Income Portfolio   502,765    4,944    36,984    12,258    54,186    18,166    (18,487)   (61)   (22,673)   (10,273)   (33,328)   20,858    523,623 

 

See accompanying notes.

12

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets (continued)
For the Year Ended December 31, 2024

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2023   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase (decrease) in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2024 
T. Rowe Price Mid-Cap Growth Portfolio  $317,166   $(2,861)  $37,523   $(8,743)  $25,919   $7,707   $(34,348)  $(31,698)  $(8,443)  $(1,746)  $(68,528)  $(42,609)  $274,557 
T. Rowe Price Moderate Allocation Portfolio   574,955    8,535    18,476    24,909    51,920    29,366    (4,182)   (560)   (24,965)   (18,334)   (18,675)   33,245    608,200 
T. Rowe Price International Stock Portfolio   409,008    56    11,661    (1,045)   10,672    17,021    (24,044)   (6,588)   (15,858)   (1,968)   (31,437)   (20,765)   388,243 
Product C                                                                 
CVT EAFE International Index Portfolio - Class F  $7,815   $-   $739   $(433)  $306   $162   $-   $-   $(24)  $(8,259)  $(8,121)  $(7,815)  $- 
CVT NASDAQ-100 Index Portfolio   11,317    -    4,618    (3,442)   1,176    163    -    -    (37)   (12,619)   (12,493)   (11,317)   - 
CVT Russell 2000® Small Cap Index Portfolio - Class F   2,442    34    59    184    277    151    -    -    (48)   -    103    380    2,822 
CVT S&P MidCap 400 Index Portfolio - Class F   118,596    1,428    8,209    5,511    15,148    8,768    (10,735)   -    (6,306)   (9,732)   (18,005)   (2,857)   115,739 
Columbia VP Small Cap Value Fund - Class 2   72,892    396    839    5,003    6,238    5,109    (6,830)   -    (3,715)   -    (5,436)   802    73,694 
DWS International Opportunities VIP - Class A   787    10    15    50    75    104    -    -    (81)   -    23    98    885 
Federated Hermes Government Money Fund II - Service Shares   2,266    112    -    -    112    369    -    -    (160)   -    209    321    2,587 
Federated Hermes Managed Volatility Fund II - Primary Shares   216    5    (2)   30    33    30    -    -    (22)   -    8    41    257 
Federated Hermes Quality Bond Fund II - Primary Shares   149,666    4,465    (1,076)   2,395    5,784    13,572    (7,497)   -    (7,628)   -    (1,553)   4,231    153,897 
Fidelity® VIP Contrafund® Portfolio - Service Class 2   151,949    58    35,872    12,879    48,809    10,468    (14,811)   -    (8,588)   (12,233)   (25,164)   23,645    175,594 
Fidelity® VIP Growth Portfolio - Service Class 2   154,263    -    50,236    (5,946)   44,290    9,910    (14,223)   -    (8,080)   (13,104)   (25,497)   18,793    173,056 
Fidelity® VIP High Income Portfolio - Service Class 2   78,412    4,538    (1,934)   3,844    6,448    6,287    (4,904)   -    (3,803)   (7,340)   (9,760)   (3,312)   75,100 
Fidelity® VIP Index 500 Portfolio - Service Class 2   17,210    118    4,955    (1,985)   3,088    538    -    -    (286)   (11,202)   (10,950)   (7,862)   9,348 

 

See accompanying notes.

13

 

EquiTrust Life Variable Account
Statements of Changes in Net Assets (continued)
For the Year Ended December 31, 2024

 

        Operations        Contract transactions                
Subaccount  Net Assets at December 31, 2023   Net investment income (loss)   Net realized gain (loss) on investments   Change in unrealized appreciation/ depreciation of investments   Net increase (decrease) in net assets from operations   Transfers of net premiums   Transfers of surrenders and death benefits   Transfers of policy loans   Transfers of cost of insurance and other charges   Transfers between subaccounts, including Declared Interest Option account   Net increase (decrease) in net assets from contract transactions   Total increase (decrease) in net assets   Net Assets at December 31, 2024 
Fidelity® VIP Mid Cap Portfolio - Service Class 2  $74,692   $242   $11,573   $169   $11,984   $4,834   $(6,017)  $-   $(3,258)  $(10,204)  $(14,645)  $(2,661)  $72,031 
Fidelity® VIP Real Estate Portfolio - Service Class 2   52,111    2,033    (550)   1,684    3,167    4,196    (4,482)   -    (2,636)   -    (2,922)   245    52,356 
Franklin Mutual Shares VIP Fund - Class 2   165,415    3,575    (590)   16,038    19,023    14,042    (15,626)   -    (10,058)   -    (11,642)   7,381    172,796 
Franklin Small Cap Value VIP Fund - Class 2   11,029    110    (353)   866    623    312    -    -    (118)   (9,261)   (9,067)   (8,444)   2,585 
Franklin U.S. Government Securities VIP Fund - Class 2   146,687    4,483    (2,659)   107    1,931    13,515    (7,237)   -    (7,418)   -    (1,140)   791    147,478 
Templeton Global Bond VIP Fund - Class 2   57,372    -    (1,496)   (5,116)   (6,612)   5,803    (2,848)   -    (3,196)   -    (241)   (6,853)   50,519 
T. Rowe Price Equity Income Portfolio   30,174    564    2,147    669    3,380    1,158    (3,330)   -    (615)   -    (2,787)   593    30,767 
T. Rowe Price International Stock Portfolio   184,100    1,655    6,369    (1,929)   6,095    14,638    (15,600)   -    (9,216)   (7,823)   (18,001)   (11,906)   172,194 

 

See accompanying notes.

14

 

EquiTrust Life Variable Account

 

Notes to Financial Statements

 

December 31, 2025

 

1. Organization and Significant Accounting Policies

 

Organization

 

EquiTrust Life Variable Account (the Account), a unit investment trust registered under the Investment Company Act of 1940, as amended, was established by EquiTrust Life Insurance Company (the Company). The Account is a funding vehicle for flexible premium variable life insurance policies (Product A), flexible premium last survivor variable life insurance policies (Product B) and variable universal life insurance policies (Product C) issued by the Company. The Company discontinued underwriting new sales of all variable life insurance products but continues to receive premiums from sales that occurred prior to this change.

 

The assets and liabilities of the Account are clearly identified and distinguished from the Company’s other assets and liabilities. The portion of the Account’s assets applicable to the life insurance policies is not available to satisfy liabilities arising out of any other business the Company may conduct.

 

At the direction of eligible policy owners, the Account invests in the following fifty investment subaccounts which, in turn, own open-end mutual fund shares of registered investment companies (the Funds). Eligible policy owners may also allocate funds to the Declared Interest Option (DIO) account. The DIO is funded by the general account of the Company and pays interest at declared rates with a guaranteed minimum. Assets and liabilities associated with funds allocated to the DIO are excluded from the Account as these are included in the Company’s general account.

 

Subaccount / Fund Product
BNY Mellon Sustainable U.S. Equity Portfolio, Inc.  
BNY Mellon Sustainable U.S. Equity Portfolio – Service Shares A & B
BNY Mellon Variable Investment Fund  
BNY Mellon VIF Appreciation Portfolio - Initial Shares A & B
BNY Mellon VIF Growth & Income Portfolio - Initial Shares A & B
BNY Mellon VIF Small Cap Portfolio - Initial Shares (4) A & B
Calvert Variable Trust, Inc.  
CVT EAFE International Index Portfolio - Class F (2) C
CVT NASDAQ-100 Index Portfolio (2) A, B & C
CVT Russell 2000® Small Cap Index Portfolio A & B
CVT Russell 2000® Small Cap Index Portfolio - Class F C
CVT S&P MidCap 400 Index Portfolio A & B
CVT S&P MidCap 400 Index Portfolio - Class F C
Columbia Variable Products, Inc.  
Columbia VP Overseas Core Fund - Class 1 (1) C
Columbia VP Select Mid Cap Value Fund - Class 1 (1) C
Columbia VP Small Cap Value Fund - Class 2 C
Columbia VP Small Company Growth Fund - Class 2 (1) C
Deutsche DWS Variable Series I  
DWS Global Small Cap VIP - Class A (1) C
Deutsche DWS Variable Series II  
DWS International Opportunities VIP - Class A (3) C
Federated Hermes Insurance Series  
Federated Hermes Government Money Fund II - Service Shares A, B & C
Federated Hermes Managed Volatility Fund II - Primary Shares A, B & C

15

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

Subaccount / Fund Product
Federated Hermes Insurance Series (continued)  
Federated Hermes Quality Bond Fund II - Primary Shares A, B & C
Fidelity® Variable Insurance Products Funds  
Fidelity® VIP Contrafund® Portfolio - Initial Class A & B
Fidelity® VIP Contrafund® Portfolio - Service Class 2 C
Fidelity® VIP Growth & Income Portfolio - Initial Class A & B
Fidelity® VIP Growth Portfolio - Initial Class A & B
Fidelity® VIP Growth Portfolio - Service Class 2 C
Fidelity® VIP High Income Portfolio - Service Class 2 A, B & C
Fidelity® VIP Index 500 Portfolio - Initial Class A & B
Fidelity® VIP Index 500 Portfolio - Service Class 2 C
Fidelity® VIP Mid Cap Portfolio - Service Class 2 A, B & C
Fidelity® VIP Overseas Portfolio - Initial Class A & B
Fidelity® VIP Real Estate Portfolio - Service Class 2 C
Franklin Templeton Variable Insurance Products Trust  
Franklin Global Real Estate VIP Fund - Class 2 A & B
Franklin Mutual Shares VIP Fund - Class 2 A, B & C
Franklin Small Cap Value VIP Fund - Class 2 A, B & C
Franklin Small-Mid Cap Growth VIP Fund - Class 2 A & B
Franklin U.S. Government Securities VIP Fund - Class 2 A, B & C
Templeton Global Bond VIP Fund - Class 2 C
Templeton Growth VIP Fund - Class 2 A & B
Lincoln Variable Insurance Products Trust  
LVIP American Century Capital Appreciation Fund – Standard II A & B
LVIP American Century Inflation Protection Bond Fund – Standard II A & B
LVIP American Century Mid Cap Value Fund – Standard II A & B
LVIP American Century Ultra Fund – Standard II A & B
LVIP American Century Value Fund – Standard II A & B
LVIP JPMorgan Mid Cap Value Fund – Standard A & B
LVIP JPMorgan Small Cap Core Fund – Standard A & B
LVIP JPMorgan Small Cap Core Fund – Service (1) C
T. Rowe Price Equity Series, Inc.  
T. Rowe Price All-Cap Opportunities Portfolio (1) A, B & C
T. Rowe Price Equity Income Portfolio A, B & C
T. Rowe Price Mid-Cap Growth Portfolio A & B
T. Rowe Price Moderate Allocation Portfolio (1) A, B & C
T. Rowe Price International Series, Inc.  
T. Rowe Price International Stock Portfolio A, B & C

16

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

(1)Product C subaccount was inactive during 2025 and 2024; accordingly, a Statement of Assets and Liabilities, a Statement of Operations and a Statement of Changes in Net Assets have not been presented herein.

(2)Product C subaccount was inactive during 2025; accordingly, a Statement of Assets and Liabilities, a Statement of Operations and a Statement of Changes in Net Assets for the year ended December 31, 2025, have not been presented herein.

(3)Effective May 1, 2025, Deutsche DWS Variable Series II changed the name of DWS International Growth VIP fund to DWS International Opportunities VIP.

(4)Effective December 31, 2025, BNY Mellon Variable Investment Fund changed the name of BNY Mellon VIF Opportunistic Small Cap Portfolio fund to BNY Mellon VIF Small Cap Portfolio.

 

Investments

 

Investments in shares of the Funds are stated at fair value, which is the closing net asset value per share as determined by the Funds. The first-in, first-out cost basis has been used in determining the net realized gain or loss from investment transactions and unrealized appreciation or depreciation on investments. Investment transactions are accounted for on the trade date.

 

At December 31, 2025, all valuation inputs used to determine the fair value of mutual fund shares owned by the Account were classified as Level 1 in accordance with accounting principles generally accepted in the United States of America. There were no transfers into or out of Level 3 during the year.

 

Dividends and realized capital gain distributions are taken into income on an accrual basis as of the ex-dividend date and are automatically reinvested in shares of the Funds on the payable date.

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of the Account’s financial statements and accompanying notes in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported and disclosed. These estimates and assumptions could change in the future as more information becomes known, which could impact the amounts reported and disclosed in the financial statements and accompanying notes.

 

2. Expense Charges and Related Party Transactions

 

Paid to the Company

 

The Account pays the Company certain amounts relating to the distribution and administration of the policies funded by the Account and as reimbursement for certain mortality and other risks assumed by the Company. The following summarizes those amounts.

 

Mortality and Expense Risk Charges: The Company deducts a daily mortality and expense risk charge from the Account at an effective annual rate of 0.90% of the average daily net asset value of the Account for Product A and B, included in the Statements of Operations. Product C assesses a monthly risk charge at a rate of 0.03% based on the accumulated value of the policy, included in Transfers of cost of insurance and other charges on the Statements of Changes in Net Assets. These charges are assessed in return for the Company’s assumption of risks associated with adverse mortality experience or excess administrative expenses in connection with policies issued.

 

Premium Expense Charge: Premiums paid by the policyholders are reduced by a 7% premium expense charge for each premium up to the target premium and 7% of each premium over the target premium for Product A. (Product A policies issued prior to May 1, 2006, the premium expense charge is 7% of each premium up to the target premium, as defined in the prospectus, and 2% for each premium over the target premium.) Premiums paid by the policyholders are reduced by a 7% premium expense charge up to the target premium, as defined in the prospectus and 2% for each premium over the target premium for Product B. The charge is used to compensate the Company for expenses incurred in connection with the

17

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

distribution of the policies and for premium taxes imposed by various states and political subdivisions. Product C is not assessed a premium expense charge.

 

Cost of Insurance and Policy Charges: The Company assumes the responsibility for providing insurance benefits included in the policy. The cost of insurance is determined each month based upon the applicable insurance rate and current net amount at risk. A policy expense charge of $7 and $10 for Product A and B, respectively, is deducted monthly for the administration of policies and the Account. (Product A policies purchased prior to May 1, 2006, a $5 expense charge is deducted monthly for administration of policies and the Account.) Product B applies an additional monthly charge of $.03 per $1,000 of the Specified Amount (amount of insurance selected) for the administration of policies and the Account. Product C applies an additional monthly charge per $1,000 (determined by the Specified Amount and age of the insured) of the Specified Amount following an increase in the Specified Amount for the first ten policy years. The aggregate cost of insurance and policy charges can vary from month to month since the determination of both the insurance rate and the current net amount at risk depends on a number of variables as described in the Account’s prospectus.

 

Other Charges: A transfer charge ($25 for Product A and B and $10 for Product C) may be imposed for the thirteenth and each subsequent transfer between subaccounts in any one policy year. In the event of a partial withdrawal, a fee equal to the lesser of $25 or 2% of the accumulated value withdrawn will be imposed. A surrender charge is applicable for all full policy surrenders or lapses within ten years following an increase in minimum death benefit for Products A and B and applicable for all full policy surrenders or lapses in the first fifteen years of the policy or within fifteen years following an increase in minimum death benefit for Product C. This surrender charge is based on a number of variables as described in the Account’s prospectus.

 

3. Federal Income Taxes

 

The operations of the Account are included in the federal income tax return of the Company, which is taxed as a life insurance company under the provisions of the Internal Revenue Code (IRC). Under the current provisions of the IRC, the Company does not expect to incur federal income taxes on the earnings of the Account to the extent the earnings are credited under the policies. Based on this, no charge is being made currently to the Account for federal income taxes. The Company will review periodically the status of this policy. In the event of changes in the tax law, a charge may be made in future years for any federal income taxes that would be attributable to the policies.

18

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

4. Purchases and Sales of Investment Securities

 

The aggregate cost of investment securities purchased and proceeds from investment securities sold by subaccount were as follows during the year ended December 31, 2025:

 

   Cost of   Proceeds 
Subaccount  Purchases   from Sales 
           
Products A & B:          
BNY Mellon Sustainable U.S. Equity Portfolio, Inc.:          
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares  $11,769   $23,520 
           
BNY Mellon Variable Investment Fund:          
BNY Mellon VIF Appreciation Portfolio - Initial Shares   119,226    48,256 
BNY Mellon VIF Growth & Income Portfolio - Initial Shares   21,796    42,561 
BNY Mellon VIF Small Cap Portfolio - Initial Shares   13,058    42,195 
           
Calvert Variable Trust, Inc.:          
CVT NASDAQ-100 Index Portfolio   24,706    62,543 
CVT Russell 2000® Small Cap Index Portfolio   21,489    7,716 
CVT S&P MidCap 400 Index Portfolio   19,065    38,753 
           
Federated Hermes Insurance Series:          
Federated Hermes Government Money Fund II - Service Shares   23,703    20,328 
Federated Hermes Managed Volatility Fund II - Primary Shares   51,948    61,456 
Federated Hermes Quality Bond Fund II - Primary Shares   46,140    95,692 
           
Fidelity® Variable Insurance Products Funds:          
Fidelity® VIP Contrafund® Portfolio - Initial Class   188,482    139,902 
Fidelity® VIP Growth & Income Portfolio - Initial Class   43,452    45,222 
Fidelity® VIP Growth Portfolio - Initial Class   89,793    32,221 
Fidelity® VIP High Income Portfolio - Service Class 2   39,081    42,808 
Fidelity® VIP Index 500 Portfolio - Initial Class   28,415    135,376 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   81,954    49,848 
Fidelity® VIP Overseas Portfolio - Initial Class   27,309    25,189 
           
Franklin Templeton Variable Insurance Products Trust:          
Franklin Global Real Estate VIP Fund - Class 2   11,489    14,215 
Franklin Mutual Shares VIP Fund - Class 2   29,322    15,061 
Franklin Small Cap Value VIP Fund - Class 2   31,417    55,817 
Franklin Small-Mid Cap Growth VIP Fund - Class 2   21,897    26,023 
Franklin U.S. Government Securities VIP Fund - Class 2   18,368    37,444 
Templeton Growth VIP Fund - Class 2   16,169    9,557 

19

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   Cost of   Proceeds 
Subaccount  Purchases   from Sales 
           
Lincoln Variable Insurance Products Trust:          
LVIP American Century Capital Appreciation Fund – Standard II  $74,523   $20,285 
LVIP American Century Inflation Protection Fund – Standard II   3,101    500 
LVIP American Century Mid Cap Value Fund – Standard II   2,255    1,346 
LVIP American Century Ultra Fund – Standard II   37,182    15,006 
LVIP American Century Value Fund – Standard II   17,480    15,042 
LVIP JPMorgan Mid Cap Value Fund - Standard   59,721    53,759 
LVIP JPMorgan Small Cap Core Fund - Standard   18,485    17,487 
           
T. Rowe Price Equity Series, Inc.:          
T. Rowe Price All-Cap Opportunities Portfolio   58,633    122,204 
T. Rowe Price Equity Income Portfolio   70,537    44,282 
T. Rowe Price Mid-Cap Growth Portfolio   35,651    28,738 
T. Rowe Price Moderate Allocation Portfolio   59,485    55,867 
           
T. Rowe Price International Series, Inc.:          
T. Rowe Price International Stock Portfolio   53,434    31,204 
           
Product C:          
Calvert Variable Trust, Inc.:          
CVT Russell 2000® Small Cap Index Portfolio - Class F  $354   $47 
CVT S&P MidCap 400 Index Portfolio - Class F   12,309    12,389 
           
Columbia Variable Products, Inc.:          
Columbia VP Small Cap Value Fund - Class 2   14,797    7,205 
           
Deutsche DWS Variable Series I:          
DWS International Opportunities VIP - Class A   113    87 
           
Federated Hermes Insurance Series:          
Federated Hermes Government Money Fund II - Service Shares   498    164 
Federated Hermes Managed Volatility Fund II - Primary Shares   42    23 
Federated Hermes Quality Bond Fund II - Primary Shares   12,670    12,730 
           
Fidelity® Variable Insurance Products Funds:          
Fidelity® VIP Contrafund® Portfolio - Service Class 2   35,058    17,661 
Fidelity® VIP Growth Portfolio - Service Class 2   28,197    15,808 
Fidelity® VIP High Income Portfolio - Service Class 2   8,245    6,664 
Fidelity® VIP Index 500 Portfolio - Service Class 2   519    292 
Fidelity® VIP Mid Cap Portfolio - Service Class 2   10,917    5,881 
Fidelity® VIP Real Estate Portfolio - Service Class 2   3,071    5,022 

20

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   Cost of   Proceeds 
Subaccount  Purchases   from Sales 
           
Franklin Templeton Variable Insurance Products Trust:          
Franklin Mutual Shares VIP Fund - Class 2  $26,629   $20,136 
Franklin Small Cap Value VIP Fund - Class 2   400    99 
Franklin U.S. Government Securities VIP Fund - Class 2   12,433    12,196 
Templeton Global Bond VIP Fund - Class 2   3,042    5,274 
           
T. Rowe Price Equity Series, Inc.:          
T. Rowe Price Equity Income Portfolio   4,945    538 
           
T. Rowe Price International Series, Inc.:          
T. Rowe Price International Stock Portfolio   26,124    17,089 

21

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

5. Summary of Changes from Unit Transactions

 

Transactions in units of each subaccount were as follows for the periods ended December 31, 2025 and 2024:

 

   Period Ended December 31, 
   2025   2024 
         Net         Net 
         Increase         Increase 
Subaccount  Purchased Redeemed (Decrease)   Purchased Redeemed (Decrease) 
      
Products A & B:                    
BNY Mellon Sustainable U.S. Equity Portfolio, Inc.:                    
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares  33  470  (437)  40  512  (472)
                     
BNY Mellon Variable Investment Fund:                    
BNY Mellon VIF Appreciation Portfolio - Initial Shares  155  714  (559)  212  1,178  (966)
BNY Mellon VIF Growth & Income Portfolio - Initial Shares  52  797  (745)  105  535  (430)
BNY Mellon VIF Small Cap Portfolio - Initial Shares  310  1,033  (723)  393  1,002  (609)
                     
Calvert Variable Trust, Inc.:                    
CVT NASDAQ-100 Index Portfolio  87  449  (362)  118  309  (191)
CVT Russell 2000® Small Cap Index Portfolio  137  126  11   214  187  27 
CVT S&P MidCap 400 Index Portfolio  61  530  (469)  114  199  (85)
                     
Federated Hermes Insurance Series:                    
Federated Hermes Government Money Fund II - Service Shares  1,416  1,846  (430)  1,674  3,257  (1,583)
Federated Hermes Managed Volatility Fund II - Primary Shares  938  2,633  (1,695)  1,180  2,176  (996)
Federated Hermes Quality Bond Fund II - Primary Shares  1,883  7,091  (5,208)  2,007  5,918  (3,911)
                     
Fidelity® Variable Insurance Products Funds:                    
Fidelity® VIP Contrafund® Portfolio - Initial Class  101  1,310  (1,209)  211  927  (716)
Fidelity® VIP Growth & Income Portfolio - Initial Class  140  692  (552)  231  815  (584)
Fidelity® VIP Growth Portfolio - Initial Class  78  329  (251)  214  162  52 
Fidelity® VIP High Income Portfolio - Service Class 2  382  1,259  (877)  498  1,688  (1,190)
Fidelity® VIP Index 500 Portfolio - Initial Class  241  1,929  (1,688)  339  753  (414)
Fidelity® VIP Mid Cap Portfolio - Service Class 2  172  591  (419)  207  426  (219)
Fidelity® VIP Overseas Portfolio - Initial Class  153  658  (505)  186  196  (10)
                     
Franklin Templeton Variable Insurance Products Trust:                    
Franklin Global Real Estate VIP Fund - Class 2  443  627  (184)  470  507  (37)
Franklin Mutual Shares VIP Fund - Class 2  138  392  (254)  170  743  (573)
Franklin Small Cap Value VIP Fund - Class 2  92  863  (771)  129  312  (183)
Franklin Small-Mid Cap Growth VIP Fund - Class 2  191  508  (317)  211  398  (187)
Franklin U.S. Government Securities VIP Fund - Class 2  644  2,431  (1,787)  650  2,683  (2,033)
Templeton Growth VIP Fund - Class 2  188  331  (143)  220  826  (606)

22

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   Period Ended December 31, 
   2025   2024 
         Net         Net 
         Increase         Increase 
Subaccount  Purchased Redeemed (Decrease)   Purchased Redeemed (Decrease) 
         
Lincoln Variable Insurance Products Trust:                    
LVIP American Century Capital Appreciation Fund – Standard II  157  279  (122)  252  207  45 
LVIP American Century Inflation Protection Fund – Standard II  76  20  56   80  20  60 
LVIP American Century Mid Cap Value Fund – Standard II  24  29  (5)  70  23  47 
LVIP American Century Ultra Fund – Standard II  79  157  (78)  137  949  (812)
LVIP American Century Value Fund – Standard II  103  408  (305)  130  741  (611)
LVIP JPMorgan Mid Cap Value Fund - Standard  137  674  (537)  196  573  (377)
LVIP JPMorgan Small Cap Core Fund - Standard  73  316  (243)  70  335  (265)
                     
T. Rowe Price Equity Series, Inc.:                    
T. Rowe Price All-Cap Opportunities Portfolio  56  1,258  (1,202)  196  303  (107)
T. Rowe Price Equity Income Portfolio  191  780  (589)  211  869  (658)
T. Rowe Price Mid-Cap Growth Portfolio  35  247  (212)  46  672  (626)
T. Rowe Price Moderate Allocation Portfolio  411  1,117  (706)  428  854  (426)
                     
T. Rowe Price International Series, Inc.:                    
T. Rowe Price International Stock Portfolio  429  1,174  (745)  498  1,840  (1,342)
                     
Product C:                    
Calvert Variable Trust, Inc.:                    
CVT EAFE International Index Portfolio - Class F  -  -  -   15  767  (752)
CVT NASDAQ-100 Index Portfolio  -  -  -   6  439  (433)
CVT Russell 2000® Small Cap Index Portfolio - Class F  4  1  3   4  1  3 
CVT S&P MidCap 400 Index Portfolio - Class F  147  481  (334)  284  1,006  (722)
                     
Columbia Variable Products, Inc.:                    
Columbia VP Small Cap Value Fund - Class 2  64  201  (137)  120  275  (155)
                     
Deutsche DWS Variable Series I:                    
DWS International Opportunities VIP - Class A  4  4  -   6  4  2 
                     
Federated Hermes Insurance Series:                    
Federated Hermes Government Money Fund II - Service Shares  34  14  20   32  13  19 
Federated Hermes Managed Volatility Fund II - Primary Shares  1  1  -   3  2  1 
Federated Hermes Quality Bond Fund II - Primary Shares  523  886  (363)  801  913  (112)

23

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   Period Ended December 31, 
   2025   2024 
         Net         Net 
         Increase         Increase 
Subaccount  Purchased Redeemed (Decrease)   Purchased Redeemed (Decrease) 
          
Fidelity® Variable Insurance Products Funds:                    
Fidelity® VIP Contrafund® Portfolio - Service Class 2  68  278  (210)  143  583  (440)
Fidelity® VIP Growth Portfolio - Service Class 2  55  203  (148)  109  470  (361)
Fidelity® VIP High Income Portfolio - Service Class 2  139  304  (165)  247  713  (466)
Fidelity® VIP Index 500 Portfolio - Service Class 2  6  4  2   10  208  (198)
Fidelity® VIP Mid Cap Portfolio - Service Class 2  56  142  (86)  99  473  (374)
Fidelity® VIP Real Estate Portfolio - Service Class 2  77  190  (113)  133  247  (114)
                     
Franklin Templeton Variable Insurance Products Trust:                    
Franklin Mutual Shares VIP Fund - Class 2  276  932  (656)  542  1,069  (527)
Franklin Small Cap Value VIP Fund - Class 2  4  3  1   9  256  (247)
Franklin U.S. Government Securities VIP Fund - Class 2  566  920  (354)  857  950  (93)
Templeton Global Bond VIP Fund - Class 2  305  569  (264)  501  537  (36)
                     
T. Rowe Price Equity Series, Inc.:                    
T. Rowe Price Equity Income Portfolio  25  13  12   27  104  (77)
                     
T. Rowe Price International Series, Inc.:                    
T. Rowe Price International Stock Portfolio  314  849  (535)  598  1,516  (918)

24

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

6. Unit Values

 

The following summarizes units outstanding, unit values, and net assets at December 31, 2025, 2024, 2023, 2022 and 2021, and investment income ratios, expense ratios, and total return ratios for the periods then ended:

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                               
Products A and B:                              
BNY Mellon Sustainable U.S. Equity Portfolio - Service Shares:                           
2025  2,614   $52.29 $ 136,686     0.06%    0.90%    14.65%
2024  3,051    45.61   139,161     0.37     0.90     23.44 
2023  3,523    36.95   130,149     0.53     0.90     22.43 
2022  3,578    30.18   107,988     0.30     0.90     (23.75)
2021  3,831    39.58   151,651     0.60     0.90     25.53 
BNY Mellon VIF Appreciation Portfolio - Initial Shares:             
2025  11,809    64.10   756,961     0.37     0.90     9.09 
2024  12,368    58.76   726,710     0.42     0.90     11.80 
2023  13,334    52.56   700,817     0.72     0.90     19.89 
2022  13,599    43.84   596,175     0.67     0.90     (18.78)
2021  14,267    53.98   770,197     0.43     0.90     26.00 
BNY Mellon VIF Growth & Income Portfolio - Initial Shares:             
2025  4,144    59.08   244,832     0.45     0.90     15.78 
2024  4,889    51.03   249,473     0.54     0.90     21.64 
2023  5,319    41.95   223,162     0.66     0.90     25.56 
2022  5,505    33.41   183,958     0.80     0.90     (15.59)
2021  5,611    39.58   222,068     0.48     0.90     24.50 
BNY Mellon VIF Small Cap Portfolio - Initial Shares:                               
2025  10,979    40.24   441,753     0.65     0.90     10.01 
2024  11,702    36.58   428,054     0.69     0.90     3.68 
2023  12,311    35.28   434,362     0.33     0.90     8.29 
2022  12,312    32.58   401,080     -     0.90     (17.35)
2021  13,659    39.42   538,450     0.11     0.90     15.43 
CVT NASDAQ-100 Index Portfolio:             
2025  6,166    137.46   847,655     0.27     0.90     19.31 
2024  6,528    115.21   752,045     0.34     0.90     24.08 
2023  6,719    92.85   623,833     0.33     0.90     53.04 
2022  7,002    60.67   424,816     0.18     0.90     (33.25)
2021  7,433    90.89   675,550     0.27     0.90     25.75 
CVT Russell 2000® Small Cap Index Portfolio:             
2025  4,553    54.69   249,022     1.61     0.90     11.43 
2024  4,542    49.08   222,898     1.26     0.90     10.24 
2023  4,515    44.52   200,994     0.89     0.90     15.58 
2022  4,460    38.52   171,805     0.83     0.90     (21.23)
2021  4,512    48.90   220,644     0.76     0.90     13.51 

25

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
CVT S&P MidCap 400 Index Portfolio:                   
2025  2,535   $72.35 $ 183,397     1.11%    0.90%    6.18%
2024  3,004    68.14   204,684     1.20     0.90     12.50 
2023  3,089    60.57   187,077     1.23     0.90     15.09 
2022  3,215    52.63   169,180     0.91     0.90     (14.10)
2021  3,785    61.27   231,900     0.85     0.90     23.30 
Federated Hermes Government Money Fund II - Service Shares:                   
2025  27,162    10.43   283,351     3.67     0.90     2.76 
2024  27,592    10.15   279,976     4.58     0.90     3.78 
2023  29,175    9.78   285,389     4.44     0.90     3.60 
2022  26,364    9.44   248,949     1.17     0.90     0.21 
2021  25,323    9.42   238,504     -     0.90     (0.84)
Federated Hermes Managed Volatility Fund II - Primary Shares:                   
2025  33,937    22.64   768,431     2.87     0.90     6.09 
2024  35,632    21.34   760,549     2.18     0.90     14.48 
2023  36,628    18.64   682,705     1.86     0.90     7.75 
2022  36,682    17.30   634,747     1.85     0.90     (14.53)
2021  38,989    20.24   789,294     1.75     0.90     17.40 
Federated Hermes Quality Bond Fund II - Primary Shares:                   
2025  54,365    13.35   725,590     3.30     0.90     6.12 
2024  59,573    12.58   749,191     2.98     0.90     2.95 
2023  63,484    12.22   775,486     2.62     0.90     5.25 
2022  62,203    11.61   722,325     2.57     0.90     (10.07)
2021  63,716    12.91   822,868     2.43     0.90     (2.34)
Fidelity® VIP Contrafund® Portfolio - Initial Class:                   
2025  10,524    114.44   1,204,410     0.14     0.90     20.40 
2024  11,733    95.05   1,115,252     0.19     0.90     32.58 
2023  12,449    71.69   892,512     0.49     0.90     32.27 
2022  13,309    54.20   721,394     0.50     0.90     (26.97)
2021  14,503    74.22   1,076,382     0.06     0.90     26.70 
Fidelity® VIP Growth & Income Portfolio - Initial Class:                   
2025  5,483    64.98   356,283     1.48     0.90     20.42 
2024  6,035    53.96   325,630     1.49     0.90     21.12 
2023  6,619    44.55   294,904     1.69     0.90     17.67 
2022  6,360    37.86   240,807     1.62     0.90     (5.80)
2021  6,771    40.19   272,141     2.43     0.90     24.81 
Fidelity® VIP Growth Portfolio - Initial Class:                   
2025  7,510    90.45   679,230     0.29     0.90     13.87 
2024  7,761    79.43   616,416     -     0.90     29.22 
2023  7,709    61.47   473,842     0.13     0.90     35.04 
2022  8,494    45.52   386,693     0.62     0.90     (25.13)
2021  9,232    60.80   561,301     -     0.90     22.11 

26

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
Fidelity® VIP High Income Portfolio - Service Class 2:                   
2025  12,610   $33.99 $ 428,604     6.74%    0.90%    9.33%
2024  13,487    31.09   419,311     6.18     0.90     7.65 
2023  14,677    28.88   423,919     5.78     0.90     9.23 
2022  14,914    26.44   394,271     5.11     0.90     (12.45)
2021  15,423    30.20   465,762     5.36     0.90     3.35 
Fidelity® VIP Index 500 Portfolio - Initial Class:                   
2025  11,816    74.79   883,657     1.15     0.90     16.73 
2024  13,504    64.07   865,217     1.30     0.90     23.78 
2023  13,918    51.76   720,436     1.45     0.90     25.05 
2022  15,860    41.39   656,372     1.45     0.90     (18.94)
2021  16,568    51.06   845,897     1.23     0.90     27.43 
Fidelity® VIP Mid Cap Portfolio - Service Class 2:                   
2025  7,226    84.96   613,969     0.25     0.90     10.50 
2024  7,645    76.89   587,835     0.35     0.90     16.11 
2023  7,864    66.22   520,740     0.39     0.90     13.78 
2022  8,265    58.20   481,004     0.27     0.90     (15.73)
2021  8,762    69.06   605,076     0.35     0.90     24.21 
Fidelity® VIP Overseas Portfolio - Initial Class:                   
2025  5,950    37.01   220,246     1.55     0.90     19.31 
2024  6,455    31.02   200,241     1.65     0.90     4.09 
2023  6,465    29.80   192,649     1.07     0.90     19.44 
2022  6,241    24.95   155,713     1.05     0.90     (25.16)
2021  6,896    33.34   229,891     0.53     0.90     18.65 
Franklin Global Real Estate VIP Fund - Class 2:                   
2025  10,368    21.40   221,886     1.40     0.90     6.95 
2024  10,552    20.01   211,107     1.83     0.90     (1.19)
2023  10,589    20.25   214,466     2.88     0.90     10.41 
2022  10,688    18.34   195,991     2.40     0.90     (26.70)
2021  10,581    25.02   264,787     0.89     0.90     25.67 
Franklin Mutual Shares VIP Fund - Class 2:                   
2025  5,803    37.44   217,233     2.06     0.90     10.54 
2024  6,057    33.87   205,160     1.91     0.90     10.25 
2023  6,630    30.72   203,664     1.91     0.90     12.49 
2022  6,592    27.31   180,069     1.85     0.90     (8.26)
2021  7,417    29.77   220,834     2.93     0.90     18.09 
Franklin Small Cap Value VIP Fund - Class 2:                     
2025  4,395    65.10   286,095     1.09     0.90     6.70 
2024  5,166    61.01   315,205     0.93     0.90     10.71 
2023  5,349    55.11   294,815     0.52     0.90     11.74 
2022  5,440    49.32   268,337     0.96     0.90     (10.86)
2021  6,465    55.33   357,761     1.00     0.90     24.25 

27

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
Franklin Small-Mid Cap Growth VIP Fund - Class 2:                   
2025  4,776   $47.77 $ 228,147     -%    0.90%    1.60%
2024  5,093    47.02   239,464     -     0.90     10.04 
2023  5,280    42.73   225,614     -     0.90     25.60 
2022  5,279    34.02   179,573     -     0.90     (34.27)
2021  5,655    51.76   292,713     -     0.90     9.04 
Franklin U.S. Government Securities VIP Fund - Class 2:                   
2025  19,517    14.97   292,157     3.33     0.90     5.72 
2024  21,304    14.16   301,593     3.09     0.90     0.50 
2023  23,337    14.09   328,877     2.73     0.90     3.53 
2022  22,403    13.61   304,932     2.39     0.90     (10.58)
2021  23,841    15.22   362,792     2.52     0.90     (2.69)
Templeton Growth VIP Fund - Class 2:                   
2025  4,982    30.41   151,516     0.87     0.90     22.72 
2024  5,125    24.78   127,003     0.94     0.90     4.47 
2023  5,731    23.72   135,948     3.28     0.90     19.92 
2022  7,336    19.78   145,113     0.16     0.90     (12.28)
2021  7,448    22.55   167,976     1.10     0.90     3.92 
LVIP American Century Capital Appreciation Fund – Standard II:                   
2025  6,276    64.45   404,527     -     0.90     5.76 
2024  6,398    60.94   389,915     -     0.90     23.86 
2023  6,353    49.20   312,601     -     0.90     19.62 
2022  6,360    41.13   261,586     -     0.90     (28.75)
2021  6,882    57.73   397,333     -     0.90     10.17 
LVIP American Century Inflation Protection Fund – Standard II:                   
2025  1,583    15.66   24,794     8.10     0.90     5.67 
2024  1,527    14.82   22,628     4.03     0.90     0.88 
2023  1,467    14.69   21,546     3.64     0.90     2.66 
2022  1,406    14.31   20,120     5.00     0.90     (13.64)
2021  1,589    16.57   26,320     3.32     0.90     5.68 
LVIP American Century Mid Cap Value Fund – Standard II:                   
2025  273    44.21   12,083     1.93     0.90     8.01 
2024  278    40.93   11,357     2.80     0.90     7.77 
2023  231    37.98   8,779     2.32     0.90     5.18 
2022  232    36.11   8,362     2.25     0.90     (2.06)
2021  231    36.87   8,535     1.16     0.90     22.09 
LVIP American Century Ultra Fund – Standard II:                   
2025  4,608    87.21   401,855     -     0.90     11.84 
2024  4,686    77.98   365,403     -     0.90     27.63 
2023  5,498    61.10   335,899     -     0.90     42.26 
2022  5,587    42.95   240,003     -     0.90     (32.98)
2021  5,760    64.09   369,165     -     0.90     22.08 

28

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
LVIP American Century Value Fund – Standard II:                   
2025  4,263   $37.76 $ 160,992     1.65%    0.90%    14.98%
2024  4,568    32.84   149,995     2.85     0.90     8.49 
2023  5,179    30.27   156,768     2.42     0.90     8.15 
2022  4,349    27.99   121,734     2.05     0.90     (0.36)
2021  5,344    28.09   150,122     1.73     0.90     23.42 
LVIP JPMorgan Mid Cap Value Fund - Standard:                   
2025  5,376    77.05   414,213     1.09     0.90     3.79 
2024  5,913    74.24   439,001     1.24     0.90     13.26 
2023  6,290    65.55   412,334     3.19     0.90     9.93 
2022  6,240    59.63   372,128     0.94     0.90     (8.98)
2021  6,751    65.51   442,275     0.88     0.90     28.73 
LVIP JPMorgan Small Cap Core Fund - Standard:                   
2025  3,337    55.72   185,949     0.64     0.90     9.28 
2024  3,580    50.99   182,536     0.81     0.90     10.70 
2023  3,845    46.06   177,074     1.37     0.90     12.10 
2022  3,888    41.09   159,745     0.45     0.90     (20.06)
2021  3,867    51.40   198,765     0.51     0.90     20.29 
T. Rowe Price All-Cap Opportunities Portfolio:                   
2025  4,757    104.03   494,821     -     0.90     15.27 
2024  5,959    90.25   537,830     0.08     0.90     24.04 
2023  6,066    72.76   441,362     0.25     0.90     27.81 
2022  6,209    56.93   353,446     -     0.90     (22.21)
2021  6,647    73.18   486,425     -     0.90     19.71 
T. Rowe Price Equity Income Portfolio:                   
2025  9,881    56.69   560,118     1.65     0.90     13.36 
2024  10,470    50.01   523,623     1.83     0.90     10.69 
2023  11,128    45.18   502,765     2.09     0.90     8.55 
2022  11,883    41.62   494,537     1.89     0.90     (4.19)
2021  11,682    43.44   507,472     1.58     0.90     24.43 
T. Rowe Price Mid-Cap Growth Portfolio:                   
2025  2,277    113.20   257,746     -     0.90     2.62 
2024  2,489    110.31   274,557     -     0.90     8.34 
2023  3,115    101.82   317,166     -     0.90     18.89 
2022  3,184    85.64   272,707     -     0.90     (23.27)
2021  3,205    111.61   357,746     -     0.90     13.82 
T. Rowe Price Moderate Allocation Portfolio:                   
2025  12,999    50.36   654,659     2.27     0.90     13.47 
2024  13,705    44.38   608,200     2.31     0.90     9.07 
2023  14,131    40.69   574,955     2.33     0.90     14.33 
2022  14,067    35.59   500,651     1.55     0.90     (19.04)
2021  14,723    43.96   647,278     0.98     0.90     9.08 

29

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
T. Rowe Price International Stock Portfolio:             
2025  16,462   $26.48 $ 435,908     1.96%    0.90%    17.38%
2024  17,207    22.56   388,243     0.92     0.90     2.31 
2023  18,549    22.05   409,008     0.99     0.90     15.20 
2022  19,539    19.14   373,984     0.79     0.90     (16.56)
2021  19,679    22.94   451,436     0.59     0.90     0.44 
                                
Product C:                               
CVT EAFE International Index Portfolio - Class F:             
2025  -   $- $ -     -%    -%    -%
2024  -    -   -     -     -     3.95 
2023  752    10.39   7,815     3.02     -     17.53 
2022  736    8.84   6,507     3.57     -     (14.75)
2021  721    10.37   7,477     1.80     -     10.67 
CVT NASDAQ-100 Index Portfolio:               
2025  -    -   -     -     -     - 
2024  -    -   -     -     -     10.37 
2023  433    26.13   11,317     0.34     -     54.43 
2022  427    16.92   7,225     0.18     -     (32.64)
2021  421    25.12   10,586     0.28     -     26.87 
CVT Russell 2000® Small Cap Index Portfolio - Class F:             
2025  81    40.62   3,281     1.64     -     12.24 
2024  78    36.19   2,822     1.29     -     11.01 
2023  75    32.60   2,442     0.93     -     16.35 
2022  71    28.02   1,993     0.82     -     (20.67)
2021  67    35.32   2,374     0.78     -     14.30 
CVT S&P MidCap 400 Index Portfolio - Class F:             
2025  4,154    27.58   114,541     1.12     -     6.94 
2024  4,488    25.79   115,739     1.17     -     13.31 
2023  5,210    22.76   118,596     1.26     -     15.89 
2022  5,121    19.64   100,592     0.96     -     (13.52)
2021  5,006    22.71   113,693     0.80     -     24.17 
Columbia VP Small Cap Value Fund - Class 2:             
2025  1,930    40.88   78,889     0.98     -     14.67 
2024  2,067    35.65   73,694     0.54     -     8.69 
2023  2,222    32.80   72,892     0.44     -     21.66 
2022  2,125    26.96   57,297     0.49     -     (8.98)
2021  2,086    29.62   61,791     0.45     -     28.78 
DWS International Opportunities VIP - Class A:             
2025  42    25.35   1,071     0.90     -     18.96 
2024  42    21.31   885     1.15     -     9.34 
2023  40    19.49   787     0.69     -     16.08 
2022  38    16.79   646     1.04     -     (28.52)
2021  36    23.49   849     0.37     -     8.10 

30

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                    
Federated Hermes Government Money Fund II - Service Shares:                   
2025  246   $11.87 $ 2,921     3.69%    -%    3.76%
2024  226    11.44   2,587     4.58     -     4.67 
2023  207    10.93   2,266     4.47     -     4.49 
2022  196    10.46   2,046     1.16     -     1.16 
2021  183    10.34   1,890     -     -     - 
Federated Hermes Managed Volatility Fund II - Primary Shares:                   
2025  17    16.58   283     2.65     -     7.04 
2024  17    15.49   257     2.08     -     15.60 
2023  16    13.40   216     2.03     -     8.68 
2022  15    12.33   188     1.60     -     (13.78)
2021  14    14.30   204     1.63     -     18.57 
Federated Hermes Quality Bond Fund II - Primary Shares:                   
2025  10,484    15.19   159,290     3.25     -     7.05 
2024  10,847    14.19   153,897     2.91     -     3.88 
2023  10,959    13.66   149,666     2.58     -     6.14 
2022  10,710    12.87   137,814     2.53     -     (9.24)
2021  10,498    14.18   148,889     2.13     -     (1.39)
Fidelity® VIP Contrafund® Portfolio - Service Class 2:                   
2025  2,631    74.91   197,079     -     -     21.19 
2024  2,841    61.81   175,594     0.03     -     33.47 
2023  3,281    46.31   151,949     0.27     -     33.11 
2022  3,310    34.79   115,182     0.27     -     (26.49)
2021  3,283    47.33   155,399     0.03     -     27.51 
Fidelity® VIP Growth Portfolio - Service Class 2:                   
2025  2,115    87.65   185,371     0.05     -     14.61 
2024  2,263    76.48   173,056     -     -     30.07 
2023  2,624    58.80   154,263     -     -     35.89 
2022  2,635    43.27   113,994     0.34     -     (24.64)
2021  2,617    57.42   150,245     -     -     22.90 
Fidelity® VIP High Income Portfolio - Service Class 2:                   
2025  3,318    23.79   78,921     6.86     -     10.34 
2024  3,483    21.56   75,100     5.81     -     8.61 
2023  3,949    19.85   78,412     5.92     -     10.22 
2022  3,808    18.01   68,578     5.21     -     (11.67)
2021  3,820    20.39   77,898     5.49     -     4.30 
Fidelity® VIP Index 500 Portfolio - Service Class 2:                   
2025  155    71.69   11,080     0.95     -     17.51 
2024  153    61.01   9,348     0.78     -     24.56 
2023  351    48.98   17,210     1.29     -     25.88 
2022  344    38.91   13,392     1.23     -     (18.43)
2021  337    47.70   16,066     1.06     -     28.19 

31

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
Fidelity® VIP Mid Cap Portfolio - Service Class 2:                   
2025  1,656   $46.11 $ 76,349     0.26%    -%    11.48%
2024  1,742    41.36   72,031     0.31     -     17.20 
2023  2,116    35.29   74,692     0.40     -     14.80 
2022  2,076    30.74   63,810     0.28     -     (14.97)
2021  2,038    36.15   73,695     0.35     -     25.30 
Fidelity® VIP Real Estate Portfolio - Service Class 2:                   
2025  1,866    27.23   50,793     1.95     -     2.91 
2024  1,979    26.46   52,356     3.88     -     6.27 
2023  2,093    24.90   52,111     2.40     -     10.86 
2022  1,782    22.46   40,025     1.10     -     (27.69)
2021  1,958    31.06   60,821     0.98     -     38.66 
Franklin Mutual Shares VIP Fund - Class 2:                      
2025  7,435    23.82   177,081     2.08     -     11.52 
2024  8,091    21.36   172,796     2.04     -     11.31 
2023  8,618    19.19   165,415     1.94     -     13.42 
2022  8,346    16.92   141,174     1.87     -     (7.39)
2021  8,583    18.27   156,847     2.86     -     19.18 
Franklin Small Cap Value VIP Fund - Class 2:                   
2025  67    42.37   2,839     1.07     -     7.65 
2024  66    39.36   2,585     1.39     -     11.69 
2023  313    35.24   11,029     0.52     -     12.77 
2022  306    31.25   9,569     0.99     -     (10.07)
2021  300    34.75   10,428     1.01     -     25.36 
Franklin U.S. Government Securities VIP Fund - Class 2:             
2025  10,905    13.98   152,400     3.26     -     6.72 
2024  11,259    13.10   147,478     3.03     -     1.39 
2023  11,352    12.92   146,687     2.70     -     4.45 
2022  10,951    12.37   135,452     2.34     -     (9.77)
2021  10,763    13.71   147,520     2.65     -     (1.79)
Templeton Global Bond VIP Fund - Class 2:             
2025  5,392    10.34   55,745     -     -     15.79 
2024  5,656    8.93   50,519     -     -     (11.41)
2023  5,692    10.08   57,372     -     -     2.86 
2022  5,508    9.80   53,958     -     -     (4.95)
2021  5,521    10.31   56,904     -     -     (4.98)
T. Rowe Price Equity Income Portfolio:             
2025  815    43.79   35,698     1.66     -     14.36 
2024  803    38.29   30,767     1.82     -     11.70 
2023  880    34.28   30,174     2.12     -     9.52 
2022  829    31.30   25,956     1.87     -     (3.34)
2021  885    32.38   28,645     1.57     -     25.55 

32

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

   As of December 31     Investment             
       Unit         Income     Expense     Total 
Subaccount  Units   Value   Net Assets     Ratio (A)     Ratio (B)     Return (C) 
                                
T. Rowe Price International Stock Portfolio:                   
2025  8,301   $23.08 $ 191,549     2.00%    -%    18.42%
2024  8,836    19.49   172,194     0.89     -     3.29 
2023  9,754    18.87   184,100     1.00     -     16.19 
2022  10,369    16.24   168,355     0.83     -     (15.81)
2021  9,079    19.29   175,110     0.59     -     1.31 

33

 

EquiTrust Life Variable Account

 

Notes to Financial Statements (continued)

 

(A)These ratios represent the dividends, excluding distributions of capital gains, received by the subaccount from the underlying mutual fund, net of management fees assessed by the fund manager, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that result in direct reductions in the unit values. For subaccounts that contained net assets for a period less than the entire reporting period presented, average net assets have been calculated using only the period in which the subaccount contained net assets. The recognition of investment income by the subaccount is affected by the timing of the declaration of dividends by the underlying fund in which the subaccounts invest.

 

(B)These ratios represent the annualized policy expenses of the separate account, consisting of applicable mortality and expense risk charges, for the period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to policy owner accounts through the redemption of units and expenses of the underlying fund are excluded.

 

(C)These ratios represent the total return for the period indicated, including changes in the value of the underlying fund, and reflect deductions for all items included in the expense ratio. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in a reduction in the total return presented. For subaccounts that contained net assets for a period less than the entire reporting period presented, total return has been calculated using only the period in which the subaccount contained net assets and has not been annualized.

 

7. Segment Reporting

 

Each subaccount, as detailed in Note 1, represents a single operating segment. The Chief Operating Officer of the Company acts as the Chief Operating Decision Maker (CODM) and monitors the operating results of each subaccount. The change in net assets resulting from operations, which is used by the CODM to assess the subaccount’s performance, is consistent with that presented within the subaccount’s financial statements. Subaccount assets are reflected on the accompanying Statement of Assets and Liabilities and significant segment expenses are listed on the accompanying Statement of Operations.

34

 

   
  KPMG LLP
  Aon Center
 

Suite 5500

200 E. Randolph Street

  Chicago, IL 60601-6436

 

 

 

Independent Auditors’ Report

 

 

The Audit Committee of the Board of Directors

EquiTrust Life Insurance Company:

 

Opinions

 

We have audited the financial statements of EquiTrust Life Insurance Company (the Company), which comprise the statutory statements of admitted assets, liabilities, and capital and surplus as of December 31, 2025 and 2024, and the related statutory statements of operations, changes in capital and surplus, and cash flow for the years then ended, and the related notes to the financial statements.

 

Unmodified Opinion on Statutory Basis of Accounting

 

In our opinion, the accompanying financial statements present fairly, in all material respects, the admitted assets, liabilities, and capital and surplus of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flow for the years then ended in accordance with accounting practices prescribed or permitted by the Arizona Department of Insurance and Financial Institutions described in Note 2.

 

Adverse Opinion on U.S. Generally Accepted Accounting Principles

 

In our opinion, because of the significance of the matter discussed in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the financial statements do not present fairly, in accordance with U.S. generally accepted accounting principles, the financial position of the Company as of December 31, 2025 and 2024, or the results of its operations or its cash flows for the years then ended.

 

Basis for Opinions

 

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

 

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

 

As described in Note 2 to the financial statements, the financial statements are prepared by the Company using accounting practices prescribed or permitted by the Arizona Department of Insurance and Financial Institutions, which is a basis of accounting other than U.S. generally accepted accounting principles. Accordingly, the financial statements are not intended to be presented in accordance with U.S. generally accepted accounting principles. The effects on the financial statements of the variances between the statutory accounting practices described in Note 2 and U.S. generally accepted accounting principles, although not reasonably determinable, are presumed to be material and pervasive.

 

Emphasis of Matter

 

As discussed in Note 2(n) to the financial statements, the Company received permission from the Arizona Department of Insurance and Financial Institutions in 2022 to account for derivatives used for indexed interest crediting hedging purposes at amortized cost with amortization expense and realized gains recorded through

 

  KPMG LLP, a Delaware limited liability partnership, and its subsidiaries are part of
the KPMG global organization of independent member firms affiliated with KPMG
International Limited, a private English company limited by guarantee.
 

 

 1 

 

 

 

 

 

net investment income. Under prescribed statutory accounting practices, the derivatives would be accounted for at fair value with changes in fair value being recognized in capital and surplus and realized gains or losses being recognized in net realized gains or losses. Also under the permitted practice, the Company calculates indexed reserves assuming the derivatives associated with the current interest crediting period have zero market value. Under prescribed statutory accounting practices, the derivatives associated with the current interest crediting period have a market value consistent with the derivatives used for indexed interest crediting hedging purposes. As of December 31, 2025 and 2024, the permitted accounting practice decreased statutory surplus below what it would have been had prescribed accounting practices been followed. Our opinions are not modified with respect to this matter.

 

Responsibilities of Management for the Financial Statements

 

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting practices prescribed or permitted by the Arizona Department of Insurance and Financial Institutions. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date that the financial statements are issued.

 

Auditors’ Responsibilities for the Audit of the Financial Statements

 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

 

In performing an audit in accordance with GAAS, we:

 

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

 2 

 

 

 

 

 

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

 

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control related matters that we identified during the audit.

 

Supplementary Information

 

Our audits were conducted for the purpose of forming an opinion on the financial statements as a whole. The supplementary information included in the supplemental schedule of assets and liabilities, summary investment schedule, supplemental investment risk interrogatories, and reinsurance risk interrogatories is presented for purposes of additional analysis and is not a required part of the financial statements but is supplementary information required by the Arizona Department of Insurance and Financial Institutions. Such information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the financial statements. The information has been subjected to the auditing procedures applied in the audits of the financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the financial statements or to the financial statements themselves, and other additional procedures in accordance with GAAS. In our opinion, the information is fairly stated in all material respects in relation to the financial statements as a whole.

 

/s/ KPMG LLP

 

Chicago, Illinois

April 17, 2026

 

 3 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus
Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   2025   2024
Admitted Assets           
Bonds  $26,344,251    $22,379,427 
Preferred stock   156,264     171,642 
Common stock, at fair value (cost of $274,856 in 2025 and cost of $244,779 in 2024)   264,718     232,672 
Mortgage loans   4,284,430     3,911,417 
Real estate   46,075     25,800 
Cash, cash equivalents and short-term investments   3,376,357     3,884,769 
Contract loans   6,735     6,705 
Derivative instruments   168,578     181,744 
Other invested assets   1,174,440     1,163,900 
Receivables for securities   140,382     30,562 
Total cash and invested assets  $35,962,230    $31,988,638 
Investment income due and accrued   737,069     611,100 
Premiums and considerations - uncollected   59     - 
Amounts recoverable under reinsurance agreements   19,246     25,438 
Assumed coinsurance funds withheld   -     67 
Current federal income tax receivable   68,844     32,450 
Deferred income tax assets   78,459     18,055 
Receivables from parent, subsidiaries and affiliates   -     11 
Other admitted assets   908     386 
Assets held in separate accounts   915,699     900,578 
Total admitted assets  $37,782,514    $33,576,723 
Liabilities, Capital and Surplus           
Liabilities:           
Life and annuity policy reserves   24,850,620     22,189,819 
Liability for deposit-type contracts   5,890,536     4,826,432 
Policy and contract claims   120,452     112,820 
Interest maintenance reserve   19,658     28,752 
Amount payable under reinsurance agreements   172,653     71,048 
Commissions to agents due and accrued   12,571     20,038 
Payable to affiliates   5,034     6,759 
Ceded coinsurance funds withheld   1,826,636     1,772,244 
Derivative liability   369,390     323,850 
Payable for securities   121,715     98,175 
Loan payable   161     852 
Borrowed money   -     75,000 
Asset valuation reserve   326,935     297,056 
Other liabilities   91,072     96,926 
Liabilities related to separate accounts   915,699     900,578 
Total liabilities  $34,723,132    $30,820,349 
Capital and surplus:           
Common stock, par value $1,500 per share – authorized 2,500 shares; issued and outstanding 2,000 shares   3,000     3,000 
Additional paid-in capital   784,667     784,667 
Unassigned funds   2,271,715     1,968,707 
Total capital and surplus   3,059,382     2,756,374 
Total liabilities, capital and surplus  37,782,514    $33,576,723 

 

 

 

 

 

 

 

See accompanying notes to statutory financial statements

 

 4 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Statutory Statements of Operations

Years ended December 31, 2025 and 2024

(In thousands of dollars)

 

   2025   2024
Revenues:           
Premiums and other considerations:           
Life and annuity premiums  $3,638,209    $6,531,514 
Supplementary contracts with life contingencies   3,466     1,686 
Net investment income   2,018,607     1,673,687 
Commissions and expense allowances on reinsurance ceded   135,891     117,297 
Miscellaneous income   9,357     - 
Total revenues   5,805,530     8,324,184 
Benefits and expenses:           
Benefits paid or provided for:           
Death benefits   43,162     34,183 
Annuity benefits   445,533     396,705 
Surrender benefits   1,635,462     1,651,399 
Interest and adjustments on policy or deposit-type contract funds   156,487     2,796 
Other benefits   1,718     1,590 
Increase in policy reserves   2,442,318     5,231,560 
Total benefits paid or provided for   4,724,680     7,318,233 
Commissions   335,183     500,877 
Commissions and expense allowances on reinsurance assumed   1,865     2,002 
General expenses   133,955     104,157 
Insurance taxes, licenses and fees   20,503     30,907 
Total benefits and expenses   5,216,186     7,956,176 
Gain from operations before federal income taxes and net           
realized capital gains (losses)   589,344     368,008 
Dividends to Policyholders   (1)    - 
Federal income tax expense (benefit)   149,645     131,457 
Gain from operations before net realized capital gains (losses)   439,700     236,551 
            
Net realized capital gains (losses), less capital gains tax (benefit) of ($9,399) in 2025 and ($11,609) in 2024 and amounts transferred (to) from the interest maintenance reserve of $48 in 2025 and $1,375 in 2024  $(35,356)   $(43,673)
Net income  $404,344    $192,878 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to statutory financial statements

 

 5 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Statutory Statements of Changes in Capital and Surplus

Years ended December 31, 2025 and 2024

(In thousands of dollars)

 

       Additional paid-  Unassigned  Total capital and
   Common Stock  in capital  funds  surplus
Balances at December 31, 2023  $3,000   $784,667   $1,630,706   $2,418,373 
                     
Correction of an error             (11,834)   (11,834)
Net income for 2024   -    -    192,878    192,878 
Change in unrealized gains (losses) on investments, net of tax   -    -    36,626    36,626 
Change in deferred income taxes   -    -    58,051    58,051 
Change in nonadmitted assets   -    -    648    648 
Change in asset valuation reserve   -    -    (10,612)   (10,612)
Change in surplus as a result of reinsurance   -    -    72,244    72,244 
Balances at December 31, 2024  $3,000   $784,667   $1,968,707   $2,756,374 
                     
Correction of an error   -    -    (3,530)   (3,530)
Net income for 2025   -    -    404,344    404,344 
Change in unrealized gains (losses) on investments, net of tax   -    -    (21,106)   (21,106)
Change in deferred income taxes   -    -    54,847    54,847 
Change in nonadmitted assets   -    -    (15,114)   (15,114)
Change in asset valuation reserve   -    -    (29,879)   (29,879)
Change in surplus as a result of reinsurance   -    -    (86,554)   (86,554)
Balances at December 31, 2025  $3,000   $784,667   $2,271,715   $3,059,382 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to statutory financial statements

 

 6 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Statutory Statements of Cash Flow

Years ended December 31, 2025 and 2024

(In thousands of dollars)

 

 

   2025  2024
Cash flow from operating activities:          
Premiums and other considerations received, net of reinsurance paid  $3,622,370   $6,533,200 
Net investment income received   1,862,761    1,542,535 
Funds held by reinsurers and miscellaneous income (loss)   83,613    111,161 
    5,568,744    8,186,896 
Benefits paid   (1,967,324)   (1,892,118)
Commissions, expenses paid and aggregate write-ins for deductions   (484,454)   (625,480)
Dividends paid to policyholders   1    - 
Federal income taxes received (paid)   (176,687)   (149,003)
Net cash provided by (used in) operating activities   2,940,280    5,520,295 
Cash flow from investing activities:          
Proceeds from sales, maturities or repayments of investments:          
Bonds   2,303,922    3,483,035 
Stocks   29,641    53,034 
Mortgage loans   283,149    254,126 
Other invested assets   42,823    142,387 
Derivatives and miscellaneous proceeds   16,254    50,041 
Total proceeds from sales, maturities or repayments of investments   2,675,789    3,982,623 
Cost of investments acquired:          
Bonds   (6,224,275)   (8,132,044)
Stocks   (43,947)   (62,053)
Mortgage loans   (692,878)   (593,166)
Real estate   1,784    - 
Other invested assets   (83,825)   (80,090)
Derivatives and miscellaneous applications   (109,819)   (79,939)
Total cost of investments acquired   (7,152,960)   (8,947,292)
Net (increase) decrease in contract loans   (30)   109 
Net cash provided by (used in) investing activities   (4,477,201)   (4,964,560)
Cash flow from financing and miscellaneous activities:          
Other cash provided (used):          
Borrowed Funds   (75,000)   74,935 
Change in deposit type funds   1,050,000    464,503 
Funds held under coinsurance   54,392    (21,276)
Repayments to parent   (1,725)   (1,145)
Cash advances to subsidiary   (1,023)   460 
Cash received from derivative positions   45,539    91,316 
Other sources, net   (43,674)   (27,926)
Net cash provided by (used in) financing and miscellaneous activities   1,028,509    580,867 
Net increase (decrease) in cash, cash equivalents and short-term          
investments:   (508,412)   1,136,602 
Cash, cash equivalents and short-term investments:          
Beginning of year   3,884,769    2,748,167 
End of year  $3,376,357   $3,884,769 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to statutory financial statements

 

 7 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Statutory Statements of Cash Flow

Years ended December 31, 2025 and 2024

(In thousands of dollars)

 

   2025  2024
Supplemental disclosures of noncash transactions:          
Interest capitalization on bonds  $23,411   $20,018 
Tax free exchanges-bonds   123,744    441,067 
Taxable exchanges-bonds   15,753    996 
Security transfers-bonds   -    28,773 
Tax free exchanges-stocks   3,450    - 
Reclass to common stocks   25,000    - 
Tax free exchanges-other invested assets   1,720    347,418 
Reclass to other invested assets   12,601    - 
Mortgage interest capitalization   -    1,165 
Reclass acquisition bonds   -    506 
Mortgage loans transferred to real estate   22,529    - 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to statutory financial statements

 

 8 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(1) Organization

 

EquiTrust Life Insurance Company (EquiTrust or the Company) operates in the life insurance industry, distributing individual annuity and life products through independent insurance marketing organizations and broker dealers. The Company is domiciled in the state of Arizona and is licensed to do business in forty-nine states and the District of Columbia. The Company has a closed block of annuity business from American Equity that was assumed through a coinsurance agreement. The Company also has executed reinsurance treaties with former affiliated, affiliated and nonaffiliated companies, to both assume and cede blocks of annuity business (see note 9).

 

On September 9, 2024, Amistad Financial Group, LLC, Atlanta Life Holdings, Inc., and Eric Holoman filed a Form A, Statement Regarding the Acquisition of Control of or Merger with a Domestic Insurer, with the Arizona Department of Insurance and Financial Institutions regarding the intended acquisition of the Company and its wholly-owned subsidiaries. On June 10, 2025, the Arizona Department of Insurance approved the acquisition and it was consummated on November 14, 2025, thereby making the Company a member of Amistad Financial Group, LLC holding company system.

 

(2) Summary of Significant Accounting Policies

 

(a) Basis of Presentation

 

The accompanying financial statements have been prepared on the basis of statutory accounting practices prescribed or permitted by the Arizona Department of Insurance, a comprehensive basis of accounting that differs from generally accepted accounting principles in the United States (GAAP). The Arizona Department of Insurance requires insurance companies domiciled in the state of Arizona to prepare their statutory basis financial statements in accordance with the National Association of Insurance Commissioners' (NAIC) Accounting Practices and Procedures Manual (NAIC SAP). On December 31, 2025 and 2024, the Company had no permitted or prescribed practices, other than NAIC SAP and permitted practices referred to in Note 2(n).

 

The Financial Accounting Standards Board promulgates the accounting principles for financial statements that are prepared in conformity with U.S. GAAP (GAAP) with applicable authoritative accounting pronouncements. As a result, the Company cannot refer to financial statements prepared in accordance with NAIC SAP as having been prepared in accordance with GAAP. The primary differences between GAAP and NAIC SAP, although not reasonably determinable are presumed to be material and pervasive and are summarized as follows:

 

Under GAAP:

 

The Asset Valuation Reserve (AVR) and Interest Maintenance Reserve (IMR) are eliminated as investments with unrealized gains and losses reported directly in equity and the realized gains and losses reported in income.
  
Certain assets designated under NAIC SAP as "nonadmitted assets" are included in the GAAP balance sheet rather than excluded from assets in the statutory balance sheet;
  
Certain policy acquisition costs and deferred sales inducements are deferred and amortized rather than being charged to operations as incurred;

 

 9 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

 Policy and contract reserves for traditional life insurance are based on best estimates of expected mortality, morbidity, persistency and interest rather than being based on prescribed statutory methodologies;

 

Policy reserves on universal life and certain investment products are reported at account value, including additional liabilities for certain guaranteed benefits such as lifetime income benefit riders valued using actuarial assumptions for GAAP, rather than using prescribed statutory methodologies under NAIC SAP;

 

Insurance contracts that contain an embedded derivative, including fixed index annuities, are bifurcated from the host contract and accounted for separately at fair value while the host is accreted to the estimated future minimum guarantee value using the effective interest method. Under NAIC SAP, contracts that contain an embedded derivative are not bifurcated and are accounted for as part of the host contract;

 

Market Risk Benefits are accounted for using discounted stochastic projections and best estimates for policyholder behavior in terms of benefits less fees rather than using prescribed integrated benefit stream mechanisms under NAIC SAP.

 

Investments in wholly owned insurance subsidiaries, other entities under the control of the parent, and certain variable interest entities are consolidated in the parent's financial statements rather than being carried at the parent's share of the underlying audited GAAP equity of a non-insurance subsidiary or statutory surplus of a domestic insurance subsidiary;

 

Bonds designated as available for sale and trading securities are reported at fair value for GAAP rather than at amortized cost, with unrealized gains and losses reported in equity and income, respectively;

 

An allowance for credit losses is established for available for sale securities under the current expected loss model under GAAP rather than being evaluated for other-than-temporary-impairments (OTTI) with impairments recorded as a direct write-down of the security's cost basis for NAIC SAP;

 

Equity securities are reported at fair value, net of tax, for GAAP with any changes reported in earnings, rather than unrealized gains and losses reported in capital and surplus;

 

Surplus notes designated as available for sale are reported at fair value for GAAP with unrealized gains and losses reported in equity whereas surplus notes rated by an NAIC Credit Rating Provider (CRP) with a designation equivalent of NAIC 1 or NAIC 2 shall be reported at amortized cost and those with an NAIC designation equivalent of NAIC 3 to NAIC 6 shall be reported at the lesser of amortized cost or fair value;

 

 Preferred stock designated as available for sale and trading securities are reported at fair value for GAAP rather than at amortized cost for redeemable preferred stocks designated highest-quality to medium-quality (NAIC designations RP1 to RP3 and P1 to P3) or the lower of amortized cost or fair value for redeemable preferred stocks that are designated low quality to in or near default (NAIC designations RP4 to RP6 and P4 to P6, respectively);

 

Under GAAP, money market mutual funds are classified as short-term investments and as cash equivalents for NAIC SAP;

 

 10 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Certain reinsurance transactions are accounted for as financing transactions under GAAP and as reinsurance for NAIC SAP. Assets and liabilities are reported gross of reinsurance for GAAP and net of reinsurance for NAIC SAP;
  
The statements of cash flow reconcile to changes in cash and cash equivalents with original maturities of three months or less. Under NAIC SAP, the statements of cash flow reconcile to changes in cash, cash equivalents and short-term investments with original maturities of one year or less. A reconciliation of net income to net cash provided by operating activities is not required under NAIC SAP;
  
Premiums, benefits and reserve changes for deposit-type and investment contracts are not included in revenue or benefits in the statement of operations; and,
  
Generally, changes in deferred taxes are reported as a component of net income under GAAP. Under NAIC SAP, a net deferred tax asset ("DTA"), for the tax effect of timing differences between book and tax assets and liabilities, is only reported as an admitted asset to the extent that it is realizable within three years and represents less than 15% of capital and surplus (adjusted to exclude any net DTAs, electronic data processing ("EDP") equipment and operating system software and any net positive goodwill), subject to limits set by Statement of Statutory Accounting Principles ("SSAP") No. 101. The change in net deferred tax asset is recorded directly to surplus.

 

(b) Risks and Uncertainties

 

Financial Statements – The preparation of the Company's statutory basis financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results may differ from those statements. The most significant estimates are associated with reserves for contract liabilities and fair value estimates of invested assets.

 

Investments – The Company is exposed to risks that issuers of securities owned by the Company will default or that interest rates will change and cause a decrease in the value of its investments. Management attempts to mitigate these risks by investing in high-grade securities and loans and by matching maturities of its investments with the anticipated payouts of its liabilities.

 

(c) Investments

 

All securities are accounted for as of the date the investments are purchased or sold (trade date).

 

 

Bonds

 

The Securities Valuation Office (SVO) of the NAIC evaluates the credit quality of the Company's bond investments when not otherwise evaluated by an independent CRP and issues related credit ratings. Bonds rated "1" (highest quality), "2" (high quality), "3" (medium quality), "4" (low quality) or "5" (lower quality) are reported in the financial statements at amortized cost, less any valuation impairment. Bonds rated "6" (lowest quality) are reported at the lower of amortized cost or fair value. The effective interest method is used to amortize any purchase premium or discount.

 

11

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Included within bonds are asset-backed securities. The carrying value of most residential mortgage-backed securities and commercial mortgage-backed securities is determined based on the results of financial modeling performed by a third party, including estimates of future prepayments that are obtained from independent sources. Certain other asset-backed securities are subject to a two-step rating process developed by the SVO for determining carrying value. The carrying value of asset-backed securities in default that are other-than-temporarily impaired is based upon estimated cash flows discounted at the current effective yield when the intent and ability exists to hold the security until recovery of that value, otherwise such securities are carried at the lower of amortized cost or fair value.

 

Prepayment assumptions are updated at least quarterly, with the retrospective method used to adjust net investment income for changes in the estimated yield to maturity.

 

Adoption of Principles-Based Bond Definitions (Effective January 1, 2025)

 

Effective January 1, 2025, the Company adopted the NAIC's Principles-Based Bond Definition Project, as set forth in the revised SSAP No. 26 and SSAP No. 43. The Project establishes new principles-based guidance for classifying investments as "bonds," distinguishing between "issuer credit obligations" and "asset-backed securities," and clarifies the characteristics needed for securities to be reported as bonds for statutory purposes. Under the revised guidance, a bond is a security that establishes a creditor relationship with a fixed schedule for one or more future payments, and qualifies either as an Issuer Credit Obligation (ICO) reported under SSAP No. 26 or as an Asset-Backed Security (ABS) reported under SSAP No. 43. The Company evaluated all investments reported on Schedule D at the CUSIP/PPN (tranche) level and updated classifications accordingly.

 

Reclassification of Investments:

 

No investments previously classified as bonds were re-characterized as other invested assets.
  
Certain structured securities and hybrids were evaluated and, where appropriate, reclassified to align with the new issuer credit obligation or asset-backed security criteria.
  
As a result, $0 of invested assets were transferred from bonds to other invested assets, and $0 were transferred from other invested assets to bonds.

 

Significant Judgments and Policies:

Management exercised significant judgment in applying the definition to complex or hybrid securities, particularly for investments with both credit and collateral-based payment features. In such instances, classification was based on the predominance of payment characteristics consistent with the issuer credit obligation or asset-backed security as defined by the NAIC.

 

Financial Statement Impact:

As a result of implementation:

Admitted asset values changed by $0, and statutory surplus was affected by $0.

 

The changes had no impact on the Company's RBC ratio and other solvency metrics.

 

12

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Preferred Stocks

 

Redeemable preferred stocks are stated at amortized cost unless they have an NAIC rating designation of 4, 5, or 6. Redeemable preferred stocks with an NAIC rating designation of 4, 5, or 6 are stated at the lower of amortized cost or fair value. Perpetual preferred stocks are valued at fair value, not to exceed any currently effective call price. Redeemable preferred stock must be redeemed by the issuing enterprise or is redeemable at the option of the reporting entity. Perpetual preferred stock has no redemption or sinking fund features and is not redeemable at the option of the issuer.

 

Common Stocks

 

Unaffiliated common stocks are stated at fair value, with changes in unrealized gains or losses credited or charged directly to unassigned surplus, net of tax. Affiliated common stocks are carried at underlying audited U.S. GAAP equity.

 

Mortgage Loans

 

Mortgage loans are stated at unpaid principal balances, net of provisions for estimated losses. Mortgage loans acquired at a premium or discount are carried at amortized cost using the effective interest rate method, net of provisions for estimated losses. A mortgage is evaluated for impairment when it is probable that the receipt of contractual payments of principal and interest may not occur when scheduled. If the impairment is considered to be temporary, a valuation reserve is established for the excess of the carrying value of the mortgage over its estimated fair value through surplus. Changes in valuation reserves for temporary impairments on mortgages are included in net unrealized capital gains/(losses) on investments in surplus. When an event occurs resulting in an impairment that is other-than-temporary, a direct write-down is recorded as a realized capital loss and any temporary valuation allowance is reversed. The Company recorded mortgage valuation allowances of $6,572 and $6,996 at December 31, 2025 and 2024, respectively.

 

Real Estate

 

Properties held for sale are stated at the lower of depreciated cost or fair value, less encumbrances and estimated costs to sell the property. Depreciation is computed on a straight-line basis for all real estate holdings. There were no encumbrances as of December 31, 2025 or 2024.

 

Cash, Cash Equivalents and Short-Term Investments

 

Cash constitutes a medium of exchange that a bank or other similar financial institution will accept for deposit and allow an immediate credit to the depositor's account. Also classified as cash for financial statement purposes, although not falling within the above definition of cash, are savings accounts and certificates of deposits or other similar financial instruments with maturity dates within one year or less from the acquisition date.

 

Cash equivalents are highly liquid, short-term investments with original maturities of three months or less that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates and are typically reported at amortized cost. Money market mutual funds that are registered under the Investment Company Act of 1940 are reported as cash equivalents and carried at fair value or net asset value as a practical expedient. Short-term investments (debt securities with maturities of one year or less at the time of acquisition) that are not impaired are stated at amortized cost using the effective interest method. Short-term investments that are impaired are stated at

 

13

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

the lower of amortized cost or fair value.

 

Contract Loans

 

Contract loans are secured by the cash surrender value or collateral assignment of the related policy or contract and are stated at outstanding principal balances inclusive of any unpaid accrued interest more than 90 days past due. The excess of unpaid contract loan balances over the cash surrender value, if any, is nonadmitted and reflected as an adjustment to surplus. Unpaid interest is capitalized on the policy or contract anniversary date.

 

Derivative Instruments

 

The Company uses currency swaps and currency forwards to hedge against the risk of fluctuations in foreign currency exchange rates. The Company also uses equity index options to hedge against certain equity indexed policyholder liabilities. Currency swaps, currency forwards and equity index options are marked to fair value. Changes in fair value are recorded as unrealized gains and losses within surplus. Effective January 1, 2022 in connection with the permitted practice discussed in Note 2(n), the Company began reporting equity index options at amortized cost, with amortization being calculated on a straight-line basis, with amortization expense and realized gains being reported in net investment income.

 

Beginning in 2024, the Company began using floating to fixed interest rate swaps to hedge exposure to floating interest rates on certain collateralized lending obligations. Hedge accounting is utilized for which the interest rate swaps are deemed cash flow hedges and are recorded at amortized cost with periodic swap settlements being recorded as investment income.

 

Other Invested Assets

 

Other invested assets are primarily comprised of investments in limited liability companies, surplus notes, limited partnerships, residual tranches of collateralized lending obligations, and collateral loans. Investments in limited liability companies and limited partnerships are stated based on the underlying GAAP audited equity of the investee. Surplus notes rated NAIC 1 through NAIC 2 by an NAIC CRP are carried at amortized cost and at the lesser of amortized cost or fair value if rated NAIC 3 through NAIC 6. Residual tranches of collateralized lending obligations are carried at the lesser of amortized cost or fair value with changes in fair value recorded in changes in capital and surplus. Collateral loans are carried at unpaid principal balance.

 

The Company held collateral loans by qualifying investment type as of December 31, 2025 and 2024 as follows:

 

   December 31, 2025   December 31, 2024 
   Aggregate           Aggregate         
   Loan   Admitted   Nonadmitted   Loan   Admitted   Nonadmitted 
Collateral type                              
Bonds  $763,823   $763,823   $                      -   $769,856   $   769,856   $                     - 
Total  $763,823   $763,823   $-   $769,856   $769,856   $- 

 

Receivable/Payable for Securities

 

The Company has entered into agreements to purchase or sell certain securities as of December 31, 2025 and 2024 that have not yet settled and are recorded as a payable or receivable at amortized cost.

 

14

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Loan Payable

 

The Company entered into a $210,000 credit facility with PNC Financial Services ("PNC") effective October 14, 2022 in order to enhance the Company's liquidity position. On October 14, 2025, the PNC credit facility was amended and restated from $210,000 to $450,000. December 31, 2025 and 2024, the outstanding loan payable was $0 and $75,000, respectively. Accrued interest on the credit facility as of December 31, 2025 and 2024 was $161 and $852, respectively.

 

Reverse Repurchase Agreements

 

The Company enters into reverse repurchase agreements under which the Company is the secured lender. Under these agreements, the Company receives unrestricted collateral which has a fair value as of the transaction date of no less than 102% of the value of cash loaned. The Company loaned cash in the amount of $113,250 and $120,144 at December 31, 2025 and 2024, respectively, and recorded the loaned amounts as short-term investments.

 

Repurchase Agreements

 

The Company enters into repurchase agreements under which the Company is the borrower. Each repurchase agreement must be evidenced by a Master Repurchase Agreement ("MRA") or other written agreement between the Company and its counterparties. Under the terms of the MRAs, the Company sells investments to the counterparty and the Company agrees to repurchase the same or similar investments back from the counterparty on a specific date at a specified price. On the maturity date, the Company and counterparty may elect to enter into a new repurchase agreement. The Company's decision to do so is dependent on the Company's liquidity needs and its assessment of the creditworthiness of the counterparty and the collateral's performance. The Company borrowed cash in the amount of $0 at December 31, 2025 and 2024 and recorded the borrowed amounts as payable for securities lending.

 

Net Investment Income

 

Investment income is recorded when earned. Dividends are recorded on the ex-dividend date. See note 6 for further discussion of the Company's investment income.

 

Investment Income Due and Accrued

 

Accrued investment income is comprised of accrued interest on bonds, preferred stock, short-term investments, mortgage loans, contract loans, other invested assets and dividends declared but not yet received. Accrued investment income more than 90 days past due is nonadmitted and reported as a direct reduction of surplus in the statements of changes in capital and surplus. The Company has no accrued investment income more than 90 days past due as of December 31, 2025 and 2024.

 

Investment Capital Gains and Losses

 

Realized capital gains and losses are determined on the basis of the specific identification method. Realized capital losses also include valuation adjustments for impairments of bonds, mortgage loans, common and preferred stocks and other investments that have experienced a decline in fair value that management considers to be "other-than-temporary." In determining whether impairments are other-than-temporary, management considers the size of the excess of carrying value over fair value, the likelihood and expected timing of a recovery in value, the credit quality and financial condition of the issuer, management's

 

15

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

intent to sell when a decline is due to interest rates, and management's intent and ability to hold the investment until maturity or a recovery in the investment's fair value. When it is determined that an investment (other than asset-backed securities, discussed below) is other-than-temporarily impaired, the cost basis of the investment is written down to fair value through a change recorded in net realized capital losses in the statements of operations.

 

For asset-backed securities the determination of OTTI is based on an estimate of the noninterest loss, which is recognized in net realized capital losses in the statements of operations. To the extent the Company determines that a non-structured security, corporate bond, common stock, preferred stock or mortgage loan is deemed to be OTTI, the difference between the cost of the security and fair value is recorded as a realized loss and the carrying amount of the investment is written down to its estimated fair value through realized capital losses. In accordance with SSAP No. 43, securities with OTTI are required to be written down to fair value only if the Company intends to sell or cannot assert the intent and ability to hold the investment until its anticipated recovery. However, if the Company can assert the intent and ability to hold the investment until its anticipated recovery, the valuation adjustment is based on the discounted future expected cash flows of the security discounted at the security's original effective interest rate. Realized capital gains and losses as reported in the statements of operations are net of any capital gains tax (or benefit) and exclude any deferrals to the IMR of interest rate related capital gains or losses.

 

Unrealized capital gains and losses include changes in the fair value of common stocks, interest rate swaps, certain bonds and preferred stocks carried at fair value due to NAIC rating and change in the equity method share of the accumulated earnings of limited liability companies and partnerships and are reported net of any related changes in deferred taxes. Changes in unrealized capital gains and losses are reported in the statements of changes in capital and surplus.

 

(d) Nonadmitted Assets

 

For statutory accounting purposes, certain assets are designated as nonadmitted assets (principally electronic data processing equipment, furniture and equipment and affiliated investments). EquiTrust had $16,550 and $1,436 in nonadmitted assets at December 31, 2025 and 2024, respectively.

 

(e) Separate Accounts

 

The assets and liabilities of the separate account shown in the statements of admitted assets, liabilities, and capital and surplus are reported at fair value or contract value in accordance with the valuation procedures in the applicable contract. The basis used for the separate accounts are as follows:

 

Separate Account I: Maintained for the benefit of the separate account policy holders and is legally insulated from general account claims. The assets and liabilities are reported at fair value.

 

Separate Account II: Maintained for the benefit of the separate account policy holders and is legally insulated from general account claims. The assets and liabilities for the Private Placement Funding Agreements, issued in 2018, are reported at contract value. The respective assets and liabilities are subject to a stable value protection master agreement which guarantees the performance of underlying investment divisions within Separate Account II to the Company and Private Placement Funding Agreement holders.

 

16

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(f) Premium Revenue and Related Expenses

 

Annuity considerations are recognized as revenue when received. Life insurance premiums are recognized as revenue over the premium paying period of the related policies when due. Premiums for traditional life insurance products are recognized as revenue when due. Considerations for deposit-type contracts, which do not have any life contingencies, are recorded directly to the related liability. Expenses incurred in connection with acquiring new insurance business are charged to operations as incurred.

 

(g) Commission

 

The Company expenses commissions at the time of sale for all products. Renewal commissions are paid for Multi-Year Guaranteed Annuity (MYGA) and for additional premiums on some other products.

 

(h) Policy Reserves and Liabilities for Deposit-Type Contracts

 

Policy reserves and liabilities consist of life and annuity policy reserves and deposit-type contracts.

 

Life and Annuity Policy Reserves

 

Life and annuity policy liabilities are developed using prescribed actuarial methods and are intended to provide, in the aggregate, reserves that are greater than, or equal to, the minimum or guaranteed policy cash values or the amounts required by law. Life reserves are calculated in accordance with the Commissioner's Reserve Valuation Method (CRVM) and Actuarial Guideline 36 as applicable. Annuity reserves are calculated in accordance with the Commissioner's Annuity Reserve Valuation Method (CARVM) and Actuarial Guidelines 33 and 35, as applicable. Mortality is based on the appropriate table from the year of issue, most recently the 2017 CSO table for life insurance and the 2012 IAR table for annuities. Valuation interest rates are also based on liability type and year of issue; the rates range from 2.50% to 8.75%. The liability under Standard Valuation Law (SVL) for income benefit riders is based on the greatest present value of all potential future guaranteed benefits. For policies with lifetime income benefit riders, there is an additional benefit stream included in the calculation. The inputs used in the calculation of the liability for lifetime benefit riders are prescribed by SVL and generally require reserves for the worst-case scenario.

 

Deposit-Type Contracts

 

Liabilities for funding agreements, premium deposit funds, investment-type contracts such as supplementary contracts not involving life contingencies and certain structured settlement annuities are based on account value or accepted actuarial methods using applicable interest rates.

 

Policy and Contract Claims

 

The liability for policy and contract claims is based upon the estimated ultimate cost of settling the claims, using past experience adjusted for current trends, and any other factors that modify past experience.

 

(i) Income Taxes

 

The Company uses a balance sheet approach of accounting for federal income taxes. Current income taxes incurred are charged to the statements of operations based on estimates for the current year. Under the balance sheet method, deferred tax assets, net

 

17

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

of any nonadmitted portion, and deferred tax liabilities are recognized for the future tax consequences attributable to differences between the statutory financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected on which those temporary differences are expected to be recovered or settled. The change in deferred taxes is charged or credited directly to surplus. The net deferred tax assets recorded are subject to the admissibility limitations and a valuation allowance, as applicable, set forth in SSAP No. 101, Income Taxes.

 

Beginning in 2022, the Company reported Equity Index Options as described in the Summary of Significant Accounting Policies Section (c) Derivative Instruments. The Company is following the Iowa prescribed method of accounting for statutory accounting purposes. For federal income tax purposes, the Company records the tax effect of mark-to-market unrealized gains (losses) in the period incurred and realized gains (losses) upon maturity. In 2023, the Company requested a change in the tax accounting method to spread the mark-to-market unrealized gains (losses) and realized gains (losses) over a three-year period. The Internal Revenue Service ("IRS") issued an approval of the requested change in tax accounting method in 2024.

 

The difference between statutory accounting and tax method results in material temporary differences that give rise to tax-effected Deferred Tax Assets ("DTA") of $18,700 and $12,400 as of December 31, 2025 and 2024, respectively. Additionally, the change in tax method of accounting requires recognition of IRC Section 481(a) adjustment to reflect the tax liability as if the new method had been used for three prior years. Per IRS guidance, the impact of Section 481(a) was recorded in 2023 and 2024. The result of application of Section 481(a) is an increase in taxable income in 2023 of $40,600 and a decrease in taxable income of $40,600 in 2024. As such, no Section 481(a) DTA remains as of December 31, 2025.

 

The Equity Options DTA is subject to admissibility rules under SSAP 101.

 

(j) Reinsurance

 

Assumed reinsurance premiums, claims and claim adjustment expenses are accounted for on a basis consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. For ceded business, the Company remains contingently liable for the liabilities in the event the reinsurers are unable to meet their obligations under the reinsurance agreements. To limit the possibility of such losses, the Company evaluates the financial condition of its reinsurers and monitors its concentration of credit risk.

 

(k) Amounts Recoverable and Payable Under Reinsurance Agreements

 

Amounts recoverable and payable under reinsurance agreements include amounts recoverable or due related to net settlements with assumed, ceded and retroceded activity.

 

(l) IMR/AVR

 

The Company is required to maintain an IMR and AVR. The IMR is used to defer realized capital gains and losses, net of any income tax, on fixed income investments and derivatives that are attributable to changes in market interest rates, including both changes in risk-free market interest rates and market credit spreads. Net realized capital gains and losses deferred to the IMR are amortized into investment income over the estimated remaining term to maturity of the investment sold. Negative IMR is admitted in accordance with the guidelines established by the Statutory Accounting Principles Working Group ("SAPWG") in their interpretive guidance within INT 23-01. The AVR represents a reserve for invested asset valuation using a formula

 

18

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

prescribed by the NAIC. The AVR is intended to protect surplus by absorbing declines in the value of the Company's investments that are not related to changes in interest rates. Increases or decreases in the AVR are reported as direct adjustments to surplus in the statements of changes in capital and surplus.

 

(m) Funds Withheld

 

The Company has coinsurance arrangements with funds withheld where the Company is both the ceding entity and the assuming entity. The following accounting applies to coinsurance arrangements with funds withheld:

 

The Company as Ceding Entity

 

Premiums paid or payable to the reinsurer reduce premium income. Policy benefits payments paid by the reinsurer reduce reported policy benefits. Commissions and expense allowances owed by the reinsurer are reported separately in the statements of operations as they are incurred. A net reduction to policy reserves is taken for the portion of the obligation assumed by the reinsurer. Any funds withheld by the Company as the ceding entity are recorded as a separate funds held liability in the statements of admitted assets, liabilities and capital and surplus.

 

The Company as Assuming Entity

 

Premiums received or receivable by the Company increase premium income. Policy benefit payments paid by the Company increase the reported policy benefits. Commissions and expense allowances owed by the Company are reported separately in the statements of operations when incurred. The Company records its share of the statutory policy reserves attributable to the business identified in the contract. Any funds withheld by the ceding entity are recorded by the Company as a separate funds held asset in the statements of admitted assets, liabilities and capital and surplus.

 

The Company also has a modified coinsurance arrangement with funds withheld where the Company is the ceding entity. The following accounting applies to modified coinsurance arrangements with funds withheld:

 

Ceding Entity

 

The Company retains assets equal to the modified coinsurance reserve. Premiums paid or payable to the reinsurer net of any experience refunds result in the reduction of premium income. Policy benefits payments paid by the reinsurer reduce reported policy benefits. Expense allowances paid by the reinsurer are reported separately in the statements of operations as they are incurred. The modified coinsurance reserve is included in policy reserves in the statements of admitted assets, liabilities and capital and surplus.

 

(n) Permitted Practice

 

In 2022, the Company requested and was granted a permitted practice by the Arizona Department of Insurance to follow the accounting practices prescribed by the Iowa Insurance Division Prescribed Method (Iowa administrative code r.191.97.1 – 191.97.7).

 

Under the permitted practice, financial options used for hedging purposes are recorded at amortized cost with amortization expense and realized gains recorded through net investment income instead of being recorded at market value with changes in

 

19

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

market value being recorded to Capital and Surplus and realized gains or losses being recorded to net realized gains (losses). For aggregate reserves for life contracts, the Company's liabilities are consistent with the guidance in AG33 CRVM which requires the crediting rate to be consistent with the market value of financial options, whereas under the permitted practice the crediting rate does not consider the market value of options.

 

The differences between NAIC and permitted practices impact to Net Income and Capital and Surplus as of December 31, 2025 and December 31, 2024 are as follows:

 

   2025  2024
Statutory summary of operations:          
Net income - permitted practice  $404,344   $192,878 
Investment income from derivatives   279,038    217,486 
Change in reserves   (99,971)   (36,196)
Realized gains and losses   (267,760)   (191,057)
Net Income - NAIC  $315,651   $183,111 
           
Capital and surplus - permitted practice  $3,059,382   $2,756,374 
Income impact from derivative instruments   97,128    85,848 
Deferred taxes   18,747    12,384 
Unrealized gains from derivatives   278,204    211,860 
Reserves   (300,331)   (157,803)
Capital and surplus - NAIC  $3,153,130   $2,908,663 

 

 

(3) Disclosures Concerning Fair Value of Financial Instruments

 

(a) Financial Instruments Fair Value Measurements

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value estimates are significantly affected by the assumptions used, including the discount rate and estimates of future cash flow. Although fair value estimates are calculated using assumptions that management believes are appropriate, changes in assumptions could cause these estimates to vary materially. In that regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in some cases, could not be realized in the immediate settlement of the instruments. Certain financial liabilities (including noninvestment type insurance contracts) and all nonfinancial instruments are excluded from the disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value to the Company.

 

The Company's financial assets and liabilities have been classified, for disclosure purposes, based on a hierarchy defined by SSAP No. 100, Fair Value Measurements and Disclosures. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). An asset or a liability's classification is based on the lowest level input that is significant to its measurement. For example, a Level 3 fair value measurement may include inputs that are both observable (Levels 1 and 2) and unobservable (Level 3).

 

20

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

The levels of the fair value hierarchy are as follows:

 

Level 1 Fair value is based on unadjusted quoted prices for identical assets or liabilities in active markets accessible at the measurement date.

 

Level 2 Fair value is based on quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads and yield curves.

 

Level 3 Fair value is based on valuations derived from techniques in which one or more significant inputs are unobservable (supported by little or no market activity). Unobservable inputs reflect the Company's best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date.

 

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument's level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. From time to time, there may be movements between levels as inputs become more or less observable, which may depend on several factors including the activity of the market for the specific security, the activity of the market for similar securities, the level of risk spreads and the source of the information from which we obtain the information. Transfers in or out of any level are measured as of the beginning of the period.

 

For financial instruments, the statement value and fair value, including level within the fair value hierarchy, at December 31, 2025 and 2024 were as follows:

 

   December 31, 2025
                       Net Asset
   Statement value   Fair value   Level 1   Level 2   Level 3   Value
General account assets:                              
Bonds - Issuer credit obligations  $17,886,768   $17,211,625   $834,619   $5,278,360   $11,098,646   $- 
Bonds - Asset-backed securities   8,457,483    7,899,085    -    6,577,043    1,322,042    - 
Preferred stocks   156,264    156,264    -    88,768    67,496    - 
Common stocks   264,718    264,718    -    201,250    63,468    - 
Mortgage loans   4,284,430    4,051,295    -    4,051,295    -    - 
Cash, cash equivalents, and short-term investments   3,376,357    3,376,357    1,158,030    2,218,327    -    - 
Contract loans   6,735    6,735    6,735    -    -    - 
Other invested assets   1,174,440    1,181,064    -    58,550    837,839    284,675 
Derivative instruments   168,578    446,600    -    387,078    59,522    - 
Receivable for securities   140,382    140,382    140,382    -    -    - 
Separate account assets   915,699    738,600    73,748    -    664,852    - 
                               
General account liabilities:                              
Liability for deposit-type contracts  $5,890,536   $5,890,536   $-   $-   $5,890,536   $- 
Amount payable under reinsurance agreements   172,653    172,653    172,653    -    -    - 
Derivative collateral   366,619    366,619    366,619    -    -    - 
Derivative instruments   2,770    2,770    -    2,770    -    - 
Payable for securities   121,715    121,715    121,715    -    -    - 
Loan payable   161    161    161    -    -    - 
Separate account liabilities   915,699    738,600    73,748    -    664,852    - 

 

21

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   December 31, 2024
   Statement                   Net Asset
   value   Fair value   Level 1   Level 2   Level 3   Value
General account assets:                              
Bonds  $22,379,427   $20,694,863   $1,171,650   $11,222,852   $8,300,361   $- 
Preferred stocks   171,642    171,559    -    94,929    76,630    - 
Common stocks   232,672    232,672    21,062    179,731    13,551    18,328 
Mortgage loans   3,911,417    3,566,176    -    3,566,176    -    - 
Cash, cash equivalents, and short-term                              
investments   3,884,769    3,883,901    3,883,901    -    -    - 
Contract loans   6,705    6,705    6,705    -    -    - 
Other invested assets   1,163,900    1,164,114    26,378    80,297    819,756    237,683 
Derivative instruments   181,744    393,125    -    363,791    29,334    - 
Receivable for securities   30,562    30,562    30,562    -    -    - 
Separate account assets   900,578    708,378    71,623    -    636,755    - 
                               
General account liabilities:                              
Liability for deposit-type contracts  $4,826,432   $4,826,432   $-   $-   $4,826,432   $- 
Amount payable under reinsurance                              
agreements   71,048    71,048    71,048    -    -    - 
Derivative collateral   323,850    323,850    323,850    -    -    - 
Payable for securities   98,175    98,175    98,175    -    -    - 
Loan payable   75,000    75,000    75,000    -    -    - 
Separate account liabilities   900,578    708,378    71,623    -    636,755    - 

 

The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments:

 

(I) Bonds

 

The statutory basis of accounting permits fair value disclosures for bonds to be based on valuations published by the SVO, quoted market prices, independent pricing services or internally developed pricing models. Management takes into consideration several sources of data in determining the fair values of bonds. The Company's valuation policy dictates that prices are initially sought from third party pricing services. In the event that pricing is not available from these services, or upon review of the prices provided it is determined the prices may not be reflective of market conditions, those securities are submitted to brokers to obtain quotes. The Company evaluates the third party pricing services and brokers to assess whether the vendor applies methodologies that will provide an appropriate value. The disclosure of fair value for bonds is primarily based on third party pricing services or broker quotes. For privately placed long-term bond investments without a readily ascertainable fair value, such values were determined utilizing a discounted cash flow methodology based on readily observable coupon rates, maturity provisions and credit assumptions from nearly-identical or similar investments.

 

The Company takes into consideration both qualitative and quantitative factors as part of its analysis, including but not limited to, an overall analysis of portfolio fair value movement against general movements in interest rates and spreads. The Company also compares price movement trends, considering the reasons for both significant price movements between periods and a lack of movement where the Company has become aware of securities that experienced a positive or negative credit or other event that would suggest the price provided has not captured market activity.

 

22

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Effective January 1, 2025, the Company adopted the NAIC Principles-Based Bond Definition Project (the "Bond Project"), as discussed in Note 2, which revised the definition of bonds for statutory accounting purposes. For further detail on the Company's implementation of the revised definitions, including management judgment in classifying investments as ICO or ABS, please refer to Note 2.

 

(II) Preferred Stocks

 

The fair values of preferred stocks are determined using prices provided by third party pricing services or broker quotes.

 

(III) Common Stocks

 

The fair value of unaffiliated common stocks is based on quoted market prices where available and internal estimates. The Company records its investments in investment funds based on the underlying U.S. GAAP audited equity of the investee which is measured at fair value.

 

(IV) Mortgage Loans

 

The fair value of mortgage loans is determined by a discounted cash flow methodology based on coupon rates, maturity provisions and credit assumptions. Depending on the credit quality and remaining term of the mortgage loan, the discount rate incorporates a spread that typically ranges from 150 to 350 basis points over treasury rates of a comparable tenor.

 

(V) Cash, Cash Equivalents and Short-Term Investments

 

The carrying values approximate fair value.

 

(VI) Contract Loans

 

The carrying values approximate fair value.

 

(VII) Other Invested Assets

 

The fair values of other invested assets in the table above, which consist of investment fund limited partnerships and limited liability companies, collateral loans, residual tranches of collateralized lending obligations, and surplus notes are determined as follows:

 

(a) Limited Partnerships and Limited Liability Companies

 

As allowed by NAIC SAP, fair values are not assigned to investments accounted for using the equity method. Fair values are determined using net asset values reported by the investee or internal estimates.

 

(b) Collateral Loans

 

The fair value of collateral loans is determined using interest and principal at a yield of interpolated swaps plus a spread. Due to the call feature, the fair value of collateral loans typically approximates their carrying value.

 

(c) Residual Tranches

 

Fair values are determined by using quoted market prices, independent pricing services, or internally developed pricing models.

 

23

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(d) Surplus Notes

 

The fair value of surplus notes is obtained from third party independent pricing services.

 

(VIII) Derivative Financial Instruments

 

The Company's derivative instruments and collateral generally represent those traded in over-the-counter markets for which fair value is estimated by the Company personnel using industry standard models with market observable inputs such as swap yield curves, Secured Overnight Financing Rate (SOFR) basis curves, option volatilities and credit spreads. The Company's derivative collateral payable primarily consists of U.S. treasuries and/or cash equivalents, for which cost approximates fair value.

 

(IX) Separate Accounts

 

Separate account assets and liabilities are carried at contract value, fair value or if there is no available market, then in accordance with the valuation procedures in the applicable contract. Separate account assets carried at fair value consist of investments recorded at net asset value, adjusted for stable value protection as applicable, and valued using a discounted cash flow methodology based on coupon rates, maturity provisions, and credit assumptions.

 

Separate account assets carried at contract value were $177,100 and $192,200 as of December 31, 2025 and 2024, respectively.

 

(X) Deposit-Type Contracts

 

For deposit-type contracts, the carrying value is payable upon demand, net of surrender charges. The account value of deposit-type contracts approximates fair value. Included in deposit-type contract liabilities are funding agreements with the Federal Home Loan Bank of Des Moines (FHLB) as well as secured funding agreements with Valerian Capital (VCAP). The Company manages these funds in an investment spread strategy, consistent with its other investment spread operations. Accordingly, the Company considers these funds policyholder liabilities (see note 11). Fair value of the FHLB funding agreements is equal to outstanding principal plus accrued interest.

 

24

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(b) Valuation of Financial Instruments held at Fair Value by Fair Value Hierarchy Levels

 

The following table presents the Company's assets and liabilities measured at fair value in the statements of admitted assets, liabilities, capital and surplus as of December 31, 2025 and 2024:

 

   December 31, 2025
   Level 1   Level 2   Level 3   Total
General account investment assets:                    
Bonds - Issuer credit obligations  $-   $-   $290   $290 
Bonds - Asset-backed securities   -    11,000    -    11,000 
Preferred stocks   -    88,768    67,496    156,264 
Common stocks   -    201,250    38,665    239,915 
Derivative instruments   -    (2,484)   -    (2,484)
Other invested assets   -    -    30,865    30,865 
Separate account assets  $73,748   $-   $664,852   $738,600 
                     
General account investment liabilities                    
Derivative instruments  $-   $2,770   $-   $2,770 
Separate account liabilities  $73,748   $-   $664,852   $738,600 

 

 

 

   December 31, 2024
   Level 1   Level 2   Level 3   Total
General account investment assets:                    
Bonds  $-   $1,521   $-   $1,521 
Preferred stocks   -    94,929    76,630    171,559 
Common stocks   21,062    179,731    13,551    214,344 
Derivative instruments        17,959    -    17,959 
Other invested assets   26,378    111    42,266    68,755 
Separate account assets   71,623    -    636,755    708,378 
                     
Separate account liabilities  $71,623   $-   $636,755   $708,378 

 

 

The Company may reclassify assets reported at fair value on a recurring basis between levels of the SSAP No. 100 fair value hierarchy if appropriate based on changes in the quality of valuation inputs available during a reporting period. There are no transfers between Level 1 and Level 2 during the years ended December 31, 2025 and 2024.

 

25

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value for the years ended December 31, 2025 and 2024:

 

   Balance,   Total gains or losses                   Transfers
to/from
   Ending
Balance
 
                           Transfer   separate     
   December 31,   Included in   Included in           Transfer into   out   account   December 31, 
   2024   net income   Surplus   Purchases   Sales   Level 3   of Level 3   assets/liabilities   2025 
Assets:                                             
Bonds - Issuer                                             
credit obligations  $-   $-   $-   $475   $(3,350)  $3,165   $-   $           -   $290 
Bonds - Asset- backed securities   -    -    -    -    -    -    -    -    - 
Common stocks   13,551    -    (462)   3,325    -    22,251    -    -    38,665 
Preferred stocks   76,630    -    (2,265)   -    (6,869)   -    -    -    67,496 
Other invested assets   42,266    -    (644)   -    (1,922)   25    (8,860)   -    30,865 
Separate account assets   636,755    34,889    15,100    -    (21,892)   -    -    -    664,852 
Total  $769,202   $34,889   $11,729   $3,800   $(34,033)  $25,441   $(8,860)  $-   $802,168 
                                              
Liabilities:                                             
Separate account liabilities   636,755    34,889    15,100    -    (21,892)   -    -    -    664,852 
Total  $636,755   $34,889   $15,100   $-   $(21,892)  $-   $-   $-   $664,852 

 

   Balance,   Total gains or losses                   Transfers
to/from
   Ending Balance 
                               separate     
   December 31,   Included in   Included in           Transfer into   Transfer out   account   December 31, 
   2023   net income   Surplus   Purchases   Sales   Level 3   of Level 3   assets/liabilities   2024 
Assets:                                    
Bonds  $ -   $ -   $ -   $ -   $      $ -   $ -   $ -   $ - 
Common stocks   20,325    -    (367)   12,159    (715)   478    (18,329)                    -    13,551 
Preferred stocks   84,826    -    861    -    (9,057)   -    -    -    76,630 
Other invested assets   79,903    -    (783)   14    (36,868)   -    -    -    42,266 
Separate account assets   620,046    102,242    (54,141)   -    (31,392)   -    -    -    636,755 
Total  $805,100   $102,242   $(54,430)  $12,173   $(78,032)  $478   $(18,329)  $-   $769,202 
Liabilities:                                             
                                              
Separate account liabilities   620,046    102,242    (54,141)   -    (31,392)   -    -    -    636,755 
Total  $620,046   $102,242   $(54,141)  $-   $(31,392)  $-   $-   $-   $636,755 

 

 

At the beginning of each reporting period, the Company evaluates whether or not any event has occurred or circumstances have changed that would cause an instrument to be transferred between levels as discussed in Note 3(a). Transfers in and out of Level 3 are primarily the result of using internal valuation models and estimates or reclassifications of invested assets.

 

26

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Quantitative Information about Level 3 Fair Value Measurements

 

The following table provides quantitative information about the significant unobservable inputs used for recurring fair value measurements categorized within Level 3:

 

 

   December 31, 2025 
   Assets/liabilities
measured at
fair value
   Valuation
technique(s)
  Unobservable input
description
  Input/range of
inputs (weighted
average)
 
Assets:                
                 
Bond                
Issuer Credit Obligation  $290   NAIC Designation  Expected recovery amount   N/A 
                 
Common stock                
Industrial   15,477   Internal model or third party valuation  Yield curve, discount rate   10-12% 
                 
Industrial   23,188   Cost  Trade price   - 
Preferred Stock                
                 
Industrial   67,496   Discounted cash flow model  Yield curve, discount rate   4.5-6.2% 
Other invested assets   30,865   Impaired value / Cost  Expected recovery amount / Trade Price   N/A 
Total equities   137,026            
                 
Separate accounts:                
Funds  $664,852   Contract value  Contract value   N/A 

 

 

 

   December 31, 2024 
   Assets/liabilities
measured at
fair value
   Valuation
technique(s)
  Unobservable input
description
  Input/range of
inputs (weighted
average)
 
Assets:                
Common stock                
Industrial  $13,551   Cost/net asset value  Yield curve, discount rate   12% 
Preferred Stock                
Industrial   76,630   Discounted cash flow model  Yield curve, discount rate   5.3-6.3% 
Other invested assets   42,266   Cost, pricing vendor, net asset value  Trade price, net asset value   N/A 
Total equities   132,447            
                 
Separate accounts:                
Funds  $636,755   Contract value  Contract value   N/A 

 

27

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(4) Investments

 

The carrying value and fair value of investments in bonds and equity securities as of December 31, 2025 and 2024 are as follows:

 

   2025
       Gross unrealized  Gross unrealized   Estimated fair
   Carrying value  gains   losses   value
Bonds - Issuer credit obligations                    
U.S. government obligations  $858,068   $5,807   $(21,124)  $842,751 
Municipal bonds – general obligations (D&G)   138,607    5    (30,662)   107,950 
Municipal bonds – special revenue   1,066,718    850    (225,143)   842,425 
Corporate bonds (unaff.)   15,385,540    103,746    (496,030)   14,993,256 
Corporate bonds - bonds issued by funds                    
representing operating entities (unaff.)   73,209    819    (2,794)   71,234 
Bank loans – acquired (unaff.)   364,625    810    (11,427)   354,008 
Bonds - Asset-backed securities                    
Financial - self liquidating                    
Agency RMBS - guaranteed   136,545    1,455    (5,433)   132,567 
Agency CMBS - guaranteed   15,658    54    (374)   15,338 
Agency RMBS - not/partially guaranteed   2,536,805    13,736    (226,423)   2,324,118 
Agency CMBS - not/partially guaranteed   128,160    1,396    (2,542)   127,014 
Non-agency RMBS (unaff.)   239,374    8,069    -    247,443 
Non-agency CMBS (unaff.)   1,023,916    6,869    (78,675)   952,110 
Non-agency - CLOs/CBOs/CDOs (unaff.)   2,043,610    7,492    (5,057)   2,046,045 
Other ABS (unaff.)   2,108,530    26,091    (306,352)   1,828,269 
Non-financial - practical expedient                    
Lease-backed securities - (unaff.)   27,114    32    (68)   27,078 
Other ABS (unaff.)   197,772    2,485    (1,154)   199,103 
Total bonds  $26,344,251   $179,716   $(1,413,258)  $25,110,709 
                     
      Gross unrealized  Gross unrealized  Estimated fair
   Cost  gains  losses  value
Common stocks  $274,856   $414   $(10,552)  $264,718 
                     
       Gross unrealized  Gross unrealized  Estimated fair
   Cost  gains  losses  value
Preferred stocks  $188,641   $394   $(32,771)  $156,264 

 

28

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   2024
       Gross  Gross    
       unrealized  unrealized  Estimated fair
   Carrying value  gains  losses  value
Bonds:                    
U.S. governments  $699,265   $1,181   $(26,255)  $674,191 
U.S. states, territories and possessions   8,913    -    (1,197)   7,716 
U.S. political subdivision of states, territories                    
and possessions   130,963    4    (28,011)   102,956 
U.S. special revenue, special assessment                    
obligations   3,353,393    2,211    (574,105)   2,781,499 
Industrial and miscellaneous unaffiliated   18,096,742    91,734    (1,143,224)   17,045,252 
Hybrid securities   90,151    7    (6,909)   83,249 
Total bonds  $22,379,427   $95,137   $(1,779,701)  $20,694,863 
                     
                     
       Gross unrealized  Gross unrealized  Estimated fair
   Cost  gains  losses  value
Common stocks  $244,779   $974   $(13,081)  $232,672 
                     
                     
       Gross unrealized  Gross unrealized  Estimated fair
   Cost  gains  losses  value
Preferred stocks  $199,764   $772   $(28,977)  $171,559 

 

 

As of December 31, 2025 and 2024, bonds with a carrying value of $6,598 and $6,597, respectively, are on deposit with various state insurance departments to meet regulatory requirements, which is approximately 0.02% of admitted assets.

 

29

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

The following tables analyze the Company's investment positions with unrealized losses segmented by type of security and period of continuous unrealized loss as of December 31, 2025 and 2024:

 

   2025
   Less than 12 months  Greater than 12 months  Total
       Unrealized      Unrealized      Unrealized
   Fair Value  losses  Fair Value  losses  Fair Value  losses
Bonds:                              
Issuer credit obligations                              
U.S. government  $392,014   $(6,315)  $228,084   $(14,809)  $620,098   $(21,124)
Municipal   2,433    (117)   925,476    (255,688)   927,909    (255,805)
Corporate   2,351,434    (95,345)   4,151,718    (400,685)   6,503,152    (496,030)
Foreign governments / Sovereigns   -    -    -    -    -    - 
All other   143,441    (7,656)   158,939    (6,565)   302,380    (14,221)
Asset-backed securities                              
Residential mortgage-backed                              
securities   204,607    (3,262)   1,338,246    (228,594)   1,542,853    (231,856)
Commercial mortgage-backed                              
securities   162,624    (2,315)   612,042    (79,276)   774,666    (81,591)
CLO / Other structured ABS   884,573    (6,798)   1,037,909    (305,833)   1,922,482    (312,631)
Total bonds  $4,141,126   $(121,808)  $8,452,414   $(1,291,450)  $12,593,540   $(1,413,258)
                               
Common stocks  $24,804   $(196)  $15,149   $(10,356)  $39,953   $(10,552)
                               
Preferred stocks  $28,128   $(1,888)  $88,768   $(30,883)  $116,896   $(32,771)

 

   2024
   Less than 12 months  Greater than 12 months  Total
       Unrealized      Unrealized      Unrealized
   Fair Value  losses  Fair Value  losses  Fair Value  losses
Bonds:                        
U.S. governments  $311,908   $(19,254)  $59,794   $(7,001)  $371,702   $(26,255)
U.S. states, territories and possessions   -    -    7,716    (1,197)   7,716    (1,197)
U.S. political subdivision of states,                              
territories and possessions   512    (3)   102,089    (28,008)   102,601    (28,011)
U.S. special revenue, special assessment                              
obligations   615,155    (11,056)   2,145,673    (563,049)   2,760,828    (574,105)
Industrial and miscellaneous unaffiliated   2,691,337    (144,672)   7,792,131    (998,552)   10,483,468    (1,143,224)
Hybrid securities   26,431    (677)   44,542    (6,232)   70,973    (6,909)
Total bonds  $3,645,343   $(175,662)  $10,151,945   $(1,604,039)  $13,797,288   $(1,779,701)
                               
Common stocks  $190   $(914)  $25,322   $(12,167)  $25,512   $(13,081)
                               
Preferred stocks  $-   $(1,002)  $94,928   $(27,975)  $94,928   $(28,977)

 

 

These securities are included in the Company's regular evaluation, on a security-by-security basis, of its investment holdings in accordance with its impairment policy in order to evaluate whether such securities are OTTI. Of all the debt securities in an unrealized loss position as of December 31, 2025 and 2024, 97.3% and 96.8% of the securities are rated investment grade, and 2.7% and 3.2% of the securities are rated as noninvestment grade. Investment grade is defined as those securities rated a "1" or "2", and noninvestment grade securities are defined as "3" through "6" by the Securities Valuation Office of the NAIC.

 

30

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

The Company believes the unrealized loss position is not necessarily predictive of the ultimate performance of these securities, and with respect to fixed maturity securities, it has the ability and intent to hold until the earlier of the recovery in value, or until maturity, and with respect to equity securities, it has the ability and intent to hold until the recovery in value. Evaluations of future OTTI will depend primarily on economic fundamentals, issuer performance, changes in collateral valuation, changes in interest rates, and changes in credit spreads. If economic fundamentals and any of the above factors continue to deteriorate, OTTI may be incurred in upcoming periods.

 

The Company recognized total realized losses for OTTI of $37,354 and $63,669 during 2025 and 2024, respectively. The Company recognized $0 and $0 realized losses for OTTI of asset-backed securities during 2025 and 2024, respectively.

 

There were no asset-backed securities as of December 31, 2025 and 2024, with a recognized OTTI for which the present value of cash flows expected to be collected was less than the amortized cost basis of the securities at the time of impairment. Expected maturities differ from contractual maturities because certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties. The carrying value and fair value of bonds as of December 31, 2025 by contractual maturity are as follows:

 

   Carrying value  Fair Value
Due in one year or less  $489,205   $488,860 
Due in one year through five years   4,264,810    4,251,629 
Due in five years through ten years   5,197,711    5,139,099 
Due after ten years   7,935,042    7,332,036 
    17,886,768    17,211,624 
Mortgage-backed and other asset-backed   8,457,483    7,899,085 
Total  $26,344,251   $25,110,709 

 

The table below indicates the amount of FHLB stock purchased/owned, which is 0.53% and 0.54% of admitted assets as of December 31, 2025 and 2024, respectively:

 

   2025   2024
FHLB stock purchased/owned as part of the agreement:          
Membership stock - Class A  $-   $- 
Membership stock - Class B   10,000    10,000 
Activity stock   191,250    166,500 
Excess stock   -    - 
Aggregate total  $201,250   $176,500 

 

 

                      6 months to     1 year to      
Membership stock (Class A and B) eligible   Current     Not eligible for     Less than     less than 1     less than 3      
for redemption   year total     redemption     6 months     year     years     3 to 5 years
Class A $ -   $ -   $ -   $ -   $ -   $ -
Class B   10,000     -     -     -     -     10,000

 

31

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Subprime Mortgage Related Risk Exposure

 

The Company does not have any direct exposure through investments in subprime mortgage loans.

 

Reverse Repurchase Agreements Transactions Accounted for as Secured Lending

 

The Company is authorized to enter into reverse repurchase agreements pursuant to the Company's investment guidelines. Each reverse repurchase agreement must be evidenced by a MRA or other written agreement between the Company and its counterparty. Under the terms of an MRA, the Company purchases investments from the counterparty and the counterparty agrees to repurchase the same, or similar, investments back from the Company on a specified date at a specified price. On the maturity date, the Company may elect to enter into a new reverse repurchase agreement with the same counterparty. The Company's decision to do so will be dependent on the Company's liquidity needs and its assessment of the counterparty and collateral's performance.

 

In order to mitigate the risk of a loss in value of the collateral securities, the Company requires its counterparties to provide assets in excess of the loan amount, otherwise known as overcollateralization. The amount of overcollateralization is up to the Company's discretion, but will not be less than 102%. Each of the Company's reverse repurchase agreements has a short duration, which further mitigates potential financial risks associated with these transactions. The Company's reverse repurchase agreements are bilateral and the Company does not enter into tri-party reverse repurchase agreements.

 

The following provides information related to reverse repurchase activity for 2025:

 

   Year Ended December 31, 2025
    First Quarter    Second Quarter    Third Quarter    Fourth Quarter 
Original flow and residual maturity                    
Maximum amount                    
One week to one month  $-   $-   $-   $- 
One to three months   -    -    -    - 
Three months to one year   114,842    114,842    113,250    113,250 
Ending balance                    
One week to one month  $-   $-   $-   $- 
One to three months   -    -    -    - 
Three months to one year   114,842    114,842    113,250    113,250 
Fair value of securities acquired under repo                    
Maximum amount  $172,218   $172,211   $161,000   $161,000 
Ending balance   172,218    172,211    161,000    161,000 

 

All reverse repurchase agreements were considered secured borrowing in 2025 for which all securities acquired under these arrangements were NAIC 1 rated instruments.

 

Repurchase Agreements Transactions Accounted for as Secured Borrowing

 

The Company is authorized to enter into repurchase agreements pursuant to the Company's investment guidelines. Each repurchase agreement must be evidenced by a MRA or other written agreement between the Company and its counterparties. Under the terms of the MRAs, the Company sells investments to the counterparty and the Company agrees to repurchase the same or similar investments back from the counterparty on a specific date at a specified price. On the maturity date, the

 

32

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Company may elect to enter into a new repurchase agreement with the same counterparty. The Company's decision to do so is dependent on the Company's liquidity needs and its assessment of the creditworthiness of the counterparty and the collateral's performance. The Company's repurchase agreements are bilateral and the Company does not enter into tri-party repurchase agreements. The Company had no outstanding repurchase agreement transactions accounted for as secured borrowing as of December 31, 2025 and 2024.

 

The following provides information related to repurchase activity for 2025:

 

   2025
   First Quarter  Second Quarter  Third Quarter  Fourth Quarter
Original flow and residual maturity                    
Maximum amount                    
One week to one month  -    $24,969   -    $             - 
One to three months   204,256    225,391    -    - 
Three months to one year   -    183,901    152,214    - 
Ending balance                    
One week to one month   $-    $24,969   $-    $- 
One to three months   204,256    225,391    -    - 
Three months to one year   -    183,901    152,214    - 
Fair value of securities provided under repo                    
Maximum amount   $196,593    $428,171   $146,871    $- 
Ending balance   196,593    428,171    146,871    - 
Carrying value of securities provided under repo                    
Maximum amount   $202,045    $431,358   $146,105    $- 
Ending balance   202,045    431,358    146,105    - 

 

33

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(5) Mortgage Loans

 

The Company purchases mortgages that are collateralized by commercial real estate and residential real estate. The Company had no commercial mortgages with interest due greater than 30 days past due and 75 residential mortgages with $5,616 in interest due greater than 30 days past due at the end of 2025. The Company had 4 commercial mortgages with $748 interest due greater than 30 days past due and 72 residential mortgages with $3,383 in interest due greater than 30 days past due at the end of 2024. Refer to the following table for further detail on the aging of the past due mortgages as of December 31, 2025 and 2024.

 

   Year Ended December 31, 2025
           Residential  Commercial                
   Farm  Insured  All Other  Insured  All Other  Mezzanine  Total
Recorded Investment (All)                                   
Current  $           -   $-   $622,988   $-   $3,527,095   $86,603   $4,236,686 
30-59 Days Past Due   -    -    11,206    -    -    -    11,206 
60-89 Days Past Due   -    -    4,525    -    -    -    4,525 
90-179 Days Past Due   -    -    10,742    -    -    -    10,742 
180+ Days Past Due   -    -    27,843    -    -    -    27,843 
Accruing Interest 90-179 Days Past Due                                   
Recorded Investment   -    -    10,742    -    -    -    10,742 
Interest Accrued   -    -    907    -    -    -    907 
Accruing Interest 180+ Days Past Due                                   
Recorded Investment   -    -    27,843    -         -    27,843 
Interest Accrued   -    -    3,925    -         -    3,925 
Interest Reduced                                   
Recorded Investment   -    -    -    -    -    -    - 
Number of Loans   -    -    -    -    -    -    - 
Percent Reduced   -    -    -    -    -    -    - 
Participant or Co-lender in a Mortgage                                   
Loan Agreement                                   
Recorded Investment   -    -    677,304    -    -    -    677,304 
Taxes, Assessments, and amounts advanced not included in mortgage loan total  $-   $-   $-   $-   $-   $-   $- 

 

34

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   Year Ended December 31, 2024
      Residential   Commercial      
   Farm  Insured   All Other   Insured   All Other   Mezzanine    Total
Recorded Investment (All)                                   
Current  $-   $-   $660,977   $-   $3,027,487   $101,720   $3,790,184 
30-59 Days Past Due   -    -    15,426    -    47,225    -    62,651 
60-89 Days Past Due   -    -    3,587    -    -    -    3,587 
90-179 Days Past Due   -    -    7,447    -    -    -    7,447 
180+ Days Past Due   -    -    31,625    -    22,530    389    54,544 
Accruing Interest 90-179 Days Past Due                                   
Recorded Investment   -    -    7,447    -    -    -    7,447 
Interest Accrued   -    -    411    -    -    -    411 
Accruing Interest 180+ Days Past Due                                   
Recorded Investment   -    -    31,625    -    22,530    389    54,544 
Interest Accrued   -    -    2,567    -    251    49    2,867 
Interest Reduced                                   
Recorded Investment   -    -    -    -    -    -    - 
Number of Loans   -    -    -    -    -    -    - 
Percent Reduced   -    -    -    -    -    -    - 
Participant or Co-lender in a Mortgage                                   
Loan Agreement                                   
Recorded Investment   -    -    719,062    -    -    -    719,062 
Taxes, Assessments, and amounts advanced not included in mortgage loan total  $-   $-   $-   $-   $-   $-   $- 

 

 

The aggregate ratio of amounts loaned to the fair value of collateral (loan-to-value ratio) for commercial mortgage loans originated during 2025 and 2024 were 55.3% and 49.5% with a maximum of 71.7% and 77.4% for any single loan during both 2025 and 2024, respectively. In circumstances where management has deemed it probable that the Company will be unable to collect all contractual principal and interest on a mortgage loan, a valuation allowance is established to reduce the statement value of the mortgage loan to its net realizable value. In 2025 and 2024, the Company recorded a valuation allowance on residential mortgages of $6,572 and $6,996 at December 31, 2025 and 2024, respectively. Commercial and residential mortgages have interest rates ranging from 2.5% to 14.5% per annum. During 2025 and 2024, the Company did not reduce coupon rates on any outstanding mortgages. The Company has accrued interest on mortgages of $33,209 and $25,999 at December 31, 2025 and 2024, respectively.

 

The tables below provide additional information regarding commercial and residential mortgage loans:

 

   December 31, 2025  December 31, 2024
Collateral Type  Carrying value  Percent of total  Carrying value  Percent of total
Multifamily  $1,391,954    32.4%  $1,263,349    32.2%
Other   777,149    18.1%   547,751    14.0%
Industrial   809,941    18.9%   826,806    21.1%
Office buildings   406,971    9.5%   335,820    8.6%
Retail   227,683    5.3%   225,625    5.8%
Residential   677,304    15.8%   719,062    18.4%
Total before allowance   4,291,002    100.0%   3,918,413    100.0%
Valuation allowance   (6,572)        (6,996)     
Total  $4,284,430        $3,911,417      

 

35

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   December 31, 2025  December 31, 2024
Geographic region  Carrying value  Percent of total  Carrying value  Percent of total
East  $671,562    15.7%  $654,914    16.7%
Midwest   704,657    16.4%   591,439    15.1%
South   1,351,144    31.5%   1,136,861    29.0%
West   1,563,639    36.4%   1,524,471    38.9%
Foreign   -    -%   10,728    0.3%
Total  $4,291,002    100.0%  $3,918,413    100.0%

 

The Company uses an internal rating system based upon the NAIC Risk Based Capital ("RBC") methodology as its primary method of monitoring credit quality. Along with specific loan terms, two key management assumptions are required including the risk rating of the loan (our current rating system AAA- highest quality to BB- low quality (watch) and then D- default or F-foreclosure) and estimated spreads for these loans over the U.S. Treasury yield curve corresponding to the remaining maturity. Spreads are updated monthly and loans are reviewed and rated annually with adjustments should significant changes occur during the year.

 

Our determination of each loan's risk rating as well as selection of the credit spread requires significant judgment and the current performance characteristics of the loan. A lower risk rating, as well as an increase in spreads would result in a decrease in discounted cash flows, and accordingly a lower fair value of the loan. We will then review the asset collateral value to determine the market value of the asset and therefore our loan value. This would involve either an outside appraisal of the property or an internal valuation based upon discussions with brokers and or appraisers in the immediate market and then desktop valuation of the asset using the direct capitalization approach to the value of the collateral.

 

The following table illustrates the Company's commercial mortgage loan portfolio categorized by the five risk cohorts established for risk-based capital which take into consideration loan-to-value and debt service coverage ratios to evaluate the relative risk of each commercial mortgage. Also provided is the equivalent Moody's designation:

 

                December 31, 2025            
                            CCC and      
    AAA/AA/A     BBB     BB     B     lower     Total
Commercial loans $ 1,384,804 $ 1,804,562 $ 324,508 $ 57,713 $ 42,111 $ 3,613,698
                         
                December 31, 2024            
                            CCC and      
    AAA/AA/A     BBB     BB     B     lower     Total
Commercial loans $ 1,224,731 $ 1,635,030 $ 275,251 $ 26,079 $ 38,260 $ 3,199,351

 

36

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(6) Net Investment Income

 

Major categories of net investment income for the years ended December 31, 2025 and 2024, are summarized as follows

 

   2025  2024
Income (loss):          
Bonds  $1,469,262   $1,123,726 
Preferred stock (unaffiliated)   13,930    12,428 
Common stock (unaffiliated)   25,475    24,587 
Mortgage loans   214,027    184,645 
Real estate   (970)   126 
Policy Loans   495    463 
Short-term investments   245,493    241,729 
Derivative instruments   111,336    119,195 
Ceded investment income   (169,854)   (176,794)
Other invested assets   70,125    122,340 
Other   70,876    37,139 
Total gross investment income   2,050,195    1,689,584 
Investment expense   (40,861)   (22,235)
           
Net investment income before amortization of net          
IMR gains   2,009,334    1,667,349 
Amortization of IMR gains   9,273    6,338 
Net investment income  $2,018,607   $1,673,687 

 

The cumulative amount of interest that has been paid-in-kind and included in the principal balance of investments in bonds at December 31, 2025 and 2024 was $38,697 and $32,817, respectively. The Company has investments in trust notes included in bonds that allow the deferral of interest. Total interest deferred related to trust notes included in investment income due and accrued at December 31, 2025 and 2024 was $260,714 and $230,485, respectively.

 

37

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   2025    2024
Net realized gains/(losses):          
Gross gains:          
Bonds  $5,745   $16,949 
Derivatives   200    9,117 
Other invested assets   1,456    1,444 
Other   -    96 
Total gross gains   7,401    27,606 
Gross (losses):          
Bonds   (29,987)   (39,734)
Derivatives   (5,914)   (5,805)
Other invested assets   (4,865)   (17,196)
Other   (18,354)   (18,888)
Total gross losses   (59,120)   (81,623)
Amounts assumed/ceded   7,191    5,281 
Net realized gains/(losses)   (44,528)   (48,736)
Net gains/(losses) allocated to IMR   227    6,546 
Net gains/(losses) allocated to AVR   (44,755)   (55,282)
Net realized gains/(losses)   (44,528)   (48,736)
Net gains/(losses) allocated to AVR   (44,755)   (55,282)
Less tax (benefit) expense   (9,399)   (11,609)
Report net realized gains/(losses)  $(35,356)  $(43,673)

 

Proceeds from sales of investments in bonds (excluding maturity proceeds) during 2025 and 2024 were $223,633 and $1,402,946, respectively. Gross losses of $3,298 in 2025 and $15,894 in 2024 and gross gains of $4,577 in 2025 and $7,249 in 2024 were realized on those sales.

 

(7) Derivative Instruments

 

The Company accounts for its interest rate swaps/forwards in accordance with SSAP No. 86, Derivatives (SSAP No. 86) (see note 2) and financial options under the Iowa Prescribed Method in connection with the permitted practice discussed further in Note 2 of the statutory financial statements. SSAP No. 86 requires derivative instruments used in hedging transactions that meet the prescribed criteria of a highly effective hedge to be valued and reported in a manner consistent with the hedged asset or liability (referred to as hedge accounting).

 

38

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(a) Financial Options

 

Financial options compensate the Company for any market appreciation over the strike price, and hedges or offsets certain insurance obligations that also increase when market appreciation exceeds a minimum level. The Company generally limits its selection of counterparties that are obligated under these derivative contracts to those with an "A" credit rating or above. Purchasing such agreements from financial institutions with long standing performance records minimizes the risk of counterparty default.

 

(b) Interest Rate Swaps

 

The Company has utilized interest rate swaps to hedge interest rate risk. Those swaps were considered to be economic hedges. The Company generally limits its selection of counterparties that are obligated under these derivative contracts to those with an "A" credit rating or above. Purchasing such agreements from financial institutions with long standing performance history minimizes the risk of counterparty default. Changes in fair value of these instruments are reported as a change in unrealized capital gains or losses until maturity or termination of the contract, at which time a realized capital gain or loss is recognized. In 2025, the Company entered into a $311,000 floating-to-fixed interest rate swap to hedge floating interest rates associated with certain private placement obligations (bonds), and the Company is utilizing hedge accounting as of December 31, 2025. As of December 31, 2025, the swap remained outstanding and, consistent with the hedged bonds, was carried at amortized cost, with a carrying value of $0 and a fair value of ($1,213). Income of ($178) was recorded in 2025 related to this swap.

 

In 2024, the Company entered into a $50,000 floating-to-fixed interest rate swap to hedge floating interest rates associated with certain collateralized lending obligations (bonds), and the Company continues to utilize hedge accounting as of December 31, 2025. This swap also remained outstanding as of December 31, 2025 and continued to be carried at amortized cost consistent with the hedged bonds. As of December 31, 2025, the swap had a carrying value of $0 and a fair value of $1,031. Income of ($145) was recorded in 2025 related to this swap.

 

(c) Currency Swaps, FX Forwards, and Futures

 

The Company utilizes currency swaps, FX forwards or futures agreements to reduce exposure to exchange rate risk on nondollar investments. The strategy the Company uses is to provide the funding for the investment they sell in U.S. dollars and buy the underlying foreign currency in the spot market. The Company also enters into a forward contract with a counterparty, usually a one-, three- or six-month transaction to sell the foreign currency and buy U.S. dollars at the forward exchange rate. The notional amount of the hedge is equal to the book value of the security. At the maturity date of the forward contract, the transaction is terminated by the Company making or receiving a payment in U.S. dollars to/from the counterparty based upon movement in the currency. The Company then hedges the book value of the position by entering into a new forward contract. This process continues until the maturity or sale of the security. Changes in fair value of these instruments are reported as a change in unrealized capital gains or losses until maturity or termination of the contract, at which time a realized capital gain or loss is recognized.

 

39

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

A summary of derivative asset and liability positions held by the Company as of December 31, 2025 and 2024, including carrying value and estimated fair values, appears below:

 

   December 31, 2025  December 31, 2024
   Number of  Carrying  Book  Estimated    Number of  Carrying  Book  Estimated
   contracts  value  Value  fair value    contracts  value  Value  fair value
Financial options   3,213   $171,062   $171,062   $449,266    2,707   $163,785   $163,785   $375,645 
Foreign currency forward   7    (3,138)   -    (3,138)   11    13,358         13,358 
Foreign currency swaps   4    (2,117)   (22)   (2,117)   4    4,601    (30)   4,601 
Interest rate swaps   3    -    -    (182)   1    -         (479)
Total derivatives   3,227   $165,807   $171,040   $443,829    2,723   $181,744   $163,755   $393,125 

 

The effects of the Company's use of derivative instruments on the statements of operations and changes in capital and surplus for the years ended December 31, 2025 and 2024 were as follows:

 

      December 31, 2025        December 31, 2024   
   Change in        Change in      
   unrealized  Net realized     unrealized  Net realized   
    capital gains  capital gains  Net investment  capital gains  capital gains  Net investment
   (losses)  (losses)    income  (losses)  (losses)    income
Financial options - Asset  $-   $               -   $110,911   $-   $               -   $118,120 
Foreign currency forward - Both   (16,496)   -    -    19,188    -    - 
Foreign currency swaps - Both   (6,726)   -    748    314    -    1,075 
Interest rate swaps - Both   -    -    (323)   (479)   -    - 
Total derivatives  $(23,222)  $-   $111,336   $19,023   $-   $119,195 

 

The Company ceded net realized gains totaling $25,126 and $38,626 during 2025 and 2024, respectively. The Company ceded option amortization expense totaling $16,029 and $19,848 at December 31, 2025 and 2024, respectively. The Company received cash collateral related to derivative transactions totaling $366,619 and $323,850 at December 31, 2025 and 2024, respectively. When collateral is received, it is invested and included in the statements of admitted assets, liabilities, capital and surplus in derivative collateral liabilities.

 

The Company held off-balance-sheet securities collateral related to derivative positions at both December 31, 2025 and 2024. Collateral is received from counterparties when the value of the related derivative positions is in the Company’s favor and is maintained in segregated custodial accounts. Fair value of collateral held totaled $93,975 at December 31, 2025 and $53,017 at December 31, 2024. The collateral consisted of investment-grade fixed-income securities provided by the Company’s derivative counterparties.

 

40

 

EQUITRUST LIFE INSURANCE COMPANY
Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

A summary of off-balance-sheet collateral held by counterparty is presented below (in thousands):

 

   December 31, 2025
      Related Derivative  Fair Value of
   Collateral Type  Types  Collateral Held
Counterparty:           
JPMorgan Chase  Investment-grade securities    Financial Options    $70,568 
Bank of America  Investment-grade securities    Financial Options     23,407 
         $93,975 

 

   December 31, 2024
      Related Derivative  Fair Value of
   Collateral Type  Types  Collateral Held
Counterparty:           
Bank of America  Investment-grade securities    Financial Options    $53,017 
         $53,017 

 

These collateral amounts reduce the Company’s credit exposure to counterparties but do not eliminate the risk of counterparty nonperformance.

 

The Company uses derivatives for hedging risks related to equity markets, interest rates, and foreign exchange rates and the details for those uses and the parameters around the Company’s management of derivatives is further documented in the Company’s Derivative Use Plan.

 

The Company is exposed to limited counterparty credit risk (the risk that the counterparty fails to perform under the terms of the derivative contract). The Company purchases derivatives from multiple counterparties and evaluates the creditworthiness of the counterparties at the time of purchase. While the contracts require the Company to pay an upfront premium, the counterparties are required to pledge collateral to the Company per the terms of the collateral support documents which further mitigates potential credit risk. The credit exposure is the fair value of the derivative instruments as of December 31, 2025 and 2024, as disclosed above. Cash is required at the initiation of the contract and contracts are settled for value at termination.

 

41

 

 

EQUITRUST LIFE INSURANCE COMPANY
Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

(8) Federal Income Taxes

 

Federal income taxes are calculated and presented in accordance with SSAP No. 101, Income Taxes, current income taxes consist of the following major components:

 

   December 31
   2025  2024
Current income tax:          
Federal  $145,284   $117,026 
Subtotal   145,284    117,026 
Federal income tax expense (benefit) on net capital gains   (9,351)   (10,235)
Other   4,360    14,431 
Total federal and foreign income taxes expense (benefit)  $140,293   $121,222 

 

The provision for federal income taxes incurred is different from that which would be obtained by applying the statutory federal income tax rate to income before income taxes including realized capital gains and losses. The significant items causing this difference for the years ended December 31, 2025, and 2024 are as follows:

 

   December 31, 2025
   Amount  Statutory 21% tax
effect
  Effective tax rate
Income before taxes (including realized capital gains/(losses))  $544,815   $114,411    21.00%
Investment related   (28,811)   (6,050)   (1.11)%
Effects of reinsurance in surplus   (85,647)   (17,986)   (3.30)%
Wholly owned disregarded entities   (8,811)   (1,850)   (0.34)%
Other tax adjustments   (14,657)   (3,078)   (0.56)%
Total   406,889    85,447    15.68%
                
Federal income taxes incurred        140,293    25.75%
Change in net deferred income taxes       $(54,847)   (10.07)%
Total statutory income taxes        85,446    15.68%

 

The most significant gross differences between the enacted 21% tax rate and the effective tax rate relates to the 2023 Hannover and RGA reinsurance treaties. The Statutory profit emergence has been reversed for tax in the amounts of ($42,311) and ($44,243) for Hannover and RGA, respectively. Since the 2023 Surplus Gain was fully included in the 2023 taxable income, the 2025 rate reconciliation reflects reversal of the 2025 Statutory profit emergence.

 

Permanent adjustments related to tax-exempt interest and IMR for the 2025 tax year contributed gross differences of ($28,408) between the enacted and effective tax rates.

 

42

 

 

EQUITRUST LIFE INSURANCE COMPANY
Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

   December 31, 2024
      Statutory 21% tax   
   Amount  effect  Effective tax rate
Income before taxes (including realized capital gains/(losses))  $319,272   $67,047    21.00%
Investment related   (25,575)   (5,371)   (1.68)%
Correction of prior period error   (58,301)   (12,243)   (3.83)%
Effects of reinsurance in surplus   73,112    15,354    4.81%
Wholly owned disregarded entities   (5,997)   (1,259)   (0.39)%
Other tax adjustments   (1,695)   (356)   (0.11)%
Total   300,816    63,171    19.79%
                
Federal income taxes incurred       $121,222    37.97%
Change in net deferred income taxes        (58,051)   (18.18)%
Total statutory income taxes       $63,171    19.79%

 

The Company corrected an error in its tax reserves as of December 31, 2023, which were understated by $56,353. The 2023 resulting federal income tax liability has been recorded separately and included in the December 31, 2024, federal income tax liabilities.

 

The components of the net deferred tax asset (liability) at December 31, 2025 and 2024 are as follows:

 

   December 31, 2025  December 31, 2024     Change   
   Ordinary  Capital  Total  Ordinary  Capital  Total  Ordinary  Capital  Total
Gross deferred tax assets  $192,970   $41,922   $234,892   $147,192   $37,732   $184,924   $45,778   $4,190   $49,968 
Statutory valuation allowance adjustment   -    -    -    -    -    -    -    -    - 
Adjusted gross deferred tax assets   192,970    41,922    234,892    147,192    37,732    184,924    45,778    4,190    49,968 
Deferred tax assets nonadmitted   -    -    -    -    -    -    -    -    - 
Subtotal - (gross admitted deferred tax asset)   192,970    41,922    234,892    147,192    37,732    184,924    45,778    4,190    49,968 
Deferred tax liabilities   126,854    29,579    156,433    120,442    46,427    166,869    6,412    (16,848)   (10,436)
Net admitted deferred tax asset (liability)  $66,116   $12,343   $78,459   $26,750   $(8,695)  $18,055   $39,366   $21,038   $60,404 

 

43

 

 

EQUITRUST LIFE INSURANCE COMPANY
Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

   December 31, 2025  December 31, 2024  Change
   Ordinary  Capital  Total  Ordinary  Capital  Total  Ordinary  Capital  Total
Federal income taxes paid in prior years recoverable through loss carrybacks  $-   $7,325   $7,325   $-   $-   $-   $-   $7,325   $7,325 
Adjusted gross deferred tax assets expected to be realized after application of the threshold limitation   85,783    5,018    90,801    62,130    29,204    91,334    23,653    (24,186)   (533)
Adjusted gross deferred tax assets expected to be realized following the balance sheet date   85,783    5,018    90,801    62,130    29,204    91,334    23,653    (24,186)   (533)
Adjusted gross deferred tax assets allowed per limitation threshold   XXX    XXX    447,138    XXX    XXX    410,583    XXX    XXX    47,663 
Adjusted gross deferred tax assets offset by gross deferred tax liabilities   107,187    29,579    136,766    85,062    8,528    93,590    22,125    21,051    43,176 
Deferred tax assets admitted as the result of application of SSAP 101  $192,970   $41,922   $234,892   $147,192   $37,732   $184,924   $45,778   $4,190   $49,968 

 

 

   2025  2024
Ratio percentage used to determine recovery period and threshold limitation amount   879.31%   948.73%
Amount of adjusted capital and surplus used to determine recovery period and threshold limitation above  $2,980,923   $3,035,375 

 

 

   December 31, 2025  December 31, 2024  Change
   Ordinary  Capital  Ordinary  Capital  Ordinary  Capital
Adjusted gross deferred tax assets  $192,970   $41,922   $147,192   $37,732   $45,778   $4,190 
Percentage of adjusted gross deferred tax assets by tax character attributable to the impact of tax planning strategies   0.0%   2.1%   0.0%   0.0%   0.0%   2.1%
Net admitted adjusted gross deferred tax assets  $192,970   $41,922   $147,192   $37,732   $45,778   $4,190 
Percentage of net admitted adjusted gross deferred tax assets by tax character admitted because of the impact of tax planning strategies   0.0%   2.1%   0.0%   0.0%   0.0%   2.1%

 

The Company does not have deferred tax liabilities that it has not recognized.

 

44

 

 

EQUITRUST LIFE INSURANCE COMPANY
Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of December 31, 2025, and 2024 are as follows:

 

   December 31
   2025  2024  Change
Deferred tax assets:               
Ordinary:               
Policyholder reserves  $134,873   $99,132   $35,741 
Investments   19,977    12,543    7,434 
Deferred acquisition costs   36,141    34,012    2,129 
Fixed assets   586    1,502    (916)
Receivables-nonadmitted   -    -    - 
Other (including items <5% of total ordinary tax assets)   1,393    3    1,390 
Subtotal   192,970    147,192    45,778 
Admitted ordinary deferred tax assets   192,970    147,192    45,778 
Capital:               
Investments   41,805    37,527    4,278 
Real estate   117    206    (89)
Other (including items <5% of total ordinary tax assets)   -    (1)   1 
Subtotal   41,922    37,732    4,190 
Admitted capital deferred tax assets   41,922    37,732    4,190 
Admitted deferred tax assets  $234,892   $184,924   $49,968 
Deferred tax liabilities:               
Ordinary:               
Investments  $57,259   $41,312   $15,947 
Policyholder reserves   69,595    79,130    (9,535)
Fixed assets   -    -    - 
Other (including items <5% of total ordinary tax assets)   -    -    - 
Subtotal   126,854    120,442    6,412 
Capital:               
Investments   29,579    46,427    (16,848)
Other (including items <5% of total ordinary tax assets)   -    -    - 
Subtotal   29,579    46,427    (16,848)
Deferred tax liabilities   156,433    166,869    (10,436)
Net deferred tax assets/liabilities  $78,459   $18,055   $60,404 

 

45

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

The change in net deferred income taxes is comprised of the following (this analysis is exclusive of nonadmitted assets as the change in nonadmitted assets is reported separately from the change in net deferred income taxes in the surplus section of the annual statement):

 

   December 31
   2025  2024  Change
Total deferred tax assets  $234,892   $184,924   $49,968 
Total deferred tax liabilities   156,433    166,869    (10,436)
Net deferred tax assets/(liabilities)   78,459    18,055    60,404 
Statutory valuation allowance adjustment   -    -    - 
Net deferred tax assets/(liabilities) after valuation allowance  $78,459   $18,055   $60,404 
Tax effect of unrealized (gains)/losses            $(5,557)
Statutory valuation allowance adjustment allocated to unrealized             - 
Other intraperiod allocation of deferred tax movement             - 
Change in net deferred income tax ((expense)/benefit)            $54,847 

 

At December 31, 2025 and 2024, the Company did not have any operating loss carryforwards, or CAMT credit carryforwards.

 

The Company has no amounts or deposits admitted pursuant to Section 6603 of the Internal Revenue Code.

 

The following capital gain taxes were incurred by the Company in the current and prior years that will be available for recoupment in the event of future net capital losses:

2025: $687

2024: $6,638

2023: -

 

The Company has reviewed open tax years for the major jurisdictions and has concluded that there is no significant federal income tax liability resulting from uncertain tax positions. As of December 31, 2025, the calendar years 2018 through 2024 remain open for examination by the IRS. The IRS audits for tax returns prior to 2017 are closed.

 

The Corporation Alternative Minimum Tax (“CAMT”), imposes a 15% minimum tax on the adjusted financial statement income of large corporations for taxable years beginning after December 31, 2022. The CAMT generally applies to large corporations with three-year average annual financial statement income exceeding $1 billion. The Company has determined that it will not be subject to CAMT based on the financial income average under $1 billion.

 

The Company has determined that all deferred tax assets are recoverable and therefore a valuation allowance is not needed.

 

Tax Law Change H.R.1, also referred to as the “One Big Beautiful Bill Act” (the “Tax Act of 2025”), was enacted into law on July 4, 2025. The Company determined that the One Big Beautiful Bill did not have a material impact on its overall financial position for the year ended December 31, 2025.

 

46

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

(9) Reinsurance

 

EquiTrust is involved in the assumption and cession of life insurance risk through various coinsurance agreements with former affiliated and nonaffiliated companies. The effects of these agreements on the components of net income in the accompanying statements of operations for the years ended December 31, 2025 and 2024 are as follows:

 

   2025  2024
   Assumed  Ceded  Assumed  Ceded
Premiums  $3,059   $891,421   $3,708   $514,457 
Annuity and surrender benefits   46,561    583,706    60,441    644,631 
Increase (decrease) in policy reserves   (34,080)   196,283    (44,172)   686,386 

 

To the extent that any reinsuring companies are unable to meet obligations under the aforementioned reinsurance agreements, the Company would remain liable for business ceded.

 

Effective October 1, 2023, the Company entered into an indemnity reinsurance agreement with Hannover Life Reassurance of America (Bermuda) Ltd. for specified closed blocks of Fixed Indexed Annuities (“FIA”) with guaranteed lifetime withdrawal benefit (“GLWB”) policies in force on the Effective Date, issued between January 1, 2014 and December 31, 2023. The financial statement impact of this treaty resulted in a reduction of reserves of $348,730, offset by a surplus increase of $288,283 and Commission and Expense Allowances on Reinsurance Ceded of $60,447 and increased Income Taxes of $49,107. For 2023, $11,340 was released into income from surplus. In 2024 the related emergence of profits moved $47,469 of Surplus through Commissions and Expenses on Reinsurance Ceded. On September 30, 2024, the companies entered into an amendment to the agreement to add 2024 policies and set new quota shares and premium factors for those policies. On January 1, 2025 and September 1, 2025, the companies entered into two amendments to the agreement which added additional issue years through 2025, updated quota share percentages, a new product, additional rider versions, and updates to premium factors and calculations. The total reinsurance credit added under the amended agreement for 2024 was $598,425. In 2025 the related emergence of profits moved $42,311 of Surplus through Commissions and Expenses on Reinsurance Ceded.

 

Effective December 31, 2023, the Company entered a quota share reinsurance treaty with RGA Reinsurance Company, LTD. to transfer risks related to its FIA block. The block includes in force policies without GLWBs issued between 2014 and 2022. The financial statement impact of this treaty resulted in a reduction of reserves of $206,923, offset by a surplus increase of $206,923. In 2024 the related emergence of profits moved $25,682 of Surplus through Commissions and Expenses on Reinsurance Ceded. An October 1, 2024, agreement amendment resulted in a Surplus increase and a reduction of reserves of $145,395 for policy periods before 2024. On April 1, 2025 and August 6, 2025, the companies entered into two amendments to the agreement which provided recapture and duration updates, changes to quota share percentages on existing issue years, developed cohort splits and quota share percentages, updated endorsements and riders, updated premium schedules to reflect by cohort years, and updated attachment points and percentages. For policies in the agreement issued in 2024, a reserve decrease of $100,103 was offset by a decrease in change in reserve. In 2025 the related emergence of profits moved $44,243 of Surplus through Commissions and Expenses on Reinsurance Ceded.

 

(10) Related Parties

 

The Company had an investment of $25,800 with EquiTrust Principal Investment Company, LLC (EPIC), an affiliated entity. The underlying asset was transferred at carrying cost to the Company in Q3 of 2023.

 

47

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

Any associated losses incurred were reimbursed to EPIC at that time. The property is now reported as real estate at $25,800.

 

The Company entered into a reinsurance treaty with affiliate Atlanta Life Insurance Company (ALIC) that became effective at the end of the last business day of 2022. The treaty is structured on a coinsurance with funds withheld basis. Beginning in April of 2023, monthly net settlements were made based on the activity under this treaty. The treaty was amended effective January 1, 2024 to include policies issued in 2019 which increased the funds withheld liability by $150,075. The treaty was amended effective July 1, 2025 to include policies issued in 2020, 2021 and 2022 which increased the funds withheld liability by $405,138. At December 31, 2025 and December 31, 2024, the funds withheld liability held by the Company for the business ceded to ALIC under this treaty was $509,717 and $242,613, respectively.

 

The Company entered into an assumption reinsurance agreement for a block of business from NCM, a North Carolina domiciled life and annuity company in receivership under The National Organization of Life & Health Insurance Guaranty Association (“NOLHGA”). The Company entered into a reinsurance treaty with affiliate ALIC that became effective at the end of the last business day of 2024. The treaty is structured on a coinsurance with funds withheld basis. The Company has agreed to reinsure the prior NCM policyholder activity and business to ALIC on a monthly basis. In the third quarter of 2025, the Company and NCM revised the original purchase agreement and underlying policies to be assumed. The Company originally agreed to assume a block of approximately 112,000 policies, but revised the agreement to only assume approximately 16,000 policies. This reduced underlying reserves by approximately $86,000. At December 31, 2025, the Company ceded reserves of $36,699 and other net assets of $1,900 to ALIC, and established a funds withheld liability for the business ceded of $34,799.

 

The Company entered into a reinsurance treaty with the affiliate ALIC that became effective December 31, 2025. The treaty is structured as a quota share coinsurance arrangement where the Company assumes from ALIC 85% of the Minnesota Life and Securian Life group life business on a quarterly basis. At December 31, 2025, the Company assumed 85% of the IBNR reserves under this treaty for $2,136.

 

On September 6, 2024, a Form A Statement Regarding the Acquisition of Control of or Merger with a Domestic Insurer was filed with the Arizona Department. On June 10, 2025, the Arizona Department approved the Acquisition and it was consummated on November 14, 2025, thereby making the Registrant, Heritage Life Insurance Company, a member of Amistad Financial Group, LLC’s holding company system. Prior to the merger, the Company had an existing reinsurance agreement effective December 31, 2012 with Heritage Life Insurance Company (HLIC). The Company reinsured to HLIC specific fixed and indexed annuity products and riders for policies issued in 2012 on a 100% quota share coinsurance funds withheld basis. At December 31, 2025 the reserves ceded under the agreement were $631,661.

 

(11) Policy Liabilities

 

The Company has $781,240 and $742,424 of life insurance reserves at December 31, 2025 and 2024, respectively. The amount of insurance in force for which gross premiums are less than the net premiums according to the valuation standard required by the Arizona Department of Insurance was $6,802 and $5,968 at December 31, 2025 and 2024, respectively.

 

The Company waives deduction of deferred fractional premiums upon death of the insured and returns any portion of the final premium beyond the date of death. Surrender values are not promised in excess of the legally computed reserves.

 

Several methods are employed in reserving for substandard lives, depending upon the plan and date of issue. In some cases,

 

48

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

extra premiums are charged for substandard lives in addition to the regular gross premium for the true age. Mean reserves are generally based on appropriate multiples of standard rates of mortality, but in some cases the extra reserve held is equal to one-half the gross annual premium. There is one plan where substandard cases are assigned an adjusted age and all reserves are calculated at standard mortality rates for the adjusted age.

 

Tabular interest, tabular cost and tabular less actual reserves release have been determined by formula for all insurance and annuities, respectively, except for universal life and variable universal life where tabular interest was determined from basic policy data. Tabular interest on funds not involving life contingencies has been determined by accounting data.

 

As of December 31, 2025, withdrawal characteristics of annuity actuarial reserves and deposit-type contract funds and other liabilities without life or disability contingencies were as follows:

 

   December 31, 2025
      Separate      
      accounts      
   General account  nonguaranteed  Total  Percent of total
A. Individual annuities:                    
(1) Subject to discretionary withdrawal:                    
a. With market value adjustment  $ 23,267,024   $ -   $ 23,267,024    83.5%
b. At book value less current surrender charge of 5% or more   1,411,320    -    1,411,320    5.1%
c. At fair value   -    -    -    -%
d. Total with market value adjustment or at fair value (total of a-c)   24,678,344    -    24,678,344    88.6%
e. At book value without adjustments (minimal or no charge or adjustment)   2,073,838    35,261    2,109,099    7.6%
(2) Not subject to discretionary withdrawal   226,571    841,952    1,068,523    3.8%
(3) Total (gross: direct + assumed)   26,978,753    877,213    27,855,966    100.0%
(4) Reinsurance ceded   3,897,906    35,261    3,933,167      
(5) Total net (3) - (4)  $ 23,080,847   $ 841,952   $ 23,922,799      
(6) Amount included in A(1)b above that will move to A(1)e in the year after the statement date:  $ 93,608   $ -   $ 93,608      

 

49

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements
Years ended December 31, 2025 and 2024
(In thousands of dollars, except per share data)

 

        Separate        
        accounts        
    General account   nonguaranteed   Total   Percent of total
B. Group annuities:                                
(1) Subject to discretionary withdrawal:                                
a. With market value adjustment   1,125,331                       -     1,125,331       84.8 %
b. At book value less current surrender charge of 5% or more     -       -       -       - %
c. At fair value     -       -       -       - %
d. Total with market value adjustment or at fair value (total of a-c)     1,125,331       -       1,125,331       84.8 %
e. At book value without adjustments (minimal or no charge or adjustment)     191,355       -       191,355       14.4 %
(2) Not subject to discretionary withdrawal     9,618       -       9,618       0.7 %
(3) Total (gross: direct + assumed)     1,326,304       -       1,326,304       100.0 %
(4) Reinsurance ceded     337,771       -       337,771          
(5) Total net (3) - (4)   988,533     -     988,533          
(6) Amount included in B(1)b above that will move to B(1)e in the year after the statement date:   -     -     -          

 

        Separate        
        accounts        
    General account   nonguaranteed   Total   Percent of total
C. Deposit-type contracts (no life contingencies):                                
(1) Subject to discretionary withdrawal:                                
a. With market value adjustment   488,242                       -     488,242       7.9 %
b. At book value less current surrender charge of 5% or more     -       -       -       - %
c. At fair value     -       -       -       - %
d. Total with market value adjustment or at fair value (total of a-c)     488,242       -       488,242       7.9 %
e. At book value without adjustments (minimal or no charge or adjustment)     323,188       -       323,188       5.2 %
(2) Not subject to discretionary withdrawal     5,402,795       -       5,402,795       86.9 %
(3) Total (gross: direct + assumed)     6,214,225       -       6,214,225       100.0 %
(4) Reinsurance ceded     323,689       -       323,689          
(5) Total net (3) - (4)   5,890,536     -     5,890,536          
(6) Amount included in C(1)b above that will move to C(1)e in the year after the statement date:   -     -     -          

 

50

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Below is a reconciliation, as of December 31, 2025, of annuity reserves, exhibit 5 and deposit fund liabilities, exhibit 7 and the Separate Accounts Statement as required by SSAP 51R:

 

   December 31, 2025 
Life & Accident & Health Annual Statement     
Exhibit 5, Annuity Reserves, Total (net)  $24,047,206 
Exhibit 5, Supplementary Contracts with Life Contingencies Section, Total (net)   22,174 
Exhibit 7, Deposit-Type Contracts   5,890,536 
Subtotal General Account   29,959,916 
Separate Account Annual Statement     
Other contract deposit funds   841,952 
Subtotal Separate Account   841,952 
Combined Total  $30,801,868 

 

As of December 31, 2024, withdrawal characteristics of annuity actuarial reserves and deposit-type contract funds and other liabilities without life or disability contingencies were as follows:

 

   December 31, 2024 
      Separate         
      accounts         
   General account   nonguaranteed   Total   Percent of total 
A. Individual annuities:                    
(1) Subject to discretionary withdrawal:                    
a. With market value adjustment  $20,231,760   $-   $20,231,760    83.2%
b. At book value less current surrender charge of 5% or more   1,124,182    -    1,124,182    4.6%
c. At fair value   -    -    -    -%
d. Total with market value adjustment or at fair value (total of a-c)   21,355,942    -    21,355,942    87.8%
e. At book value without adjustments (minimal or no charge or adjustment)   1,962,244    34,272    1,996,516    8.2%
(2) Not subject to discretionary withdrawal   134,270    828,956    963,226    4.0%
(3) Total (gross: direct + assumed)   23,452,456    863,228    24,315,684    100.0%
(4) Reinsurance ceded   3,151,703    34,272    3,185,975      
(5) Total net (3) - (4)  $20,300,753   $828,956   $21,129,709      
(6) Amount included in A(1)b above that will move to A(1)e in the year after the statement date:  $83,941   $-   $83,941      

 

 51 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

   General account   Separate
accounts
nonguaranteed
   Total   Percent of total 
B. Group annuities:                
(1) Subject to discretionary withdrawal:                    
a. With market value adjustment  $1,367,064   $-   $1,367,064    88.9%
b. At book value less current surrender charge of 5% or more   -    -    -    -%
c. At fair value   -    -    -    -%
d. Total with market value adjustment or at fair value (total of a-c)   1,367,064    -    1,367,064    88.9%
e. At book value without adjustments (minimal or no charge or adjustment)   160,300         160,300    10.4%
(2) Not subject to discretionary withdrawal   10,374         10,374    0.7%
(3) Total (gross: direct + assumed)   1,537,738    -    1,537,738    100.0%
(4) Reinsurance ceded   391,095         391,095      
(5) Total net (3) - (4)  $1,146,643   $-   $1,146,643      
(6) Amount included in B(1)b above that will move to B(1)e in the year after the statement date:  $-   $-   $-      

 

   General account   Separate
accounts
nonguaranteed
   Total   Percent of total 
C. Deposit-type contracts (no life contingencies):                    
(1) Subject to discretionary withdrawal:                    
a. With market value adjustment  $464,353   $-   $464,353    9.0%
b. At book value less current surrender charge of 5% or more   -    -    -    -%
c. At fair value   -    -    -    -%
d. Total with market value adjustment or at fair value (total of a-c)   464,353    -    464,353    9.0%
e. At book value without adjustments (minimal or no charge or adjustment)   322,328    -    322,328    6.3%
(2) Not subject to discretionary withdrawal   4,363,472    -    4,363,472    84.7%
(3) Total (gross: direct + assumed)   5,150,153    -    5,150,153    100.0%
(4) Reinsurance ceded   323,721    -    323,721      
(5) Total net (3) - (4)  $4,826,432   $-   $4,826,432      
(6) Amount included in C(1)b above that will move to C(1)e in the year after the statement date:  $-   $-   $-      

 

 52 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Below is a reconciliation, as of December 31, 2024, of annuity reserves, exhibit 5 and deposit fund liabilities, exhibit 7 and the Separate Accounts Statement as required by SSAP 51R:

 

   December 31, 2024 
Life & Accident & Health Annual Statement     
Exhibit 5, Annuity Reserves, Total (net)  $21,426,971 
Exhibit 5, Supplementary Contracts with Life Contingencies Section, Total (net)   20,425 
Exhibit 7, Deposit-Type Contracts   4,826,432 
Subtotal General Account   26,273,828 
Separate Account Annual Statement     
Other contract deposit funds   828,956 
Subtotal Separate Account   828,956 
Combined Total  $27,102,784 

 

As of December 31, 2025, withdrawal characteristics of life actuarial reserves were as follows:

 

    General account    Separate account - guaranteed and nonguaranteed 
    Account value    Cash value    Reserve    Account value    Cash value    Reserve 
A. Subject to discretionary withdrawal, surrender                              
values, or policy loans:                              
(1) Term policies with cash value  $-   $2,053   $422   $-   $-   $- 
(2) Universal life   71,254    71,871    75,032    -    -    - 
(3) Universal life with secondary guarantees   9    2    309    -    -    - 
(4) Indexed universal life   715,593    706,536    720,847    -    -    - 
(5) Indexed universal life with secondary guarantees   -    -    -    -    -    - 
(6) Indexed life   -    -    -    -    -    - 
(7) Other permanent cash value life insurance   -    35,413    37,845    -    -    - 
(8) Variable life   -    -    -    -    -    - 
(9) Variable universal life   6,498    6,374    6,560    38,487    38,487    38,487 
(10) Miscellaneous reserves   -    -    -    -    -    - 
B. Not subject to discretionary withdrawal or no cash values                              
(1) Term policies without cash value   XXX    XXX    735    XXX    XXX    - 
(2) Accidental death benefits   XXX    XXX    22    XXX    XXX    - 
(3) Disability - active lives   XXX    XXX    2    XXX    XXX    - 
(4) Disability - disabled lives   XXX    XXX    40    XXX    XXX    - 
(5) Miscellaneous reserves   XXX    XXX    252    XXX    XXX    - 
(6) Indexed life   XXX    XXX    -    XXX    XXX    - 
C. Total (gross: direct + assumed)   793,354    822,249    842,066    38,487    38,487    38,487 
D. Reinsurance ceded   18,301    55,637    60,827    38,487    38,487    38,487 
E. Total (net) (C) - (D)  $775,053   $766,612   $781,239   $-   $-   $- 

 

 53 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Below is a reconciliation, as of December 31, 2025, of life reserves, exhibit 5 and the Separate Accounts Statement as required by SSAP 51R:

 

  December 31, 2025 
Life & Accident & Health Annual Statement    
Exhibit 5, Life Reserves, Total (net)  $781,240 
Subtotal General Account   781,240 
Separate Account Annual Statement      
Other contract deposit funds   38,481 
Combined Total  $819,721 

 

As of December 31, 2024, withdrawal characteristics of life actuarial reserves were as follows:

 

    General account    Separate account - guaranteed and nonguaranteed 
    Account value    Cash value    Reserve    Account value    Cash value    Reserve 
A. Subject to discretionary withdrawal, surrender                              
values, or policy loans:                              
(1) Term policies with cash value  $-   $6,845   $575   $-   $-   $- 
(2) Universal life   80,837    81,182    84,774    -    -    - 
(3) Universal life with secondary guarantees   18    10    289    -    -    - 
(4) Indexed universal life   661,672    659,710    676,387    -    -    - 
(5) Indexed universal life with secondary guarantees   -    -    -    -    -    - 
(6) Indexed life   -    -    -    -    -    - 
(7) Other permanent cash value life insurance   -    113,307    119,649                
(8) Variable life   -    -    -    -    -    - 
(9) Variable universal life   6,323    6,214    6,371    37,351    37,351    37,351 
(10) Miscellaneous reserves   -    -    -    -    -    - 
B. Not subject to discretionary withdrawal or no cash values                              
(1) Term policies without cash value   XXX    XXX    1,961    XXX    XXX    - 
(2) Accidental death benefits   XXX    XXX    74    XXX    XXX    - 
(3) Disability - active lives   XXX    XXX    5    XXX    XXX    - 
(4) Disability - disabled lives   XXX    XXX    68    XXX    XXX    - 
(5) Miscellaneous reserves   XXX    XXX    463    XXX    XXX    - 
(6) Indexed life   XXX    XXX    -    XXX    XXX    - 
C. Total (gross: direct + assumed)   748,850    867,267    890,616    37,351    37,351    37,351 
D. Reinsurance ceded   22,169    142,189    148,191    37,351    37,351    37,351 
E. Total (net) (C) - (D)  $726,681   $725,078   $742,424   $-   $-   $- 

 

 54 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Below is a reconciliation, as of December 31, 2024, of life reserves, exhibit 5 and the Separate Accounts Statement as required by SSAP 51R:

 

  December 31, 2024 
Life & Accident & Health Annual Statement    
Exhibit 5, Life Reserves, Total (net)  $742,424 
Subtotal General Account   742,424 
Separate Account Annual Statement     
Other contract deposit funds   37,336 
Combined Total  $779,760 

 

Reserves for life and annuity contracts increased from 2024 to 2025 as premium inflow from new sales outpaced benefit outflows. There are $22,174 and $20,424 of supplementary contracts with life contingencies included in the table above in 2025 and 2024, respectively.

 

Effective December 20, 2024, the Company issued a secured funding agreement in the amount of $500 million to VCAP 2024‑A LLC. Effective June 24, 2025, the Company issued an additional secured funding agreement in the amount of $500 million to VCAP 2025‑A LLC. Under the terms of these agreements, EquiTrust receives cash consideration and records a corresponding deposit obligation, with interest credited to the holders in accordance with the contractual interest rates and payment schedules.

 

Consistent with the nature of these arrangements and the Company's use of the proceeds in its investment spread strategy, the Company applies SSAP No. 52 – Deposit‑Type Contracts to these obligations. The funding agreements are recorded as deposit liabilities and are not part of the Company’s strategy to finance general operating activities. Should the Company obtain funds for general corporate operations in the future, such borrowings would be accounted for under SSAP No. 15 – Debt.

 

The Company is a member of the FHLB. Through its membership, the Company has conducted business activity with the FHLB. It is part of the Company's strategy to utilize these funds to achieve a spread over the attendant borrowing costs.

 

The table below indicates the carrying value of collateral pledged related to the membership agreement with the FHLB as of December 31, 2025 and 2024, respectively:

 

   2025   2024 
Collateral held in FHLB custody account  $6,420,526   $5,499,132 

 

The amount of collateral to admitted assets is 17.0% and 16.4%, in 2025 and 2024, respectively:

 

The fair value of maximum collateral pledged during 2025 and 2024 is $5,699,549 and $4,534,664, respectively.

 

 55 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

Information regarding the liabilities related to the membership agreement with the FHLB as of December 31, 2025, and 2024 is as follows:

 

   2025 
   General account   Separate account   Total 
Borrowing from FHLB:               
Funding Agreement  $4,250,000   $-   $4,250,000 
Other   -    -    - 
Aggregate total  $4,250,000   $-   $4,250,000 
Policyholder liabilities related to FHLB  $4,081,000   $-   $4,081,000 
Maximum amount of borrowing reported:               
Funding Agreement  $4,250,000   $-   $4,250,000 
Other   -    -    - 
Aggregate total  $4,250,000   $-   $4,250,000 

 

   2024 
   General account   Separate account   Total 
Borrowing from FHLB:               
Funding Agreement  $3,700,000   $-   $3,700,000 
Other   -    -    - 
Aggregate total   3,700,000    -    3,700,000 
Policyholder liabilities related to FHLB  $3,530,000   $-   $3,530,000 
Maximum amount of borrowing reported:               
Funding Agreement  $3,700,000   $-   $3,700,000 
Other   -    -    - 
Aggregate total  $3,700,000   $-   $3,700,000 

 

The Company does not have prepayment obligations under debt, funding agreements, or other borrowings.

 

 56 

 

 

EQUITRUST LIFE INSURANCE COMPANY

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024

(In thousands of dollars, except per share data)

 

(12) Separate Accounts

 

The Company's separate accounts relate to variable individual annuities (in run-off), supplemental contracts, individual private placement funding agreements, and private placement variable universal life insurance products. The Company has $915,699 and $900,578 of assets legally insulated from the general account as of December 31, 2025 and 2024, respectively. The Company has no non-insulated assets as of December 31, 2025 and 2024, respectively. Information regarding the separate accounts of the Company is as follows:

 

   2025   2024 
Premiums, considerations or deposits  $1,359   $2,058 
Reserves at December 31, for accounts with assets at          
Fair value   738,599    708,378 
Contract value   177,100    192,200 
Total reserves  $915,699   $900,578 
Reserves with withdrawal characteristics at fair value  $73,747   $71,623 
Not subject to discretionary withdrawal   841,952    828,955 
Total reserves  $915,699   $900,578 

 

Fees paid by the separate accounts associated with investment management and administration of the separate accounts were $1,760 and $1,725 at December 31, 2025 and 2024, respectively. There were no amounts reported as transfers to and from separate accounts in the summary of operations of the Company's NAIC separate account annual statements or amounts reported as net transfers to separate accounts in the accompanying statements of operations for the years ended December 31, 2025 and 2024.

 

(13) Capital and Surplus

 

As of December 31, 2025 and 2024, the Company has 2,500 authorized shares of common stock, with a par value of $1,500 per share and 2,000 shares issued and outstanding.

 

The Company did not receive capital contributions from EquiTrust Holdings LLC during 2025 and 2024. There is no capital contribution accrued as of December 31, 2025 and 2024. The Company is subject to statutory and regulatory restrictions imposed by the Arizona Department of Insurance which limits the amount of cash dividends that may be paid to the stockholders. Under Arizona law, cash dividends may be paid only from unassigned surplus. Additionally, the maximum aggregate amount of ordinary dividends that the Company may declare or pay during any twelve month period is the greater of (1) 10% of its statutory surplus, or (2) net gain from operations provided that unassigned surplus is positive and sufficient to cover the payment, each as reported in the prior year's annual statement, unless written approval is obtained from the Arizona Department of Insurance granting a greater amount (extraordinary dividend). The Company may declare an ordinary dividend to shareholders without prior approval from the Arizona Department of Insurance in the amount of up to $404,344 in 2026.

 

The ability of the Company to pay future dividends is dependent on business conditions, income, cash requirements of the Company, and other relevant factors.

 

 57 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Notes to Statutory Financial Statements 

Years ended December 31, 2025 and 2024 

(In thousands of dollars, except per share data)

 

(14) Commitments and Contingencies

 

a. Lease Commitments

 

The Company leases office space in four locations. A ten-year lease extension for an office in West Des Moines was signed on August 29, 2016 and the new payment terms took effect on January 1, 2017. A ten year lease for an office in Chicago was signed on January 11, 2016. On July 23, 2020, a second amendment to the Chicago lease was signed to include additional office space, that is coterminous with the original space. A five year lease for an office in Scottsdale, AZ was signed on July 24, 2023. Rent expense under these leases totaled $1,043 and $931 in 2025 and 2024, respectively.

 

At December 31, 2025, the minimum aggregate future lease commitments of $7,997 are summarized as follows:

 

Year ended December 31  Operating leases 
2026  $1,422 
2027   1,098 
2028   1,056 
2029   1,033 
2030   965 
2031 and thereafter   2,423 
   $7,997 

 

b. Capital Funding Commitments

 

The Company has future outstanding commitments to fund or make certain additional investments to issuers of debt and equity investments. The table below provides additional information regarding the outstanding commitments:

 

   2025 - Open Commitments 
PD BridgeCo Holdings  $250,000 
USIT Investor LLC DDTL I   225,000 
PDIF Capital Funding   205,000 
USIT Investor LLC DDTL II   200,000 
Commercial mortgages   176,410 
All other   171,654 
   $1,228,064 

 

c. Other Contingencies

 

Under insurance guaranty fund laws, in most states insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. The Company does not believe such assessments will be materially different from amounts already provided for in the financial statements. Most of the laws do provide, however, that an assessment may be excused or deferred if it would threaten an insurer's own financial strength.

 

 58 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Notes to Statutory Financial Statements

Years ended December 31, 2025 and 2024 

(In thousands of dollars, except per share data)

 

d. Litigation

 

The Company is involved in various lawsuits in the normal course of business. The status of these legal actions is actively monitored by management. If management believed, based on available information, that an adverse outcome upon resolution of a given legal action was probable and the amount of that adverse outcome was reasonably estimable, a loss would be recognized and a related liability recorded. No such liabilities were recorded by the Company as of December 31, 2025 and 2024.

 

(15) Reconciliation with Statutory Financial Statements Filed

 

There were no adjustments subsequent to the filing of the 2025 annual statement.

 

Subsequent to the filing of the 2024 annual statement, management identified presentation differences in the statutory Cash Flow included in the accompanying statutory financial statements. Management has moved cash activity associated with Changes in Deposit-Type Funds from Net Cash from Operations to Cash from Financing and Miscellaneous Activities for 2024. Other Sources, Net, has been broken out to provide transparency to some of its larger components for 2024. A reconciliation of presentation as reported in the annual statement to the amounts included in the accompanying Statutory Financial Statements as of and for the year ended December 31, 2024 is provided below:

 

 

 

           2024 Annual   2024 Statutory     
Cash Flow (Use)/Source  Change   Note   Statement   Audit Report   Note 
Cash flow from operating activities:                         
Benefits paid  $(463,418)   #   $(1,428,700)  $(1,892,118)   # 
Cash flow from financing and miscellaneous activities:                         
Other cash provided (used):                         
Borrowed funds   -         74,935    74,935      
Change in deposit-type funds   464,503    #    -    464,503    # 
Funds held under coinsurance   (21,276)   *    -    (21,276)   * 
Changes in receivable from subsidiary   (1,145)   *    -    (1,145)   * 
Changes in payable from subsidiary   460    *    -    460    * 
Payable for Securities Lending   -    *    -    -    * 
Change in derivative liability   91,316    *    -    91,316    * 
Other sources, net   (70,440)   *#    42,514    (27,926)   *# 
Net cash used in financial and miscellaneous   463,418         117,449    580,867      

* Breakout Item

# Reclassifications Subsequent

2024 Annual Statement

 

 

(16) Subsequent Events

 

Management has evaluated events subsequent to December 31, 2025 through April 17, 2026, the date these financial statements were available to be issued.

 

 59 

 

 

SUPPLEMENTAL SCHEDULES

 

 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Schedule of Assets and Liabilities 

December 31, 2025 

(In thousands of dollars)

 

The following is a summary of certain financial data included in other exhibits and schedules and utilized by actuaries in the determination of reserves.

 

Investment Income Earned (excluding amortization of IMR):    
Government bonds  $33,613 
Other bonds (unaffiliated)   1,435,649 
Bonds affiliates   - 
Preferred stocks (unaffiliated)   13,930 
Preferred stocks of affiliates   - 
Common stocks (unaffiliated)   25,475 
Common stocks of affiliates   - 
Mortgage loans   214,027 
Real estate   (970)
Premium notes, policy loans, and liens   495 
Collateral loans (not included in codification)   - 
Cash on hand and on deposit   39,024 
Short-term investments   206,469 
Other invested assets   70,125 
Derivative instruments   111,336 
Ceded investment income   (169,854)
Aggregate write-ins for investment income   70,876 
Total gross investment income (excluding amortization of IMR)  $2,050,195 
Real estate owned (book value less encumbrances)     
Mortgage loans (book value):     
Farm mortgages  $- 
Residential mortgages   670,732 
Commercial mortgages   3,613,698 
Total mortgage loans  $4,284,430 
Mortgage loans by standing (book value):     
Good standing     
Good standing with restructured terms  $4,245,845 
Interest overdue more than 90 days, not in foreclosure   10,742 
Foreclosure in process   27,843 
Total mortgage loans  $4,284,430 
Other long-term assets (statement value)  $410,617 
Collateral loans   763,823 

 

 

(continued)

 

 61 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Schedule of Assets and Liabilities 

December 31, 2025 

(In thousands of dollars)

 

Bonds and short-term investments by class and maturity    
Bonds and short-term investments by maturity (statement value):    
Due within one year  $3,486,044 
Over 1 year through 5 years   6,430,559 
Over 5 years through 10 years   8,196,796 
Over 10 years through 20 years   6,481,005 
Over 20 years   4,081,423 
Total by maturity  $28,675,827 
Bonds and short-term investments by class (statement value):     
Class 1  $12,719,385 
Class 2   15,303,315 
Class 3   445,357 
Class 4   117,046 
Class 5   79,434 
Class 6   11,290 
Total by class  $28,675,827 
Total bonds publicly traded  $10,795,797 
Total bonds privately placed   17,880,031 
Preferred stocks (statement value)   156,264 
Common stocks (fair value)   264,718 
Cash, cash equivalents and short-term investments (book value)   3,376,357 
Financial options owned (current value)   171,062 
Financial options written and in-force (current value)   - 
Financial forwards/swaps contracts open (current value)   (5,255)
Life insurance in-force:     
Industrial   - 
Ordinary   1,066 
Credit life   - 
Group life   16,590 
Amount of accidental death insurance in-force under ordinary policies   - 
Life insurance policies with disability provision in-force:     
Industrial   - 
Ordinary   40,229 
Credit life   - 
Group life   - 
Supplementary contracts in-force:     
Ordinary – not involving life contingencies:     
Amount on deposit   - 
Income payable   25,949 
Ordinary – involving life contingencies:     
Income payable   2,021 

 

(continued)

 

 62 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Schedule of Assets and Liabilities 

December 31, 2025 

(In thousands of dollars)

 

Group – not involving life contingencies:    
Amount on deposit  $ - 
Income payable   1,276 
Group – involving life contingencies:     
Income payable  $167 
Annuities:     
Ordinary:     
Immediate – amount of income payable  $79,160 
Deferred – fully paid account balances   14,063,716 
Deferred – not fully paid account balances   10,253,259 
Group:     
Amount of income payable  $2,302 
Deferred – fully paid account balances   812,552 
Deferred – not fully paid account balances   232,163 
Accidental and health insurance – premiums in force:     
Ordinary  $- 
Group   - 
Credit   - 
Deposit-funds and dividends accumulations:     
Deposit-funds – account balance   - 
Dividend accumulations – account balance   - 
Claim payments 2019:     
Group accident health:     
2019  $- 
2018   - 
2017   - 
2016   - 
2015   - 
Prior   - 
Other accident and health:     
2019  $- 
2018   - 
2017   - 
2016   - 
2015   - 
Prior   - 
Other coverages that use developmental methods to calculate claim reserves:     
2019  $- 
2018   - 
2017   - 
2016   - 
2015   - 
Prior  $- 

 

See accompanying independent auditors' report

 

 63 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Summary Investment Schedule 

December 31, 2025 

(In thousands of dollars)

 

           Admitted assets as reported in the annual 
   Gross investment holdings   statement 
   Amount   Percentage   Amount   Percentage 
Issuer credit obligations                    
U.S. governments  $858,068    2.4%  $858,068    2.4%
Other U.S. government obligations   -    0.0%   -    0.0%
Non-U.S. sovereign jurisdiction securities   -    0.0%   -    0.0%
Municipal bonds - general obligations (direct & guaranteed)   138,607    0.4%   138,607    0.4%
Municipal bonds - special revenue   1,066,718    3.0%   1,066,718    3.0%
Project finance bonds issued by operating entities   -    0.0%   -    0.0%
Corporate bonds   15,385,541    42.8%   15,385,541    42.8%
Mandatory convertible bonds   -    0.0%   -    0.0%
Single entity backed obligations   -    0.0%   -    0.0%
SVO-identified bond exchange traded funds - fair value   -    0.0%   -    0.0%
SVO-identified bond exchange traded funds - systematic value   -    0.0%   -    0.0%
Bonds issued by funds representing operating entities   73,209    0.2%   73,209    0.2%
Bank loans - issued   -    0.0%        0.0%
Bank loans - acquired   364,625    1.0%   364,625    1.0%
Mortgage loans that qualify as SVO-identified credit tenant loans   -    0.0%        0.0%
Certificates of deposit   -    0.0%        0.0%
Other issuer credit obligations   -    0.0%        0.0%
Total issuer credit obligations   17,886,768    49.7%   17,886,768    49.7%
Asset-backed securities                    
Financial asset-backed securities - self-liquidating   8,232,597    22.9%   8,232,597    22.9%
Financial asset-backed securities - not self-liquidating   -    0.0%   -    0.0%
Non-financial asset-backed securities   224,886    0.6%   224,886    0.6%
Total asset-backed securities   8,457,483    23.5%   8,457,483    23.5%
Preferred stocks:                    
Industrial and miscellaneous (unaffiliated)   156,264    0.4%   156,264    0.4%
Parent, subsidiaries and affiliates   -    0.0%   -    0.0%
Total preferred stocks   156,264    0.4%   156,264    0.4%
Common stocks:                    
Industrial and miscellaneous - publicly traded (unaffiliated)   216,922    0.6%   216,922    0.6%
Industrial and miscellaneous - other   47,796    0.1%   47,796    0.1%
Parent, subsidiaries and affiliates - publicly traded   -    0.0%   -    0.0%
Parent, subsidiaries and affiliates - other   -    0.0%   -    0.0%
Mutual funds   -    0.0%   -    0.0%
Unit investment trusts   -    0.0%   -    0.0%
Closed-end funds   -    0.0%   -    0.0%
Total common stocks   264,718    0.7%   264,718    0.7%
Mortgage loans:                    
Farm mortgages   -    0.0%   -    0.0%
Residential mortgages   677,304    1.9%   677,304    1.9%
Commercial mortgages   3,527,095    9.8%   3,527,095    9.8%
Mezzanine real estate loans   86,603    0.2%   86,603    0.2%
Valuation allowance   (6,572)   -    (6,572)   - 
Total mortgage loans   4,284,430    11.9%   4,284,430    11.9 
Real estate                    
Properties occupied by company   -    0.0%   -    0.0%
Properties held for production of income   -    0.0%   -    0.0%
Properties held for sale   46,075    0.1%   46,075    0.1%
Total real estate   46,075    0.1%   46,075    0.1%
Cash, cash equivalents and short-term investments:                    
Cash   8,951    0.0%   8,951    0.0%
Cash equivalents   1,102,846    3.1%   1,102,846    3.1%
Short-term investments   2,264,560    6.3%   2,264,560    6.3%
Total cash, cash equivalents and short-term investments   3,376,357    9.4%   3,376,357    9.4%

 

(continued)

 

 64 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Summary Investment Schedule 

December 31, 2025 

(In thousands of dollars)

 

           Admitted assets as reported in the 
    Gross investment holdings    annual statement 
    Amount    Percentage    Amount    Percentage 
Contract loans  $6,735    0.0%  $6,735    0.0%
Derivatives   168,578    0.5%   168,578    0.5%
Other invested assets   1,174,440    3.3%   1,174,440    3.3%
Receivables for securities   148,100    0.4%   140,382    0.4%
Securities lending   -    0.0%   -    0.0%
Total invested assets  $35,969,948    100.0%  $35,962,230    100.0%

 

See accompanying independent auditors' report

 

 65 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Investment Risk Interrogatories 

December 31, 2025 

(In thousands of dollars)

 

The Company’s total admitted assets excluding separate account assets was $36,866,815 as filed in the 2025 annual statement.

 

The Company’s ten largest exposures to a single issuer/borrower/investment, excluding U.S. government, U.S. government agency securities and those U.S. government money market funds listed in the Appendix to the SVO Purposes and Procedures Manual as exempt, property occupied by the Company and policy loans at December 31, 2025 are as follows:

 

          Percent of total 
Issuer Type  Type  Amount   admitted assets 
American Media Productions, LLC  Bonds  $350,000    0.9%
LCN, LLC  Bonds/Common Stock/Other Invested Assets   286,018    0.8 %
Kosmos Management, LLC  Bonds   210,981    0.6%
Supreme Universal Holdings LTD  Bonds   150,000    0.4%
JLC Infrastructure Fund 1 & 2 LP  Other Invested Assets   138,095    0.4%
Plus Power Enterprises LC  Bonds   100,000    0.3%
Harbourview Strategic Core Partners  Bonds/Other Invested Assets   98,737    0.3%
Washburn Financial Trust A-1  Bonds   93,550    0.3%
Virginia St Hsg Dev Auth  Bonds   86,056    0.2%
Secured Finance 2020-12 LLC  Bonds   85,000    0.2%

 

The amounts and percentages of the Company’s total admitted assets held in bonds and preferred stocks at December 31, 2025 by NAIC rating are as follows:

 

Bonds Preferred Stocks 
       Percentage of total          Percentage of total 
NAIC Rating  Amount   Admitted   NAIC Rating  Amount   Admitted 
NAIC-1  $12,712,756    34.5%  P/RP-1  $39,738    0.1%
NAIC-2   15,309,945    41.5%  P/RP-2   90,767    0.2%
NAIC-3   445,357    1.2%  P/RP-3   25,760    0.1%
NAIC-4   117,046    0.3%  P/RP-4   -    -%
NAIC-5   79,434    0.2%  P/RP-5   -    -%
NAIC-6   11,290    0.0%  P/RP-6   -    -%

 

The Company holds admitted assets in foreign investments of approximately $3,101,124 or 8.4% of total admitted assets.

 

The amounts and percentages of the Company’s total admitted assets held in foreign investments at December 31, 2025 by NAIC rating were as follows:

 

       Percentage of total 
   Amount   admitted assets 
Countries rated NAIC-1  $3,071,810    8.3%
Countries rated NAIC-2   29,314    0.1%
Countries rated NAIC-3 and below   -    -%
   $3,101,124    8.4%

 

(continued)

 

 66 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Investment Risk Interrogatories 

December 31, 2025 

(In thousands of dollars)

 

The largest foreign investment exposures in a single country categorized by NAIC sovereign rating:

 

       Percentage of total 
   Amount   admitted assets 
Countries rated NAIC-1          
Country: Cayman Islands  $1,842,505    5.0%
Country: United Kingdom   357,177    1.0%
Countries rated NAIC-2          
Country: Mexico   29,314    0.1%
Country: None   -    0.00%
Countries rated NAIC-3 and below          
None   -    0.00%

 

The ten largest non-sovereign (i.e., nongovernmental) foreign issues:

 

           Percentage of total 
Issuer  NAIC Rating   Amount   admitted assets 
LCN EUROPEAN LLC   1   $160,710    0.4%
BRITISH TELECOM PLC   2    65,855    0.2%
HSBC HOLDINGS PLC   2    50,341    0.1%
1769 FUNDING INC   2    44,624    0.1%
VODAFONE GROUP PLC   2    32,177    0.1%
PFIZER IVNESTMENT ENTERPRISSES pte   1    30,977    0.1%
AERCAP IRELAND CAP GLOBA   2    30,450    0.1%
ESSAR OIL UK LIMITED   1    30,000    0.1%
TELEFONICA EMISIONES SAU   2    29,445    0.1%
TAKEDA PHARMACEUTICAL CO LTD   2    27,831    0.1%

 

(continued)

 

 67 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Investment Risk Interrogatories 

December 31, 2025 

(In thousands of dollars)

 

The Company holds admitted assets in Canadian investments of $101,420 or 0.3% for 2025.

 

The Company holds no assets with contractual sales restrictions; therefore, detail is not provided.

 

The ten largest equity interests:

 

       Percentage of total 
Issuer  Amount   admitted assets 
           
FEDERAL HOME LOAN BANK OF DES MOINES  $201,250    0.5%
JLC INFRASTRUCTURE FUND I LP   100,545    0.3%
MC CREDIT FUND II LP   81,749    0.2%
ARBOR REALTY TRUST INC   52,399    0.1%
JLC INFRASTRUCTURE FUND II LP   37,550    0.1%
1543 CAPITAL MANAGEMENT   30,840    0.1%
HARBOURVIEW STRATEGIC CORE PARTNERS I LP   28,737    0.1%
VINEBROOK HOMES TRUST INC   28,128    0.1%
KKR REAL ESTATE FINANCE TRUST INC   25,760    0.1%
ANTARES PRIVATE CREDIT FUND   24,804    0.1%

 

The Company holds no assets in general partnership interests; therefore, detail is not provided.

 

The Company holds mortgage loans of approximately $4,284,430 or 11.6% and $3,911,417 or 12.0% of total admitted assets for 2025 and 2024, respectively; Information regarding the Company's ten largest aggregate mortgage interests at December 31, 2025 and 2024 is as follows:

 

           Percentage of total 
Borrower  Type   Amount   admitted assets 
                
GREENPOINT IOS PORTFOLIO   COMMERCIAL   $66,825    0.2%
GENESIS SKYWAY   COMMERCIAL    60,000    0.2%
BBWI MIDWEST FULFILLMENT CENTE   COMMERCIAL    53,510    0.1%
HALLE INDUSTRIAL PORT (A&R)   COMMERCIAL    52,412    0.1%
FEDEX BOYLSTON   COMMERCIAL    51,429    0.1%
56 North Apartments   COMMERCIAL    46,082    0.1%
RESIDENCES AT ROCK RANCH   COMMERCIAL    44,621    0.1%
THE LINX CLUB   COMMERCIAL    44,000    0.1%
GRAND CENTRAL STUDENT APARTMEN   COMMERCIAL    42,801    0.1%
OAK FOREST APARTMENTS   COMMERCIAL    41,000    0.1%

 

(continued)

 

 68 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Supplemental Investment Risk Interrogatories 

December 31, 2025 

(In thousands of dollars)

 

Aggregate mortgage loans have the following loan-to-value ratios as determined from the most recent appraisal as of the audited statement date:

 

Loan-value  Residential   Commercial   Agricultural 
                               
Above 95%  $6,020    0.0%  $-    0.0%  $-    -%
91% to 95%   -    0.0%   196    0.0%   -    -%
81% to 90%   34,925    0.1%   217    0.0%   -    -%
71% to 80%   241,921    0.7%   108,955    0.3%   -    -%
Below 70%   394,438    1.1%   3,504,330    9.5%   -    -%

 

The Company holds investments in real estate of $46,075 or 0% and $25,800 or 0% of total admitted assets for 2025 and 2024, respectively; therefore, detail is not provided.

 

The Company holds investments in mezzanine real estate loans of $86,603 or 0.2% and $96,557 or 0.3% of total admitted assets for 2025 and 2024, respectively; therefore, detail is not provided.

 

Amounts and percentage of the Company's total admitted assets subject to the following types of agreements:

 

               At end of each quarter 
   December 31, 2025   Percentage of total             
   amount   admitted assets   1st Qtr amount   2nd Qtr amount   3rd Qtr amount 
Repurchase agreements  $-    0.0%  $202,045   $431,358   $146,105 
Reverse repurchase agreements   161,000    0.4%   172,218    172,211    161,000 

 

The amounts and percentages of potential exposure (defined as the amount determined in accordance with the NAIC Annual Statement Instructions) for swaps and forwards are as follows:

 

   Owned At end of each quarter 
   December 31, 2025   Percentage of total             
Swaps and forwards  amount   admitted assets   1st Qtr amount   2nd Qtr amount   3rd Qtr amount 
Hedging  $8,099    -%  $2,083   $2,063   $8,215 
Replications   -    -%   -    -    - 
Other   -    -%   -    -    - 

 

The amounts and percentages of potential exposure (defined as the amount determined in accordance with the NAIC Annual Statement Instructions) for futures are as follows:

 

    Owned    At end of each quarter 
    December 31, 2025    Percentage of total                
Futures   amount    admitted assets    1st Qtr amount    2nd Qtr amount    3rd Qtr amount 
Other  $-    -%  $-   $-   $- 

 

See accompanying independent auditors' report

 

 69 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Reinsurance Risk Interrogatories 

December 31, 2025 

(In thousands of dollars)

 

The following information regarding reinsurance contracts is presented to satisfy the disclosure requirements in SSAP No. 61R, Life, Deposit-Type and Accident and Health Reinsurance, which apply to reinsurance contracts entered into, renewed or amended on or after January 1, 1996.

 

1.Has the Company reinsured any risk with any other entity under a reinsurance contract (or multiple contracts with the same reinsurer or its affiliates) that is subject to Appendix A-791, Life and Health Reinsurance Agreements, and includes a provision that limits the reinsurer's assumption of significant risks identified in Appendix A-791?

 

Examples of risk-limiting features include provisions such as a deductible, a loss ratio corridor, a loss cap, an aggregate limit or other provisions that result in similar effects.

Yes  No

 

If yes, indicate the number of reinsurance contracts to which such provisions apply: N/A

 

If yes, indicate if deposit accounting was applied for all contracts subject to Appendix A-791 that limit significant risks.

 

Yes  No  N/A

 

2. Has the Company reinsured any risk with any other entity under a reinsurance contract (or multiple contracts with the same reinsurer or its affiliates) that is not subject to Appendix A-791, for which reinsurance accounting was applied and includes a provision that limits the reinsurer's assumption of risk?

 

Examples of risk-limiting features include provisions such as a deductible, a loss ratio corridor, a loss cap, an aggregate limit or other provisions that result in similar effects.

 

Yes  No

 

If yes, indicate the number of reinsurance contracts to which such provisions apply: N/A

 

If yes, indicate whether the reinsurance credit was reduced for the risk-limiting features.

 

Yes  No  N/A

 

3.Does the Company have any reinsurance contracts (other than reinsurance contracts with a federal or state facility) that contain one or more of the following features which may result in delays in payment in form or in fact:

 

a.Provisions that permit the reporting of losses to be made less frequently than quarterly;

 

b.Provisions that permit settlements to be made less frequently than quarterly;

 

c.Provisions that permit payments due from the reinsurer to not be made in cash within ninety (90) days of the settlement date (unless there is no activity during the period); or

 

d.The existence of payment schedules, accumulating retentions from multiple years, or any features inherently designed to delay timing of the reimbursement to the ceding entity.

 

Yes  No

 

(continued)

 

 70 

 

 

EQUITRUST LIFE INSURANCE COMPANY 

Reinsurance Risk Interrogatories 

December 31, 2025 

(In thousands of dollars)

 

4.Has the Company reflected reinsurance accounting credit for any contracts that are not subject to Appendix A-791 and not yearly renewable term reinsurance, which meet the risk transfer requirements of SSAP No. 61R?

 

    Identify reinsurance Has the insured event(s) triggering  
Type of Contract Response: contract(s): contract coverage been recognized?  
Assumption reinsurance – new for the reporting period Yes   No N/A N/A  
Non-proportional reinsurance, which does not result in significant surplus relief Yes  No N/A Yes  No  N/A  

 

5. Has the Company ceded any risk, which is not subject to Appendix A-791 and not yearly renewable term reinsurance, under any reinsurance contract (or multiple contracts with the same reinsurer or its affiliates) during the period covered by the financial statements, and either:

 

(a) Accounted for that contract as reinsurance under statutory accounting principles (SAP) and as a deposit under generally accepted accounting principles (GAAP); or

Yes  No  N/A

 

(b) Accounted for that contract as reinsurance under GAAP and as a deposit under SAP?

 

Yes  No  N/A

 

If the answer to item (a) or item (b) is yes, include relevant information regarding GAAP to SAP differences from the accounting policy footnote to the audited statutory-basis financial statements to explain why the contract(s) is treated differently for GAAP and SAP below:

 

See accompanying independent auditors' report

 

 71 

 

GRAPHIC 2 tm262349d11_etlicfinimg001.jpg GRAPHIC begin 644 tm262349d11_etlicfinimg001.jpg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end GRAPHIC 3 tm262349d11_etlicfinimg002.jpg GRAPHIC begin 644 tm262349d11_etlicfinimg002.jpg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